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III. ZUSAMMENFASSUNG 
Numb ist ein membrangebundenes Adapterprotein, welches Ähnlichkeiten zu seinem 
cytoplasmatischen Homolog Numblike aufweist. Beide Gene spielen beispielsweise 
eine große Rolle in Gehirn- oder auch Herzentwicklung. Auf molekularer Ebene ist 
Numb in verschiedenste Prozessen involviert, wie z.B. bei Endocytose, Proteasom 
regulierter Proteindegradierung oder auch der Inhibition des Notch Signalwegs. Des 
weiteren spielt Numb auch eine wichtige Rolle bei der Etablierung von Zell-Zell 
Kontakten, sowie epithelialer Polarität. In dieser Studie sollte untersucht werden, ob 
ein Fehlen von Numb und Numlike im Lungenepithel dessen Integrität oder auch 
dessen Regenerationsfähigkeit beeinflusst. Hierzu wurde Numb konditionell und 
lungenepithelspezifisch in Mäusen mit Numblike ablatiertem Hintergrund genetisch 
inaktiviert. Dabei wurde ein durch Doxycyclin induzierbares Inaktivierungssystem 
(SPCrtTA-tet-O-Cre) benutzt, welches die funktionelle Charakterisierung von Numb 
und Numblike im Lungenepithel ermöglicht. Tiere, die einen Verlust der Genaktivität 
von Numb und Numblike im Epithel zeigen, sind lebensfähig und offenbaren 
lediglich schwache morphologische Veränderungen epithelialer Zellen. Diese Zellen 
weisen eine veränderte Lokalisation der Adhärenzkontaktproteine E-Cadherin und ß-
Catenin in der Zellmembran auf. Zudem ist in den Doppelmutanten eine deutliche 
Reduktion von Alveolaren Zellen des Typs II zu verzeichnen. Diese Veränderungen 
deuten auf eine wichtige Funktionen von Numb und Numblike in der Erhaltung von 
epithelialer Integrität sowie Polarität hin. Erstaunlicherweise zeigen doppelmutante 
Tiere eine merklich schwächer ausgeprägte Fibrose nach Behandlung mit Bleomycin. 
Die Tiere weisen eine höhere Überlebensrate auf und zeigen auch sonst verbesserte 
Werte auf molekularer und histologischer Ebene. Besonders auffällig hierbei sind 
Veränderungen des Wnt/ß-Catenin Signalwegs als möglicher Effekt der Numb/ 
Numblike Inaktivierung. Der Fibroseverlauf könnte hierdurch maßgeblich beeinflusst 
und abschwächt sein. Durch die Inaktivierung von Numb und Numblike in der 
lungenepithelailen Zelllinie MLE12 erlangte ich einen tieferen Einblick in veränderte 
molekulare Prozesse und konnte ebenso bereits in vivo ermittelte Ergebisse, wie E-
Cadherin/ß-Catenin Lokalisierung sowie beeinträchtigte Expression von Wnt-
Zielgenen reproduzieren und validieren. Expression von ß-Catenin, ebenso wie die 
seiner Zielgene, konnte hier mittels GSK-3ß Inhibition verbessert werden, was 
weiterhin eine Beeinträchtigung von Wnt/ß-Catenin Signalen in Numb/Numblike 
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defizienten Epithelzellen unterstreicht. Schließlich konnten mit Hilfe von 
massenspektrometrischer Analyse die Kinase CK2 sowie Cortactin, ein F-Aktin 
bindendes Protein, als neue Interaktionspartner von Numb und Numblike identifiziert 
werden. Diese könnten das Mitwirken von Numb in der Ausbildung von Zell-Zell 
Kontakten, sowie deren Stabilisierung, unterstützt durch cytoplasmatisches Numblike, 
erklären.  
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IV. ABSTRACT 
Previously it was shown that the membrane associated adaptor protein Numb and its 
cytosolic mammalian homolog Numblike (Numbl) exert redundant functions during 
neurogenesis and heart development [1-3]. Numb is involved in multiple processes 
such as endosomal trafficking, proteosomal degradation as well as the inhibition of 
Notch signaling [4-9]. Furthermore, Numb is reported to mediate epithelial polarity as 
well as cell-cell adhesion [10]. In this work I want to examine if loss of Numb and 
Numblike has an impact on lung epithelial integrity and its regenerative capacities 
upon lung damage. Therefore, I have generated conditional knockout animals for 
Numb on a Numblike deficient background using the doxycycline inducible SPCrtTA-
tet-O-Cre system, which enables to analyze functions of Numb during pulmonary 
development and regenerative processes after damage of the distal lung epithelium. 
While SPCrtTApos//tetO-Crepos//Numbfl/fl//Numblike-/- mutants (dKO) are viable they 
exhibit a complete loss of Numb in proximal and distal lung epithelium. Concomitant 
lung epithelial ablation of Numb and Numblike causes only mild morphological 
changes of epithelial cells accompanied by a basal-to-apicolateral translocation of E-
Cadherin as well as a mislocalization of ß-Catenin. In addition, adult dKOs show a 
significant decrease in SPC+ Alveolar Type II cell numbers compared to littermate 
control animals (Ctrl). These changes suggest a potential function of Numb/Numblike 
in mediating lung epithelial polarity and integrity. Interestingly, in experimental 
pulmonary fibrosis Numb/Numblike deficient mice show better survival and a 
significant milder fibrotic damage on molecular and histological levels. I revealed 
impaired WNT signaling as a potential secondary effect of Numb/Numblike depletion, 
which might ameliorate disease progression. To further investigate the underlying 
molecular processes, I took advantage of shNumb/shNumblike MLE12 knockdown 
cells, which show mislocalization of E-Cadherin, decreased ß-Catenin levels and 
reduced Wnt target gene expression similar to the in vivo state. In vitro rescue of ß-
Catenin protein levels and relative expression of Wnt targets by GSK-3ß inhibition 
support an involvement of WNT/ß-Catenin signaling. Moreover, I identified Cortactin 
and CK2 as a novel interaction partners of Numb and Numblike mediating cell 
junctional stability in epithelial cells.  
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1 INTRODUCTION 
1.1 The respiratory system 
The mammalian respiratory system mainly consists of the trachea, the lung and the 
vasculature system that pervades throughout the entire lung. It is a highly important 
organ system that serves as a gateway to the oxygen-enriched atmosphere. Hence, the 
main function of this complex and specialized respiratory unit lies in the maintenance 
of a proper gas exchange of oxygen and carbon dioxide between the atmosphere and 
the blood circulation system, which is a fundamental requirement for survival in a 
terrestrial environment. The blood circulation system takes over an important role 
within this process of gas exchange that basically takes place at the boundary of 
respiratory surface and the thin-walled capillary vessels of the lung. It supplies all 
organs and tissues in the body with oxygen that gets absorbed at this boundary where 
it simultaneously releases the carbon dioxide produced by these tissues. Although the 
basic function of this ventilation system works out the same way in all mammals, 
there are slight differences between the structural setup of human and rodent lungs. 
Macroscopically, the human lung is subdivided into two left and three right lobes, 
while the mouse lung is organized in one left and 4 smaller right lobes, the cranial, 
medial, caudal and the accessory lobe. Furthermore, there are also slight differences 
in the composition of the different cell types that sit along the proximo-distal axis of 
the respiratory epithelium, which will be highlighted more detailed in section 1.1.2 
(also see Table 1). In general both respiratory systems can be functionally grouped 
into conducting and respiratory tract. The conducting tract, which anatomically 
comprises nose, nasal cavity, pharynx, larynx, trachea, bronchi and bronchioles, 
serves as a tube system that permits entry and release of gas, removes intruding 
particles as well as pathogens and also warms and humidifies the inhaled air. Further, 
while in humans the branching pattern of the conducting airways proceeds 
symmetrically (dichotomous), mice in contrast exhibit an asymmetrical (monopodial) 
branching of the conducting tract. The respiratory tract is significantly involved in gas 
exchange and anatomically represented by alveolar sacs at the most distal areas in 
mouse lung. The respiratory compartment of human lungs is comprised by the acinus, 
which consists of alveolar sacs that are supplied via alveolar ducts by the respiratory 
bronchioles. Respiratory bronchioles are almost not found or very rare in mice as their 
INTRODUCTION 
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terminal bronchioles directly branch into respiratory units given by the alveoli [11]. 
The table below compares prominent structural differences of both murine and human 
respiratory systems. 
 
 Feature Mouse Human 
Gross Lung lobes 
Airway generations 
Airway branching pattern 
Diameter, main bronchus (mm) 
4 right, 1 left 
13 – 17 
Monopodial 
1 
3 right, 2 left 
17 – 21 
Dichotomous 
10 – 15  
Tissue Diameter, terminal bronchiole (mm) 
Respiratory bronchioles 
Lung parenchyma/ total lung volume (%) 
Alveoli (µm) 
Blood-gas barrier thickness (µm) 
0.01 
None or one 
18 
39 – 80  
0.32 
0.6 
Yes 
12 
200 – 400 
0.62 
Airway epithelial 
cells 
Tracheal epithelium 
- Epithelial thickness (µm) 
- Ciliated cells (%) 
- Clara cells (%) 
- Mucous goblet cells (%) 
- Serous cells (%) 
- Basal cells (%) 
- Other (%) 
Proximal intrapulmonary epithelium 
- Epithelial thickness (µm) 
- Ciliated cells (%) 
- Clara cells (%) 
- Mucous goblet cells (%) 
- Serous cells (%) 
- Basal cells (%) 
- Other (%) 
Terminal bronchioles 
- Epithelial thickness (µm) 
- Ciliated cells (%) 
- Clara cells (%) 
- Mucous goblet cells (%) 
- Serous cells (%) 
- Basal cells (%) 
- Other (%) 
 
11 – 14  
39 
49 
<1 
<1 
10 
1 
 
8 – 17 
28 – 36  
59 – 61 
<1 
<1 
<1 
2 – 14 
 
7 – 8  
20 – 40  
60 – 80  
0 
0 
<1 
0  
 
50 – 100 
49 
- 
9 
<1 
33 
- 
 
40 – 50 
37 
- 
10 
3 
32 
18 
 
Not determined 
52 
- 
- 
35 
<1 
13 
Table 1: Murine and human respiratory systems in comparison. 
Source: Adapted and modified from Treuting, P. M., et al. (2012) [11] as well as Fox (2007) and 
Plopper and Hyde (2008). 
  
1.1.1 Murine lung development 
The morphogenesis of mouse lung proceeds in 5 different stages (Figure 1A), which 
are very similar to those in humans. Solely the time courses of these developmental 
stages differ, as they are more extended in human lung organogenesis. Murine lung 
development starts with the budding of a primitive lung tube derived from the anterior 
foregut endoderm at embryonic day E9.0. The whole developmental process is 
characterized and driven by the onset of a spatial and temporal expression cascade 
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involving different transcription factors and signaling molecules (also depicted in 
Figure 1). 
  
 
Figure 1: Murine lung development. 
A: Schematic overview of the 5 stages of murine lung development including spatial expression of the 
prominently involved signaling molecules like Nkx2.1 (blue, purple), Sox2 (orange), Sox9 and Id2 
(green), see also legend. B: Signaling interactions of ventral anterior mesoderm and anterior foregut 
entoderm. Nkx2.1 expression in epithelial progenitor cells arising from anterior forgut endoderm (blue) 
regulated by Wnt/ß-Catenin and Bmp4 signaling from the mesoderm (orange). Wnt2/2b and ß-Catenin 
signaling positively influence Nkx2.1 expression while Bmp4 signaling represses Nkx2.1 inhibition by 
Sox2. C: Regulation of proximal to distal branching morphogenesis by gradients of distal mesenchymal 
Fgf10 expression (green) which gets restricted by epithelial Shh and Bmp4 signals (purple). Outgrowth 
direction of branching points is further determined by regulation of epithelial Ras/Sprouty expression 
(purple) via Fgf10. Together with epithelial ß1-Integrin expression, which promotes epithelial cell 
polarity, Ras/Sprouty direct the orientation of epithelial cell divisions at the branching points. Figures 
adapted and modified from Herriges, M. and Morrisey, E. E. (2014) [12].  
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Nkx2.1 is one of the first transcription factors that are expressed in the early lung bud 
at day E9.0. Wnt/ß-Catenin signaling promoted by Wnt2/2b expression derived from 
the anterior foregut endoderm surrounding ventral anterior mesoderm positively 
influences Nkx2.1 expression in the resident epithelial progenitors together with Bmp4 
signaling, which represses the Sox2 mediated Nkx2.1 inhibition [13, 14] (Figure 1B). 
During this first stage of lung development, the embryonic stage (E9.5 – E12.5), these 
Nkx2.1 expressing epithelial progenitor cells evaginate ventraly from the foregut 
endoderm, to form a tube, which will later give rise to the trachea. At the distal end of 
this primordial tube the epithelial progenitor cells form two lung buds. Lung epithelial 
specification continues from these buds during the pseudoglandular stage (E12.5 – 
E16.5), which is characterized by complex branching morphogenesis. During this 
branching process both lung buds sprout and expand in a proximo-distal manner into 
the surrounding mesenchyme, forming a tree-like structure with terminal branches. 
Hence, this branching is essential for the later specification of proximal conducting 
airways and the distal respiratory tract. Another transcription factor that plays an 
important role in defining the specific branching points of the outgrowing terminal 
branches is Fgf10 [15]. Fgf10 is expressed by mesenchymal lung tissue that surrounds 
the distal tips of the developing airways. It has been suggested that this expression is 
regulated and restricted by epithelial endoderm derived Bmp4 and Shh signaling [16-
18]. Furthermore, epithelial Ras/Sprouty expression, which is regulated by Fgf10 at 
branching points, directs the orientation of epithelial cell divisions at these sites [19]. 
This is supported by epithelial ß1-Integrin expression, which mediates epithelial cell 
polarity and prevents a multilayered development of the epithelium [20]. These 
signaling interactions between the primitive lung epithelium and the mesenchyme are 
necessary for a further directed branching proceeding during the canalicular stage 
(E16.5 – E17.5) and the following saccular stage (E17.5 – P0). These stages are 
mainly characterized by further specification of the proximal airway tube system, 
prolongation and narrowing of the terminal branches, the arrangement of the distal 
respiratory compartments in epithelial sacs and also vascularization in the lung 
mesenchyme. Finally, lung development ends with the specification of the distal 
epithelial sacs during the stage of alveolarization (P0 – P21). Here, secondary 
septation occurs to further specialize the alveolar structures and the capillary system 
is already closely surrounding the distal respiratory airways to provide a fully 
functional gas exchange together with the maturing alveoli [12, 21].  
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1.1.2 Specification of the murine lung epithelium 
The proper specification of epithelial progenitor cells to a mature and functional lung 
epithelium with its distinct cell types sitting along the proximal-distal axis is first of 
all strongly dependent on the expression of transcription and growth factors in the 
developing endoderm, including Nkx2.1 and Fgf10. As described in the previous 
section, cooperative and reciprocal signaling interactions between mesoderm and 
endoderm initiate and dictate the formation and branching of primitive lung epithelial 
buds. However, it is necessary to direct the emerging branching morphogenesis in a 
specific proximal to distal fashion, which guarantees a proper specification of the 
developing lung epithelium. Therefore, not only signals coming from the distal 
mesoderm, like Fgf10, are sufficient. Also signal gradients within the developing 
endoderm play an important role here. Accordingly, a high Sox2 expression level in 
proximal endodermal progenitor lineages (see also Figure 1A) regulates their 
differentiation to cell types that are characteristic for tracheal and bronchial 
epithelium [22]. In contrast, the branching of distal progenitor lineages is marked by 
co-expression of the transcriptional regulators Sox9 and Id2 (Figure 1A) [23, 24]. 
Lineage tracing experiments have revealed that these Sox9/Id2 double positive distal 
epithelial tip progenitor cells exhibit multipotent capacities promoting differentiation 
to all lung epithelial cell fates up to embryonic stage E13.5 [25]. At later stages their 
fate commitment gets restricted to distal lineages. Moreover, regulatory factors like 
the zinc finger protein Gata6 or proteins of the forkhead box (Fox) family, such as 
Foxa1 and Foxa2, are not only markedly involved in early branching morphogenesis 
but play also important roles in later epithelial specification as well as regeneration 
processes after injury. Though, it has been shown that Gata6 is important for proper 
differentiation of bronchioalveolar stem cells (BASCs) during postnatal stages as well 
as for regeneration by regulating Wnt/ß-Catenin signaling [26]. During early lung 
development Gata6 exhibits a synergistic action together with Nkx2.1 in promoting 
epithelial differentiation [27]. Foxa2, which is expressed at high levels also in the 
primitive foregut endoderm, exhibits strong expression in the proximal epithelium 
during branching morphogenesis. Hence, it inhibits further branching of proximal 
regions and thereby directing the branching progression towards distal parts [28, 29]. 
Furthermore, Foxa1 and Foxa2 jointly promote transcription of genes that are crucial 
for the determination of different epithelial cell lineages in the maturing lung 
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epithelium such as the distal alveolar epithelial type 1 and type 2 cells (ATI and 
ATII), and also the more proximal resident secretory (Clara) cells as well as Ciliated 
cells for example. In general, a more distinct specification of the developing lung 
epithelium starts as previously mentioned with the saccular stage from E17.5 on 
followed by further postnatal maturation and secondary septation of the distal formed 
primitive sacculi during alveolarization progress. Once this last stage of maturation is 
completed, lung epithelium eventually comprises many different specific cell types 
that are distributed in a characteristic pattern along the proximodistal axis. By this 
pattern the mature respiratory epithelium can be subdivided from proximal to distal 
roughly into three sections, the tracheobronchial, intrapulmonary bronchiole and the 
bronchioalveolar region (Figure 2). The bronchioalveolar regions are mainly lined 
with long flat-shaped type 1 cells (ATI) and cuboidal type 2 (ATII) cells. While ATI 
cells are closely attached to the respiratory capillaries and therefore significantly 
facilitate gas exchange, ATII cells are characterized by their surfactant production 
(Sftpc or SP-C), which decreases the alveolar surface tension. Moreover ATII cells 
have been shown to contribute to alveolar homeostasis promoting absorption as well 
as secretion of fluid [30]. Another important feature of ATII cells is their potential to 
proliferate and to self-renew in the steady state and after injury, while ATI cells lack 
this ability [31]. ATI cells are derived from ATII cells during development and also 
after injury and are marked by Aqp5 (Aquaporin 5) and Pdpn (Podoplanin) expression 
[32, 33]. Another source that is claimed to give rise to both proximal bronchiolar and 
distal alveolar cell types are the BASCs that are localized as sparse populations at the 
bronchioalveolar duct junctions and co-express Sftpc and Scgb1a1 [34]. Clara Cells 
belong to the group of secretory cells and are marked by Scgb1a1 (also CC10) 
expression. They line up in higher numbers along the more proximal bronchiolar 
region and represent as well another stem cell population. Clara cells have been 
shown to self-renew over time and they have the potential to give rise to ciliated cells, 
which express Foxj1 as a characteristic marker. Ciliated cells are resident in rather 
proximal regions of the intrapulmonary bronchioles as well as in higher numbers 
along the tracheobronchial region [35]. These and some more characteristic cell types 
of the mature respiratory epithelium are depicted in Figure 2. In line with this, Table 2 
lists a summary of all the epithelial cells together with their specific markers, 
localization and special functions and features. 
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Figure 2: Proximodistal cell type pattern of the mature murine respiratory system. 
Tracheobronchial region of the lung epithelium (a). This segment is marked by a pseudostratified 
epithelium consisting of basal, some individual neuroendocrine, ciliated (higher abundance) and Clara 
cells. The columnar epithelial segment of the intrapulmonary bronchioles (b) is characterized by a 
higher abundance of Clara and a lower amount of ciliated cells, a sparse distribution of goblet cells and 
clusters of neuroepithelial bodies (NEBs). The most distal segment comprising the alveoli (c) is lined 
by long and flat-shaped ATI and cuboidal ATII cells. In the region of the alveolar duct junction there 
are few Clara cells and a sparse BASC population. Figure adapted and modified from Rock, J. R. and 
Hogan, B. L. (2011) [36]. 
 
Cell type Marker Location Features 
ATI cell Aqp5,  
Cftr,  
Pdpn 
distal, alveoli 
 
long, flat-shaped or squamous, gas exchange, 
alveolar fluid homeostasis, about 95 % of the lung 
surface area 
ATII cell Sftpc distal, “corners” of 
alveoli 
cuboidal, SP-C production to reduce surface 
tension and for host defense, alveolar fluid 
homeostasis, self-renewal, differentiation to ATI 
BASC Sftpc, 
Scgb1a1 
alveolar duct junction columnar, self-renewal, contribution to 
bronchiolar and alveolar lineages, tissue stem cell 
Clara cell Scgb1a1 proximal, high 
intralobar bronchiole, 
lower tracheal/ 
bronchi abundance 
columnar, secretory cell, secretoglobin production, 
contribute to mucociliary clearance of 
microorganisms and particles, self-renewal, can 
differentiate to Ciliated cells, tissue stem cell 
Ciliated cell Foxj1 Proximal, high in 
trachea/bronchi, 
lower intralobar 
bronchiole abundance 
columnar and apically multiciliated, contribute to 
mucociliary clearance of microorganisms and 
particulates 
Basal cell Trp63, 
Krt5, 
Krt14 
proximal, trachea and 
bronchi, as separate 
layer attached to the 
basal lamina 
desmosomal and hemidesmosomal attachments, 
structural functions [37], self-renewal, tissue stem 
cell pool, differentiation to ciliated and secretory 
lineages [38, 39] 
Goblet cell Scgb1a1, 
Spdef, 
Muc5ac 
proximal, sparse, 
intralobar bronchioles 
columnar, mucus production, involved in 
obstructive lung diseases [40] 
Neuro- 
endocrine  
cell 
Calca, 
CGRP, 
Ascl1 
proximal, 
individually in 
trachea/bronchi,  
as clusters in 
bronchioles 
columnar, sensing stimuli in the airway lumen 
(hypoxia, nicotine), secretory, production of 
serotonin, calcitonin and bombesin, influence of 
epithelial cells, immune function or air/blood flow 
[41], clustering in neuroepithelial bodies (NEBs) 
Table 2: Cell types of the mature respiratory epithelium and their features. 
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1.1.3 Wnt/ß-Catenin signaling during lung epithelial development 
The following section will provide an overview of canonical Wnt/ß-Catenin signaling 
and its implication in lung epithelial development. Canonical Wnt signaling involves 
the molecule ß-Catenin, which is associated to cadherin-mediated cell adhesion, as a 
transmitter of signals that are relevant for development and regeneration [42, 43]. The 
general mechanism of Wnt/ß-Catenin signaling is shown in Figure 3.  
 
 
Figure 3: Wnt/ß-Catenin signaling pathway. 
Absence of a Wnt ligand: ß-Catenin levels are kept low through its interaction with the destruction 
complex consisting of APC and Axin as well as the kinases CK1α, GSK3ß, which mediate subsequent 
phosphorylation of ß-Catenin leading to its proteosomal degradation initiated by the E3 ubiquitin ligase 
component ß-TrCP. This prevents the interaction of ß-Catenin with the transcription factors LEF1 and 
TCF in the nucleus. In the presence of Wnt ligands a receptor complex of Frizzled (Fzd) and LRP5/6 
forms by recruiting Dishevelled (Dsh) to the intracellular domain of phosphorylated LRP5/6, which is 
promoted by CK1γ and GSK3ß. Subsequently, this leads to interaction of Dsh with Fzd and 
polymerisation with other Dsh molecules. Thereby, Axin gets recruited to the phosphorylated LRP5/6 
receptor resulting in a destabilization of the ß-Catenin destruction complex and a cytoplasmic 
accumulation of ß-Catenin. Eventually, translocation of ß-Catenin into the nucleus, replacement of 
Groucho as well as interaction with TCF/LEF and additional co-factors (Bcl9, CBP, Pygo) drives the 
expression of downstream targets. Figure adapted from Heuberger, J. and Birchmeier, W. (2010) [43]. 
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In the absence of Wnt ligands the cytosolic ß-Catenin levels are kept low through its 
enhanced proteasomal degradation, promoted by CK1α and GSK3ß mediated 
phosphorylation of ß-Catenin in the Axin/APC destruction complex. However, the 
binding of Wnt ligands to Frizzled (Fzd), a seven transmembrane receptor, initiates its 
heterodimerization with the Lrp5/6 transmembrane receptor. This receptor complex 
further interacts with Dishevelled (Dsh) at the intracellular part, which promotes 
phosphorylation of Lrp5/6 by GSK3ß, CK1γ and other kinases. Hence, Axin gets 
recruited to the intracellular domain of the phosphorylated LRP5/6 receptor thereby 
leading to a destabilization of the destruction complex followed by an accumulation 
of ß-Catenin in the cytoplasm. The cytoplasmic ß-Catenin eventually translocates to 
the nucleus where it binds together with other co-factors like Bcl9, Pygo or CBP to 
the transcription factors TCF/LEF. Ultimately, these interactions lead to the 
transcriptional activation of Wnt/ß-Catenin downstream targets by replacing the 
Groucho repressors. As described in the previous section it has been shown that 
Wnt/ß-Catenin signaling plays a fundamental role during lung development. Besides 
the fact, that mesodermal derived Wnt signals (Wnt2/2b) have a direct impact on 
Nkx2.1 expression in the lung epithelium marking the early lung budding, Wnt/ß-
Catenin signaling is an important signaling pathway throughout entire lung epithelial 
development. Wnt-reporter lines like TOPGAL and BATGAL revealed a ß-Catenin 
expression pattern emerging in epithelial precursors of the early endodermal tube and 
lung buds from embryonic day E9.5 on, which is maintained during early lung 
branching [44, 45]. While the lack of ß-Catenin in the developing proximal 
respiratory epithelium has no effect on the structural specification of the lung, an 
early ß-Catenin inactivation in the distal epithelium impairs normal distal epithelial 
development characterized by a loss of Sftpc expression and a simultaneous 
proximalization of lung epithelium [46, 47]. These data revealed a notable importance 
for Wnt/ß-Catenin signaling in proximal-distal patterning and specification of distal 
respiratory epithelium.  
1.2 Lung diseases and regeneration 
In order to analyze the response of a certain tissue to its damage it is important to 
keep in mind that all tissues differ in their capability to self-renew senescent or 
injured cells. Some tissues like intestine, skin or the hematopoietic system exhibit a 
high potential of repair and renewal with a constant turnover of their cells already 
INTRODUCTION 
 21 
during adult homeostasis due to their well-defined setting of stem/progenitor cells. 
Other organ systems like heart or brain are marked by quiescence during adulthood 
and show only poor response to tissue damage. The lung resembles a quiescent tissue 
system with a very slow cellular turnover during adult stages but contains, as already 
described in the previous sections, several cell populations along its proximal-distal 
epithelial axis that retained tissue stem cell characteristics. Intriguingly, these various 
stem/progenitor cell niches of the tracheobronchial (basal stem cells), intrapulmonary 
bronchiolar (clara stem cells) or alveolar region (BASCs and ATII cells) are not only 
capable to contribute to regeneration of local injury as recent studies also report about 
the existence of stem/progenitor cells that migrate to distant areas of damaged tissue. 
Trp63/Krt5 positive basal cells are able to migrate from the area of their origin in the 
tracheobronchial niche to distal alveolar regions to repopulate damaged ATI and ATII 
cells, after injury through H1N1 influenza virus infection [48]. These features 
eventually enable the lung to respond with robust regeneration to injury and disease. 
During the process of repair both activation of different progenitor cell niches and 
replacement of damaged tissue by proliferating undamaged cells is required [25, 39, 
49, 50]. Overall, respiratory diseases are characterized by their pathological changes 
in the cellular composition and physiological functions of the airway epithelium. 
These epithelial abnormalities usually marked by loss of damaged cells, expansion 
and migration of surviving epithelial cells, hyperplasia, altered proliferation or 
impaired differentiation, might directly disturb lung function [51]. Airway 
obstructions caused by an increased mucus secretion of hyperplastic secretory cells, 
squamous metaplasia, dysplasia or malignant transformation, can be the result of 
these pathological alterations in the epithelium. Mutually, thickening of the basal 
lamina, smooth muscle hyperplasia, fibrosis and chronic inflammation account for 
mesenchymal lung perturbations. Combinations of these changes are commonly 
found in human lung diseases like chronic asthma, cystic fibrosis, chronic obstructive 
pulmonary disease (COPD) or cancer. In order to study the molecular pathways and 
mechanisms that are relevant for tissue regeneration and which drive these processes 
of pathologic remodeling after damage or during disease, a variety of different mouse 
injury models have been established. Ideally, a mouse model should mimic the 
pathological state of a human disease as close as possible. Gained insights in the 
occurring physiological and pathological changes can thereby ultimately be translated 
for therapeutic purposes. The robust reproducibility of an injury phenotype as well as 
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the simplicity to induce it resemble as well quite important criteria considering the 
application of a murine injury model. Induction of pulmonary fibrosis in mice is a 
good example for such kind of injury models that combine all these features to study 
idiopathic pulmonary disease (IPF). The following sections will provide a more 
detailed overview about this murine lung injury model as well as its importance for a 
better understanding of IPF.         
1.2.1 IPF and a murine fibrosis model 
Idiopathic pulmonary disease (IPF) is a rare human disease with severe features of a 
progressive lung structure disruption by fibrotic scars causing stiffness and the loss of 
its physiological function in providing a proper gas exchange. About 5 million people 
worldwide are affected, while incidents tend to increase [52]. The prevalence of this 
disease is about 20 per 100000 people for men and 13 per 100000 people for women 
[53] showing an average outbreak of the disease at an age greater than 50. Causes for 
this interstitial lung disease are still poorly defined but it is currently believed that 
cigarette smoke, exposure to certain dust particulates like metal, silica or wood belong 
to the potential risk factors [54, 55]. The chance of genetic transmission is existent but 
low [56]. Currently there are no effective medical treatments available to cure this 
disease. Hence, the necessity of using appropriate animal models to study the cellular 
sources and mechanisms that contribute to the progression of IPF gained increased 
importance. Therefor, various animal models of lung fibrosis have been established 
and characterized, which resulted so far in the identification of pathologically affected 
cellular targets, molecular pathways and processes that might be crucial as well in 
human disease. Although there is still some controversy, three cell sources have been 
suggested as potential fibrogenic populations, namely intrapulmonary fibroblasts or 
pericytes, bone marrow-derived stem cells and alveolar epithelial cells [57-60]. 
However, recent studies strongly propose alveolar epithelial cells as the most likely 
source triggering fibrogenesis. In this respect it is believed that abnormally activated 
ATII cells might either directly generate myofibroblasts via the process of epithelial 
to mesenchymal transition (EMT) [61] or stimulate and activate resident fibroblasts 
by secretion of signaling molecules mediating their differentiation to profibrotic 
myofibroblasts [62]. Thus, after their formation in fibrotic foci activated 
myofibroblasts promote scarring and disruption of lung architecture by their enhanced 
production and deposition of extracellular matrix proteins, like collagens or matrix 
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metalloproteinases. In order to induce pulmonary fibrosis in mice the usage of several 
different approaches evolved like for example the application of inorganic particles 
(silica) [63], FITC instillation [64], exposure to irradiation [65], gene overexpression 
models (TGFß) [66, 67], H1N1 influenza virus infection [48] or administration of 
bleomycin [68, 69]. The bleomycin injury model is the most extensively used animal 
model to induce pulmonary fibrosis. Bleomycin, originally a chemotherapeutic drug, 
is easy accessible and its application is relatively simple. The most common way to 
administer this profibrotic agent is its pharyngeo- or intra-tracheal instillation. This 
leads to the development of bronchiolocentric accentuated fibrotic changes, similarly 
found in human disease [70], over a time frame of only 14 to 28 days. Intravenous or 
intraperitoneal application is as well possible but results only in subpleural scarring. 
In detail, intra-tracheal induced bleomycin injury is characterized by acute interstitial 
and intra-alveolar inflammation, enhanced accumulation of neutrophils and activated 
macrophages, epithelial cell damage with consequent hyperplasia, disruption of the 
basement membrane as well as upregulation of cytokines like TNF-alpha, IL-6, IL-8, 
TGF-ß and CTGF [69, 71]. Thereby, the bleomycin animal model closely mimics 
several pathologic features that are reproducible, consistent and can also be observed 
in IPF. Despite its dose dependent reversibility, which is inconsistent with human 
disease, the bleomycin animal model provides a highly beneficial system to study 
injury responses and progression of pulmonary fibrosis in regard to discover medical 
treatments for this devastating disease. 
1.2.2 Signaling pathways in pulmonary fibrosis 
Molecular signaling and communication between cells of the same or different tissues 
is not only important during development but also plays a crucial role in regeneration 
and repair. Signaling pathways that play an important role during lung development 
have been studied and well characterized over the past decades. These studies further 
provided considerable evidences delineating a deregulation of some embryonic 
pathways in lung disease or injury by using animal models. Thereby, these indications 
strongly suggest a fundamental role of reactivated developmental programs during 
processes of tissue remodeling or repair following abnormal stimulation. Wnt/ß-
Catenin pathway marks one of the signaling pathways that is essential for early lung 
morphogenesis and specification, as described above, but gets reactivated again 
during the progression of pulmonary fibrosis. IPF patients for example exhibit an 
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enhanced expression of diverse members of the Wnt/ß-Catenin pathway like secreted 
Wnt ligands (Wnt1, 7b, 10b), Frizzled receptors (Fzd2, 3), ß-Catenin or Lef1 [72]. The 
increased expression of those components has been localized to alveolar epithelial 
cells. Simultaneous upregulation of Wnt target gene expression additionally suggests 
functional signaling leading to hyperproliferation of epithelial cells. Moreover, a 
pronounced secretion of Wnt ligands derived from these aberrant ATII cells results in 
the stimulation and activation of myofibroblasts, which respond with an excessive 
extracellular matrix deposition [72-74]. These phenotypic observations can be 
similarly achieved in bleomycin treated mice [62]. Another critical pathway, which 
triggers pulmonary fibrosis, is represented by TGFß signaling. Several studies, 
including TGFß overexpression models [66, 67], revealed its significant contribution 
to the progression of this disease. These studies indicate that TGFß acts as an 
important cytokine, which is able to induce migration, proliferation and 
differentiation of mesenchymal cells like fibroblasts by regulation and activation of 
additional cytokines, including platelet-derived growth factor (PDGF), tumor necrosis 
factor alpha (TNF-alpha), fibroblast growth factor (FGF), epidermal growth factor 
(EGF) or endothelin-1 [75]. TGFß thereby acts as a chemotactic factor secreted by 
alveolar epithelial cells to mobilize resident fibroblasts and to induce their 
differentiation to myofibroblasts as well as the production of matrix proteins [71]. 
Further studies provide evidence that epithelial cells not only stimulate myofibroblast 
differentiation and their matrix protein deposition but also might contribute directly to 
the expansion of a myofibroblast population by EMT [76]. This process is described 
by the transformation of epithelial cells to cells that acquire mesenchymal properties 
characterized by enhanced motility and interstitial matrix production. EMT is mainly 
induced and driven by TGFß-signaling involving key regulators such as Snai1, 2 and 
Twist. Both factors are upregulated in IPF affected lungs especially in hyperplastic 
ATII cells [77-79]. Last not least, there are yet other signaling molecules that have 
been implicated in IPF, namely sonic hedgehog (Shh) and phosphatase and tensin 
homologue (Pten). Similar to TGFß, Shh represents an important mediator of early 
branching morphogenesis in lung. However, it has been shown that under disease 
conditions, e.g. IPF, Shh expression was upregulated especially in epithelial cells 
located in areas of fibrotic foci while its receptor Patched 1 is highly abundant in 
infiltrating immune cells [80]. This suggests a communication of the aberrant 
epithelial cells with the immune system during pulmonary remodeling processes of 
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damaged lung tissue. Pten on the other hand, as a regulator of cell polarity, 
proliferation and apoptosis [81], displays an attenuated expression in myofibroblasts 
that accumulate in fibrotic foci of IPF lungs. It is suggested that this circumstance 
explains an increased resistance of myofibroblasts to apoptosis. Furthermore, in vitro 
studies demonstrated that Pten inhibits myofibroblast differentiation, which is an 
important feature of fibrogenesis [82]. In summary, a better understanding of such 
deregulated developmental signaling pathways during damage induced tissue 
remodeling, remains an important issue concerning the development of more efficient 
medical therapies or drugs. However, there are recent studies that have already 
successfully identified potential therapeutic targets of the disease involved signaling 
pathways promising an amelioration of pulmonary fibrosis such as the Wnt signaling 
downstream target Wisp1 (Wnt1-inducible signaling protein 1). Animal models of 
bleomycin induced pulmonary fibrosis as well as in vitro studies have shown that 
Wisp1, which is extensively secreted by ATII cells during fibrosis, induces ATII cell 
hyperplasia as well as activation of myofibroblasts and their matrix production in a 
paracrine manner [62]. Hence, targeting Wisp1 attenuates the fibrotic phenotype and 
might serve as a therapeutic target. 
1.3 Controlling gene activity via inducible Cre-loxP systems 
The identification of the Cre-loxP recombination system considerably revolutionized 
the control and modulation of gene activity in different eukaryotic model systems [83-
85]. In order to use this system in various experimental approaches it was increasingly 
refined over the past decades and thus became indispensable for modern genetics. 
However, especially the functional characterization of genes that are relevant during 
the development of an advanced model organism like the mouse promoted the need 
for more specialized approaches. The generation of loxP site-specific recombination 
systems allowing conditional regulation of in vivo gene expression (activation or 
inactivation) was achieved by driving the Cre gene expression under the control of 
tissue-specific promoters. This enables a tissue restricted gene recombination during 
embryo- or organogenesis in order to prevent embryonic lethality and to study tissue-
specific gene functions at later developmental stages. Though, the control of gene 
modulation underlies the temporal and spatial expression pattern of the corresponding 
developmentally regulated and tissue-specific promoter mediating an irreversible Cre-
recombination induced loss or gain of gene function. Hence, tissue-specific inducible 
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recombination systems were designed to govern reversibility of genetic modifications 
at any desired time point. Thereby it is beneficial to develop a regulatory system, 
which creates no off-target effects, can be efficiently induced in all cells, guarantees a 
low basal but high induced expression levels and is easy to establish in vivo. One of 
these inducible recombination systems, which fulfill all these beneficial criteria, is the 
bacterial tetracycline-dependent regulatory system. While this system was slightly 
modified for eukaryotic organisms, the original role and function of the tetracycline-
system (Tet-system) in bacteria (Escherichia coli) is the regulation of their antibiotic 
resistance against tetracycline (Tet) [86]. In the absence of Tet, a Tet-repressor 
protein TetR is expressed. TetR binds to its operator in the promoter region of the 
Tn10-specified tetracycline-resistance operon (tetO), which consequently leads to the 
limitation of its own expression and the transcriptional repression of the Tet-
resistance gene (tetRes) (Figure 4A). In the presence of Tet, which easily penetrates the 
bacteria or cells by passive diffusion [87], Tet interacts with TetR mediating its 
conformational change. This structural change of the regulatory element leads to a 
loss of binding affinity for tetO, which results in the expression of the resistance 
protein. In order to improve this basic system a tet-controlled transactivator (tTA), 
which comprises the tetR fused with the C-terminal domain of the virion protein 16 
(VP16) derived from herpes simplex virus [88], was generated. VP16 is a strong 
transcriptional activator of viral genes and thereby enables the tTA fusion protein to 
effectively stimulate minimal promoters (TATA-box) that can be combined with tetO 
sequences, in total representing the tetracycline responsive element (TRE). Their 
silenced activity at low Tet concentrations (Tet-Off), which prevents transactivation 
of the repressed genes downstream of the tetO sequences by tTA, is a clear advantage 
of this TRE system. Together, the specificity of tetR for its operator [86], the high 
affinity of tetracycline for tetR [89] combined with the high transactivation potential 
mediated by the tTA-VP16 fusion protein [90], creates the basis for a highly efficient 
inducible recombination system. Hence, this system allows the temporal and spatial 
regulation of gene inactivation or overexpression in all tissues by application or 
withdrawal of the tetracycline derivate doxycycline (Dox). An alternative system that 
requires Dox for the activation of the Tet-repressor protein promoting its binding to 
the TRE is provided by the mutated version of tTA, which was also found in 
Escherichia coli. This reverse Tet-dependent transactivator (rtTA), fused with the 
VP16 domain, finally enabled the generation of a Dox inducible system, which can be 
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activated upon administration of Dox (Tet-On, Figure 4B) [90]. In combination with 
Cre/loxP, this system offers a powerful tool to induce and activate Cre mediated 
recombination of a floxed target gene, which we also attempted in this study.  
  
 
Figure 4: Tetracycline dependent gene regulatory systems. 
A: Procaryotic tetracyclin-dependent regulatory system (E. coli). Tet-system is silenced in the absence 
of Tet. TetR (blue) interacts with Tet-operator (tetO) sequence (orange) repressing the tetRes gene 
(green) and limits also its own expression. In presence of Tet (red), TetR binding to tetO is abolished 
due to conformational changes. Consequently, the Tet-resistance gene (tetRes) expression is switched on 
and promotes bacterial resistance against Tet. B: Eucaryotic doxycycline inducible Tet-On and –OFF 
system. In the Tet-ON system the default state is a repression of the gene of interest (GoI, red), due to 
the inactive form of rtTA (grey), a fusion protein of mutated TetR and VP16 (magenta). Upon 
application of Dox rtTA gets activated, binds to the TRE (tetO & minimal promoter i.e. TATA, yellow) 
and drives GoI expression. The vice versa model Tet-OFF is permanently switched on as default state. 
To repress the system it is necessary to apply Dox in order to induce inactivation of the tTA 
transactivator and consequently inhibition of GoI expression. 
 
However, this system provides the major advantage of reversibility compared to the 
conditional alteration of gene expression mediated via constitutive Cre/loxP systems 
or analog also Flp-FRT, another site-directed recombination technology [91]. The use 
of inducible systems emerged tremendously and remains till today a versatile method 
not only to generate genetic knockout or overexpression models but also to study 
stem/progenitor cell fate relations during normal and pathological development. The 
discovery of the Rosa26 locus in mice by Philippe Soriano in 1991 [92] allowed to 
generate reporter mouse strains by the insertion of specific reporter genes like GFP, 
YFP or LacZ into this locus flanked by stop-flox sites that enable an activation of 
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reporter gene expression only after Cre-expression and recombination. Thereby, the 
joint application of Cre-expressing systems together with reporter gene mouse lines, 
like Rosa26-Stopflox-LacZ or Rosa26-Stopflox-eYFP permits the visualization of Cre 
mediated recombination activity in cells. Thus, especially doxycycline induced Cre-
reporter gene expression provides an eclectic tool to investigate tissue-specific lineage 
and cell fate origins in developing or regenerating tissues. Such lineage tracing 
experiments have been extensively studied in different tissues so far, including lung. 
As mentioned above, lineage tracing studies thereby revealed novel stem/progenitor 
cell pools that are relevant during lung epithelial specification as well as after lung 
injury using the Tet-system under the control of lung epithelial specific promoters like 
SPC or CC10 (SPC-rtTA, CCSPrtTA [93]). Hence, the identification of different cell 
type specific markers is essential in order to design Cre-recombination systems that 
exhibit restricted tissue specificity. Taken together, inducible Cre-loxP systems are 
indispensable whenever a higher resolution in the temporal-spatial control of gene 
activity is needed. 
1.4 Numb and Numblike – multifunctional proteins 
The multifunctional protein Numb was originally discovered in Drosophila Numb 
mutants, which display changes in the establishment of cell identities derived from 
sensory organ precursors [1]. Thus, it has been suggested that Numb plays a critical 
role in cell fate determination during development of sensory neurons in the 
peripheral nervous system of Drosophila. The membrane-associated protein Numb 
has further been shown to localize in an asymmetrical manner as a cortical crescent to 
one pole of a dividing sensory organ precursor cell [94, 95]. Hence, during this 
process of asymmetric cell division Numb gets segregated to the developing daughter 
cell, where it further promotes cell fate decisions via an interaction and inhibition of 
Notch-signaling cascade [96]. The evolutionary conserved Numb has two mammalian 
homologs, namely Numb and its cytosolic homolog Numblike [97, 98]. Mammalian 
Numb, which exhibits closely related cellular functions to Drosophila Numb, however 
displays much more versatility in mammals. This will be highlighted more detailed in 
the following sections. 
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1.4.1 Structural features of Numb and Numblike 
Both, mouse and human Numb and Numblike share a high similarity in their protein 
structures. Numb has four different biological active isoforms that are derived from 
four alternatively spliced transcript variants, which differ in the sequences encoding 
for protein domains of two major binding sites of the Numb protein (Figure 5) [99, 
100]. One of the alternative peptide sequences is located in the N-terminal phospho-
tyrosine-binding domain (PTB) comprising an 11 amino acid insert that is present in 
Numb isoform 1 and 2 (Numb1 and 2) and absent in isoform 3 and 4 (Numb3 and 4). 
 
 
Figure 5: Structural features of Numb and Numblike. 
Mammalian Numb is encoded by four alternatively spliced transcript variants. Each of the protein 
isoforms have an N-terminal phospho-tyrosine binding domain (PTB, red) and a C-terminal proline-
rich region (PRR, grey). Numb3 and 4 lack 11 amino acids in their PTB domain, which are included in 
Numb1 and 2 (black). The N-terminal PRR domain of Numb2 and 4 are missing 48 amino acids that 
are included in Numb1 and 3. This results in four different protein isoforms of a molecular mass 
between 65 and 72 kDa. Moreover, all isoforms are characterized by C-terminal located DPF and NPF 
motivs. Numblike is structurally highly similar to Numb1 isoform but lacks the PRR domain in the C-
terminus while it contains a repeat of 15 glutamines. Furthermore, Numblike also includes DPF and 
NPF motivs. The length of each protein is depicted by the number of amino acids (aa). 
 
Correspondingly, the isoforms that contain the PTB insert are exclusively membrane-
associated, while those without the insert localize in the cytoplasm. The second 
alternative peptide sequence spans 48 amino acids of the C-terminally located proline-
rich region (PRR) that is present in Numb1 and 3 or missing in Numb2 and 4. 
Furthermore, all Numb isoforms contain Eps15 (EH) homology domains (DPF and 
NPF), which enroll Numb in endocytic functions [101, 102]. Mammalian Numblike 
on the other hand shows a strong sequence similarity to mammalian Numb and to a 
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smaller magnitude also to Drosophila Numb [98]. Like Numb it contains a N-terminal 
PTB-domain but lacks the C-terminal PRR-domain. Moreover, Numblike contains a 
poly-glutamine stretch in its C-terminal region, which is missing in all four Numb 
isoforms. Besides this, its subcellular localization is restricted exclusively to the 
cytoplasm, where Numblike is homogenously distributed. Although, its functions 
have been less well characterized yet, Numblike is believed to partially mimic the 
functions of Numb, according to its high structural similarity to Numb1, but it might 
likely inherit distinct functions in the cytosol as well. However, specific subcellular 
localization and structural features given by the interaction domains of the different 
isoforms enable Numb to interact with a broad spectrum of proteins serving as an 
adaptor protein involved in divers cellular functions. 
1.4.2 Functional features of Numb and Numblike 
As already mentioned previously Numb has originally been identified in Drosophila, 
where it exerts Notch-signaling inhibition during cell fate determination of sensory 
organ precursors. In brief, Notch proteins (Notch1-4) are transmembrane receptors 
presenting their extracellular domain to their ligands Delta-like (Dll1-4) or Jagged 
(Jag1, 2), which are expressed by neighboring signal sending cells. Upon binding of 
the ligand to the Notch extracellular domain cleavage of the Notch intracellular 
domain (NICD), mediated by γ-secretase, occurs leading to the translocation of NICD 
to the nucleus where it binds to CSL (RBPJκ) and promotes expression of Notch-
signaling target genes like the hes or hey family [103, 104].  Similar to Drosophila 
Numb, mammalian Numb can directly interact with NICD. Through additional 
recruitment of the E3-ubiquitin ligase Itch, which thereby interacts with the PTB 
domain of Numb, polyubiquitination of NICD is mediated initiating its consequent 
degradation by the proteasome. Hence, translocation of NICD to the nucleus is 
abolished leading to the inhibition of canonical Notch signaling [6]. At this juncture, 
the involvement of Numb in endosomal trafficking plays a crucial role in controlling 
the internalization of the Notch receptor, thus contributing to a suppression of signal 
transduction [5]. It has been shown that Numb interacts with α-Adaptin, Eps15 or 
EHD, components of the Clathrin mediated endosomal trafficking machinery, via the 
DPF and NPF domains. Thereby Numb regulates membrane-tethered receptors like 
Notch by recruiting them into early endosomal vesicles followed by either their 
recycling and reorganization to the cell surface or their degradation [5, 102]. The 
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interaction between Numb and Itch has furthermore been reported to mediate 
proteasomal degradation of Notch receptors as well as Gli1, which is a transcription 
factor acting downstream of Hedgehog-signaling [105, 106]. The Hedgehog pathway, 
an important regulator of tissue development, plays a fundamental role also during 
self-renewal of neural progenitor cells and their physiological maintenance [106]. The 
proteasome-dependent degradation of Gli1 initiated by Numb/Itch association results 
in the inhibition of Hedgehog signals, which in turn promotes the differentiation of 
neural stem cells. This further emphasizes Numbs function as a cell fate determinant. 
Besides its interaction with the E3-ubiquitin ligase Itch, Numb has also been shown to 
associate with other E3 ligases like LNX, Siah-1 or Mdm2 via the PTB domain [8, 
107, 108]. These E3 ligases directly mediate the polyubiquitination of Numb itself 
and thereby regulate its abundance promoting degradation of Numb by the 
proteasome. By Numb binding to Mdm2, which is simultaneously regulating the 
levels of the tumor suppressor p53, furthermore has a stabilizing effect on p53 [109]. 
Finally, Numb has also been reported in mediating cell migration and adhesion. Both 
of these processes are closely related since trafficking and redistribution of adhesion 
molecules like integrins is necessary for the action of cell migration. Numb has 
thereby been implicated in directing the endocytic trafficking of directly associated 
Integrin-ß to membrane protrusions at the leading edge of the cell, where it is 
fundamental for the progression of cell movement [110]. This process is further 
regulated by the phosphorylation of Numb through atypical protein kinase C (aPKC), 
which promotes its release from Integrin-ß and clathrin-coated sites at the protrusions. 
Moreover, Numb as well as Numblike have been shown to mediate and maintain 
adherens junctions and cell polarity in neural stem cells and in epithelial cells [10, 
111]. In this respect, Numb binds directly with E-Cadherin via the PTB domain to 
stabilize the adherens junctional complex at the lateral part of the cells. Besides the 
interaction with E-Cadherin, it has been shown that Numb interacts with Par3 of the 
polarity complex Par3-aPKC-Par6, which additionally promotes maintenance of cell-
cell contacts as well as polarity of epithelial cells [10]. At this juncture, cell contacts 
and polarity can be negatively regulated by Src tyrosine kinase or HGF stimulation, 
which destabilize Numb interaction with E-Cadherin and Par3, likely mediating EMT 
[10]. In addition to this, it has been shown that a loss of Numb in epithelial cells 
results in mislocalization of E-Cadherin and ß-Catenin from baso-lateral to apical 
domains, which consequently causes disruption of the adherens junctional complex 
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[10]. In vivo studies of epicardial development in mice revealed similar results 
showing that vice versa epicardial specific depletion of ß-Catenin results in disruption 
of adherens junctions as well accompanied by mislocalization of Numb and 
randomization of mitotic spindle orientation within epicardial cells [112]. Mice that 
lack both Numb and Numblike in epicardial cells also show a randomized orientation 
of mitotic spindle [112]. Regardless of Numb potential to interfere with the Notch-
signaling cascade [98, 113] and its contribution to cell adhesion and polarity 
maintenance [111, 112], Numblike functions still remain, unlike those of its homolog 
Numb, less well studied. However, there is some data suggesting that Numblike, 
differently from Numb, does not exert stabilizing and enhancing effects on p53. In 
addition to this observation Numblike rather potentiates downstream signaling of Shh 
(sonic hedgehog) than reducing it, resulting in an advanced expression of 
pluripotency markers like Sox2 or Oct4 in embryonic stem cells [113]. Moreover, 
Numblike is similar to Numb (see following section) involved in tumorigenesis. 
There are studies, which revealed an increased expression of Numblike in divers 
human tumors including lung cancer [114]. This Numblike overexpression is related 
to a loss of the tumor suppressor miR-296, a micro-RNA that directly inhibits 
translation of Numblike. During cancer progression Numblike thereby maintains 
together with Klf4 signaling a pool of cancer progenitor cells. However, this data only 
suggested correlations of Numblike expression with tumorigenesis but does not yet 
explain specific and mechanistic functions of the Numblike protein in this process so 
far. In summary, all these findings underline once more the homologies of both Numb 
and Numblike but highlight as well that they potentially inherit distinct and specific 
functions. 
1.4.3 Numb and Numblike during development and disease 
The roles of Numb and Numblike have been well described during neurogenesis in 
Drosophila and also mammals. Both have been implicated as cell fate determinants of 
neuronal progenitor cells, regulating their differentiation [97, 98]. However, both 
genes are widely expressed also in other tissues during development and adulthood 
implicating that their purpose is not restricted to the development of the nervous 
system [97, 115]. Moreover, the different isoforms of Numb (isoform 1 – 4) seem to 
play distinct roles at different developmental stages. The long isoforms Numb1 and 3, 
containing the 48 amino acid insert in their PRR-domain, are expressed early during 
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neural development between E7 and E10, emphasizing their role rather in controlling 
proliferation. The shorter isoforms Numb2 and 4 on the other hand are expressed 
during all developmental stages and also in mature brain, suggesting their importance 
for differentiation [99, 100, 116]. Total gene inactivation studies demonstrate that 
Numblike depleted mice are viable and don’t exhibit any severe defects except an 
infertility of homozygous mutant females. Homozygous loss-of-function mutants for 
Numb in contrast are embryonic lethal and die at stage E11.5. These animals reveal 
prominent defects in cranial neural tube closure and precocious neuron production in 
the forebrain at this stage [117]. However, the cause of their lethality is most likely 
the result of vascular defects, since the embryos show extensive bleeding as well. 
Indeed, both Numb and Numblike inherit common roles in maintenance of neural 
progenitor cells during neurogenesis. Neural tissue specific inactivation of the two 
cell fate determinants during embryogenesis shows that early neurons emerge at a 
normal time point while the expansion of self-renewing neural progenitor cells fails 
leading to a loss of dividing cells shortly after onset of neurogenesis resulting 
eventually in a highly specific malformation of the neocortex and hippocampus [118, 
119]. Observations of an asymmetric localization of Numb to the apical membrane in 
dividing progenitor cells propose a general mechanism for mammalian stem cells to 
regulate self-renewal and differentiation by Numb-mediated asymmetric cell division 
[97, 119, 120]. Further evidence for redundant functions of Numb and Numblike was 
provided by combined constitutive knockout studies for both genes resulting in an 
earlier embryonic lethality at E9.5. The severe and widespread defects depicted by 
these Numb/Numblike double mutants suggested a fundamental role of both proteins 
in regulating proliferation and differentiation also in other tissues than the central 
nervous system [118]. Tissue specific deletion of both Numb and Numblike in 
developing epicard for example results in embryonic lethality between E12.5 and 
E14.5 suggesting an important role of both proteins during heart specification [112]. 
As previously mentioned, the loss of Numb and Numblike specifically in developing 
epicardial cells results in disruption of adherens junctions and cell polarity similar to 
an epicardial specific deletion of ß-Catenin [112]. Additionally, it is believed that the 
proteins Numb, Numblike and ß-Catenin synergistically control the orientation of 
mitotic spindle and thereby direct the division of epicardial cells [112]. Moreover, 
Numb and Numblike once more have been shown to interfere with Notch signaling 
during heart development as well [2]. Here, Numb and Numblike are capable to 
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suppress Notch2 activity during the process of myocardial compaction, trabeculation 
and ventricular septum formation. Only the concomitant inactivation of both genes 
results in an upregulation of Notch2 activity accompanied by Bmp10-signaling with 
defects characterized by hypertrabeculation as well as incomplete myocardial 
compaction and ventricular septum development. Thus, Numb and Numblike were 
identified as important inhibitors of Notch- and Bmp10-signaling in mouse heart 
development. Furthermore, Numb is highly expressed in developing and adult lung 
epithelium with a characteristic cortical distribution of the adaptor protein [99, 121]. 
Distal lung epithelial progenitors exhibit asymmetric segregation of Numb to their 
apical pole similar than in neural progenitor cells. In these distal epithelial progenitor 
cells, Numb has been shown to promote cell polarity as well as asymmetric cell 
division, which are both features that play an important role during the progress of 
proper lung morphogenesis and epithelial specification [122, 123]. Consistent with 
this observation, the polarity proteins Inscuteable (Insc), G-protein-signaling 
modulator 2 (Gpsm2/LGN), Nuclear mitotic apparatus protein 1 (NuMA) as well as 
the Eyes absent protein 1 (Eya1) depict asymmetric distribution in distal embryonic 
lung epithelium similar to Numb localization and exhibit the potential to regulate 
mitotic spindle orientation during lung epithelial morphogenesis [122, 124, 125]. 
Functional disruption of these polarity proteins in vitro randomizes mitotic spindle 
orientation and negatively influences the balance between proliferation and 
differentiation. In case of Eya1, in vitro but also in vivo inactivation of Eya1 impairs 
epithelial cell polarity, proper spindle orientation as well as cell fate decision 
accompanied by the loss of asymmetric Numb segregation. In support of this, shRNA 
mediated depletion of Numb in the lung epithelial cell line MLE15 results in an 
increased expression of the progenitor cell marker Sox9 and decreased cell 
differentiation [122]. These pivotal features of Numb, acting as an intrinsic key 
determinant of asymmetric versus symmetric cell division and defining cell polarity, 
are upon their impairment also critical for the formation and progression of tumors. 
There is indeed evidence that Numb and Numblike are implicated in different human 
tumors, such as breast cancer [109, 126] or non-small-cell lung carcinomas (NSCLCs) 
[114, 127]. At this juncture, tumorigenesis has generally been correlated with a loss of 
Numb expression and consequent activation of oncogenic Notch-signaling as well as 
attenuation of p53 tumor suppressor pathway [109, 128]. Moreover, loss of Numb 
abundance has also been described in brain tumorigenesis, where hedgehog signaling 
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is consequently hyperactivated promoting tumor growth [106]. In contrast, Numblike 
usually shows overexpression and mislocalization in tumor cells, which correlates 
with a loss of tumor suppressive micro RNA 296 (miR-296) that negatively regulates 
Numblike in normal cells [114]. In lung carcinomas (NSCLCs) Numblike and the 
stem cell specific transcription factor Klf4 might act synergistically in maintaining 
progenitor-like cell populations [114]. Taken together, these results show clear 
correlations between Numb/Numblike expression, their control of cell polarity as well 
as cell fate balance between proliferating progenitor cells and their differentiation for 
several tissues. Observations in human tumors evidently point out associations of 
Numb and Numblike deregulation with carcinogenesis but mechanistic insights are 
superficial, just as explicit actions of Numb and Numblike during lung epithelial 
development and regeneration are only poorly understood so far.    
1.5 Aim of this study 
In this study I aimed to investigate the role of Numb and its cytosolic homolog 
Numblike during murine lung epithelial development as well as their potential impact 
in lung disease in more detail. Functional characterization of both genes upon their 
concomitant lung epithelial specific inactivation in mouse should help to pinpoint 
their importance during epithelial specification, the establishment of cell polarity as 
well as the maintenance of epithelial integrity and last not least their functions in lung 
regeneration after injury. To my knowledge there are no existing data describing the 
role of Numb and Numblike in lung fibrosis, which represents another devastating 
lung disease besides lung cancer. Using bleomycin to induce experimental lung 
fibrosis in Numb/Numblike double mutant mice, I tried to elucidate potential functions 
of both proteins in the regulation of fibrosis triggering pathways like Wnt/ß-Catenin 
signaling. In support of this, I wanted to reveal novel mechanisms that might help to 
explain the establishment and maintenance of epithelial integrity and cell polarity, as 
Numb and Numblike have recently been involved in such processes. The performance 
of interactome analysis for both proteins by mass spectrometry, validation of novel 
potential interaction partner as well as shRNA-mediated silencing of Numb and 
Numblike in lung epithelial cell lines are aspired to provide advanced mechanistic 
insights. 
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2 MATERIAL AND METHODS 
2.1 Transgenic mice 
The animal experiments in this work were done according to the regulations issued by 
the Committee for Animal Rights Protection of the State of Hessen (Regierungs-
pärsidium Darmstadt) or the Instituto de Investigacion en Biomedicina de Buenos 
Aires (IBioBA)-CONICET-Partner Institute of the Max Planck Society (C1425FQD 
Buenos Aires, Argentina). The animals were kept under sterile approved animal 
facility conditions with an appropriate day and night cycle.  
2.1.1 Numb//Numblike 
Mice containing homozygous Numb-floxed alleles (Numbfl/fl) were kindly provided 
and originally generated by Zilian, O., et al. (2001) [129]. These animals were crossed 
with mice containing a Numblike null allele (Numblike+/-), lacking 90% of the coding 
region (originally from Petersen, P. H., et al. (2002) [118]). Females homozygous for 
Numblike null are infertile. In order to obtain double homozygous Numb/Numblike 
mutants we mated Numbfl/fl//Numblike-/- males with Numbfl/fl//Numblike+/- females. 
2.1.2 SPCrtTA//tetOCre 
The doxycycline inducible lung epithelial specific Cre line used for our studies was 
originally generated by Perl, A. K., et al. (2002) [130]. These mice express the rtTA 
activator under control of the human SPC promoter. Gene expression is exclusively 
directed to the developing and mature lung epithelium in epithelial cells of primordial 
lung buds, with maintenance of expression in alveolar and bronchiolar epithelial cells 
after birth [131, 132]. These transgenic SPCrtTA mice were previously crossed to the 
transgenic (tetO)7-Cre (tetOCre) line to obtain the transgenic doxycycline inducible 
SPCrtTA//tetOCre animals. This line was always kept heterozygous. 
2.1.3 SPCrtTA//tetOCre//Numb//Numblike 
This transgenic line was generated in crossing SPCrtTA+/-//tetOCre+/- mice either with 
Numbfl/fl//Numblike-/- males or vice versa with Numbfl/fl//Numblike+/- females to obtain 
double mutants. Upon doxycycline application (Dox; Doxycycline hyclate; # D9891-
25G – Sigma) in the drinking water of the animals the floxed Numb alleles are 
recombined by the activated Cre generating the inactivation of Numb on a Numblike 
deficient background later on referred to as dKO. 
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2.1.4 SPCrtTA//tetOCre//Numb//Numblike//RosaYFP 
This reporter line was generated the same way as in 2.1.3 including breeding to the 
Rosa26-Stopflox-eYFP reporter line (The Jackson Laboratory). This reporter line was 
crossed in for the purpose of lineage tracing, monitoring Cre activity or FACS sorting 
of epithelial cells. As wild type control mice we especially crossed SPCrtTA//tetOCre 
animals with Rosa26-Stopflox-eYFP mice obtaining mice with Numb/Numblike in 
their wild type state. These mice are later on referred to as WtCtrl. 
2.2 Genotyping of mice 
2.2.1 Mouse tail biopsies and extraction of tail DNA 
The preparation of mouse-tail biopsies (tailing) was done by the local animal-
caretakers in the animal facilities under appropriate conditions. After obtaining the 
tails the samples were digested in 500 µl TENS-Buffer (Table 23) with Proteinase K 
(500 mg Proteinase K - Roth) over night at 56°C. After complete digestion of the tails 
each sample is centrifuged at 14000 rpm in a table centrifuge (Centrifuge 5417R, 
Centrifuge 5430 - Eppendorf), the supernatant is collected in a fresh tube, and the 
DNA precipitated by adding 500µl Isopropanol. After another centrifugation step 
(14000 rpm) DNA gets pelleted and can be washed 1x with 70 % Ethanol (EtOH). 
Finally the dried DNA pellet is resuspended in 300 µl TE-Buffer (Table 24) or Milli-
Q H2O (Milli-Q® Advantage A10 System – Millipore) 3h at 56 °C. The tail DNA is 
then ready to use for genotyping. 
2.2.2 Polymerase Chain Reaction (PCR) 
To genotype the different mouse strains we performed PCR on extracted genomic tail 
DNA (2.2.1) using corresponding primer combinations (2.2.3 Primer by Sigma-
Aldrich) either with the Sigma REDTaq® DNA Polymerase mix (D4309) or a 
homemade Taq-mix (Table 3; Table 4). PCR was performed in a Thermocycler 
(Mastercycler Nexus – Eppendorf, Labcycler – Sensoquest) at a cycle program 
corresponding to the PCR (2.2.3). The PCR products were loaded on a 1 – 2% 
agarose gel (LE Agarose, #840004 – Biozym) and separated in 1x TAE (Tris-acetate-
EDTA) buffer (Table 16) at 100 – 180 mV (Power Supply: E455 – Consort, Power 
Pack P25 T – Biometra, T100 Thermal Cycler – Biorad). Gel documentation was 
performed with a UV gel documentation device (BioDocAnalyze - Biometra). 
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Homemade-Taq-Mix 25µl Mix 
dNTPs 0.5µl 
10x Taq-Buffer with MgCl2 2.5µl 
Primer 5’ 1µl 
Primer 3’ 1µl 
Homemade-Taq 0.25µl 
Milli-Q-H2O 18.75µl 
Template DNA 1µl 
Table 3: Homemade-Taq-Mix 
 
REDTaq® DNA Polymerase Mix 23µl Mix 
Primer 5’ 0.5µl 
Primer 3’ 0.5µl 
REDTaq® DNA Polymerase Mix 8µl 
Milli-Q-H2O 13µl 
Template DNA 1µl 
Table 4: REDTaq® DNA Polymerase Mix 
 
2.2.3 Primers and PCR programs 
SPCrtTA Homemade-Taq-Mix 
Primer 5’ GACACA TATAAGACCCTGGTCA 
Primer 3’ AAAATCTTGCCAGCTTTCCCC 
Program (35 cycles) 
94°C 3:00 min 
94°C 0:30 min 
58°C 0:30 min 
72°C 0:30 min 
72°C 5:00 min 
12°C Hold 
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Expected size 340bp 
Table 5: SPCrtTA PCR 
 
CMV-Cre Homemade-Taq-Mix 
Primer 5’ GACCAGGTTCGTTCACTCATGG 
Primer 3’ AGGCTAAGTGCCTTCTCTACAC 
Program (39 cycles) 
94°C 3:00 min 
94°C 0:30 min 
61°C 0:30 min 
72°C 0:30 min 
72°C 5:00 min 
12°C Hold 
Expected size 218bp 
Table 6: CMV-Cre PCR 
 
Numb Homemade-Taq-Mix 
Primer 5’ GAA GGA GCC TTC CAA AAT CGT ATT C 
Primer 3’ TAA GGG CTA CAG AGT AAG TTC AAG GAC AG 
Program (36cycles) 
94°C 3:00 min 
94°C 0:30 min 
53°C 0:30 min 
72°C 0:30 min 
72°C 5:00 min 
12°C Hold 
Expected size Wt 341bp, Mut 360bp 
Table 7: Numb PCR 
 
Numblike Homemade-Taq-Mix 
Primer 5’ AS196 CTG TTT CCT GCC TTC CTT CCT AGT C 
Primer 3’ AS197 GCA GGC AGT GAA AAA CCA TCT CTC 
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Primer 3’ AS198 CAC TCT GCC ACC TAG CTT CAT GTC 
Program (35cycles) 
94°C 3:00 min 
94°C 0:30 min 
62°C 0:30 min 
72°C 0:35 min 
72°C 5:00 min 
12°C Hold 
Expected size Wt 258bp, Mut 341bp, 3rd band at 500bp (heterozygous) 
Table 8: Numblike PCR 
 
RosaYFP REDTaq® DNA Polymerase mix 
Primer 5’ RosaFA AAA GTC GCT CTG AGT TGT TAT 
Primer 3’ RosaRF GGA GCG GGA GAA ATG GAT ATG 
Primer 3’ RosaSpliAC CAT CAA GGA AAC CCT GGA CTA CTG 
Program (39cycles) 
94°C 3:00 min 
94°C 0:30 min 
57°C 0:30 min 
72°C 0:50 min 
72°C 5:00 min 
12°C Hold 
Expected size Wt 650bp, Mut 250bp 
Table 9: RosaYFP 
 
 
SPC-YiCreZ Homemade-Taq-Mix 
Primer 5’  TACCAGCTCTCAGGTGGCCCT 
Primer 3’  CAGCTCCTCGCCCTTGCTCAC 
Program (36cycles) 
94°C 3:00 min 
94°C 0:30 min 
65°C 0:30 min 
72°C 0:30 min 
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72°C 5:00 min 
12°C Hold 
Expected size 426bp 
Table 10: SPC-YiCreZ PCR 
 
2.3 Cloning and preparation of plasmid DNA 
2.3.1 Transformation of bacteria with plasmid DNA 
In order to amplify a DNA fragments or plasmid DNA constructs it is necessary to 
bring this foreign DNA into bacterial microorganisms. Therefor, we made use of 
electrocompetent XL1 blue bacterial stocks, which we transformed by electroporation 
with an electroporator (Gene PulserTM – Bio-Rad). At first, we diluted a 50µl 
XL1blue stock with an appropriate amount of pre-cooled sterile H2O (maximum 
500µl) and transferred 100µl of this bacterial dilution to a pre-cooled electroporation 
cuvette (Electroporation Cuvettes, #71-2020 blue cap – Peqlab). Then, 250 ng – 1µg 
of DNA was added and the cuvettes were subjected to the electroporator. As 
transformation control we used sterile H2O instead of DNA. All previous steps were 
processed on ice to prevent the bacteria of loosing their electrocompetence. The 
electroporation was performed at 2.5 kV and poration time was always in a range of 
4.6 to 4.7 ms. After that, the electroporated bacteria were resuspended in 400µl of 
cold LB-medium (LB-Medium (Lennox), #X964.2 - Roth) without antibiotics and 
pre-incubated at 37°C on a heating block (Thermo Mixer F 1.5 - Eppendorf) for 30 
min. The pre-incubated bacteria suspension was finally transferred to an antibiotics 
containing (50-100 µg e.g. Ampicillin, Amp) agar dish (LB-Agar (Lennox), #X965.2 
– Roth), nicely distributed on the dish with a sterile Drigalski scoop and finally the 
inoculated dish was incubated upside-down in a bacteria incubator (#26126010 – 
Heraeus) at 37 °C over night. 
2.3.2 Preparation of plasmid DNA – Mini-preparation 
After bacteria were successfully transformed with the plasmid DNA of interest and 
formed colonies on the Amp-agar dish, the colonies could be picked with a pipet tip 
and inoculated in 3 ml of LB-Amp in a glass tube (Mini-preparation). Once the Minis 
got incubated at 37°C in a bacteria shaker (Innova® 44 Incubator Shaker Series – New 
Brunswick Scientific) over night, the preparation of the Mini-DNA was performed. 
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First, 1.5 ml of over night grown bacterial suspension was transferred to a 1.5 ml 
reaction tube and centrifuged at 14000 x rpm for 1 min to pellet the bacteria. After 
supernatant was removed the bacterial pellet was resuspended in 200 µl of cold 
Buffer I (Table 20). Then, 200µl of Buffer II (Table 21) was added, samples were 
inverted several times and incubated at RT for 5 min. After incubation, 200 µl cold 
Buffer III (Table 22) was added and the samples were vortexed well. The vortexed 
samples were then centrifuged at 4 °C, 14000 x rpm for 5 min and the supernatant 
was carefully transferred with a pipet to a fresh 1.5 ml reaction tube. 400 µl of 
Isopropanol was added to each sample and the tubes were inverted to precipitate the 
DNA. Samples were then again centrifuged at 14000 x rpm for 5 min at RT. Once the 
supernatant was removed the pelleted DNA was washed with 500 µl of 70 % EtOH 
and the samples were centrifuged once more for 5 min at RT and 14000 x rpm. After 
the washing step, the DNA pellet was dried at RT and then got resuspended in 100 µl 
of TE-Buffer (Table 24) supplemented with 10 µg of RNaseA. Finally, the isolated 
DNA was usually validated by restriction enzyme digest, which was controlled on a 
1% agarose gel, and additionally sequenced with corresponding primer.  
2.3.3 Preparation of plasmid DNA – Maxi-preparation 
In order to obtain larger quantities of plasmid DNA we performed Maxi-preparation 
with a purchased plasmid DNA purification kit (NucleoBond® Xtra Maxi, 
#740.414.100 – Macherey-Nagel). Therefor, we first inoculated transformed bacteria 
either directly from bacterial suspensions of a previously performed Mini-preparation 
or by inoculating a single bacterial colony grown on an agar dish in 250 ml of LB-
medium in a glass flask with an appropriate antibiotic (e.g. Amp). The inoculated LB-
medium was incubated and shaken over night at 37 °C in a bacterial incubator. The 
next day, the over night grown bacterial culture suspension was centrifuged at 5000 x 
g for 15 min at 4 °C in an ultra centrifuge (Sorvall® RC 5B Plus or Sorvall® Evolution 
RC #72811 – Thermo Scientific) and the bacterial pellet was further processed as 
described by the manufacturers protocol (NucleoBond® Xtra Maxi). After the DNA 
pellet was washed twice with 70 % EtOH and dried we resuspended the pellet in 
minimum 100 µl of TE-Buffer (Table 24). The DNA purity and concentration was 
measured in a spectrophotometer (NanoDrop 2000c - Peqlab). 
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2.4 Cell culture 
2.4.1 Mouse lung epithelial cells (MLE12) 
In vitro studies were mainly performed with the mouse lung epithelial cell line 
(MLE12). The cells were cultured in Dulbecco’s Modification of Eagle’s Medium (D-
MEM⁄F-12 (1:1) (1X); #21331-046 – Gibco) supplemented with 10% Fetal Calf 
Serum (FCS, #F7524 – Sigma) and 1% Penicillin/ Streptomycin/ Glutamin (P/S/G 
100x, #G1146 – Sigma). To keep the cells in culture for longer time they were 
passaged twice a week, depending on their density. Therefor the used culture media 
was removed from the dish first. Then cells were washed once with sterile 1x PBS 
pH7.4 (phosphate buffered saline, Table 18; 10ml per 10 cm dish) and trypsinized 
with 1x Trypsin/EDTA (10x T/E,  #59418C – Sigma; Table 19) to detach the cells 
from the culture dish. To obtain a single cell suspension culture media was added to 
stop trypsination and cells were resuspended nicely with a glass pipet. Finally, cells 
were seeded in a low density to a fresh cell culture dish (ratio 1:5 – 1:10 per 10 cm 
dish; Cellstar® #664160 – Greiner Bio-One) and kept at humidified conditions (37°C/ 
5% CO2) in an incubator (Heracell 150i – ThermoFisher Scientific). All cell culture 
work was done at a sterile hood (HeraSafe KS – ThermoFisher Scientific) at either 
safety level 1 or 2 (S1, S2) facilities. 
2.4.2 Human Embryonic Kidney Cells (HEK293T) 
Human Embryonic Kidney Cells (HEK293T) cells were cultured in DMEM/10% 
FCS/1% PSG (1 x Dulbecco’s Modified Eagle Medium (DMEM 4.5 g/L D-Glucose, 
#42430-025 – Gibco). The cells were passaged every 2nd day and used as packaging 
cells to produce lenti-virus containing shRNA for the generation of knockdown cells 
(2.4.4). The cells were kept at humidified conditions (37°C/ 5% CO2). Stocks were 
prepared in 90% FCS/ 10% DMSO (Dimethyl sulfoxide, #D4540-100ML - Sigma) 
and frozen and stored at -80°C (in a styrofoam box). 
2.4.3 Transient transfection of cell lines with Calcium-Phosphate 
Cultivated HEK293T cells were passaged one day in advance or the same day of 
transfection to grow to a density of about 70% of the culture dish (amounts according 
to a 6-well-plate: Cellstar® #657160 – Greiner Bio-One). Two aliquots A and B were 
prepared for transfection in advance. Aliquot A contains 5µg DNA and 30.5 µl 2M 
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CaCl2 filled up to 250 µl with sterile H2O. Shortly before performing the transfection 
aliquot A is applied drop wise to 250 µl of 2x HBS (Aliquot B), mixed once with the 
pipet and added drop wise to the media of the cultured HEK293T. The cells are 
incubated and kept at humidified conditions at 37°C/ 5% CO2 in a cell culture 
incubator. 
2.4.4 Generation of stable shNumb/shNumblike RNA silenced MLE12 
cells 
MLE12 cells were virally transduced using small hairpin RNA against Numb and 
Numblike (shNb/shNbL) that are generated on a pLKO.1-puro vector backbone (Table 
11). As packaging and lentivirus producing cells, HEK293T were cultured in 
DMEM/10% FCS/1% PSG and co-transfected with the corresponding shRNA 
vectors, psPAX2 packaging vector and pMD2.G envelope vector (Table 11). As 
controls we used pLKO.1-puro-Scrambled (shScr), as well as pLKO.1-GFP 
(transfection efficiency control). The used vector DNA was obtained in using 
methods described in 2.3. The target cells (MLE12) were then infected with the 
lentivirus containing culture media of the transfected, virus producing HEK293T 
cells. To obtain stably transduced knockdown (kd) cells, MLE12 cells were cultured 
in puromycin ( # - ) supplemented (5 µg/ml) culture media (D-MEM⁄F-12 (1:1) 
(1X)/10% FCS/ 1% PSG/ Puro), selecting for successfully transduced cells for several 
passages. Cryo-stocks of stably transduced shNb/shNbL and shScr MLE12 cells were 
prepared in 90% FCS/10% DMSO and frozen in -80°C. 
 
Plasmid Description Source 
pLKO.1-puro 
(SHC001) 
MISSION® TRC lentiviral control vector 
with puromycin resistance gene. 
Sigma-Aldrich 
Chemie GmbH, 
Steinheim 
pLKO.1-GFP 
MISSION® TRC lentiviral control vector for 
expression of a green fluorescence protein 
(GFP). This vector contains no puromycin 
resistance gene. 
Sigma-Aldrich 
Chemie GmbH, 
Steinheim 
pLKO.1-puro-
Scrambled shRNA 
MISSION® TRC lentiviral control vector 
with puromycin resistance for the expression 
Sigma-Aldrich 
Chemie GmbH, 
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of a shRNA, that doesn’t match and interfere 
with a known mouse or human gene. 
Steinheim 
pLKO.1-puro-
Numb shRNA 
(NM_010949) 
Set of five different MISSION® TRC 
lentiviral vector with puromycin resistance 
for the expression of shRNA against mouse 
Numb. 
Sigma-Aldrich 
Chemie GmbH, 
Steinheim 
pLKO.1-puro-
Numblike shRNA 
(NM_010950) 
Set of five different MISSION® TRC 
lentiviral vector with puromycin resistance 
for the expression of shRNA against mouse 
Numblike. 
Sigma-Aldrich 
Chemie GmbH, 
Steinheim 
psPAX2 
Plasmid for the expression of the packaging 
genes gag, pol and rev for the production of 
lentivirus. 
Sigma-Aldrich 
Chemie GmbH, 
Steinheim 
pMD2.G 
Plasmid for the expression of the viral 
envelope proteins VSV-G for the production 
of lentivirus. 
Sigma-Aldrich 
Chemie GmbH, 
Steinheim 
Table 11: List of plasmids/ shRNA  
 
2.4.5 Generation of stable Numb and Numblike overexpressing MLE12 
cells 
MLE12 cells that stably express one of the four human Numb isoforms or Numblike 
N-terminally fused to GFP (Numb1-4:GFP, Numblike:GFP) as well as GFP 
expressing control MLE12 cells (GFP Ctrl) were kindly generated and provided by 
Dr. André Görgens (Group Bernd Giebel, University of Duisburg-Essen). Originally, 
the Numb expression plasmids were provided by Verdi et al. [100] and the coding 
regions of all isoforms were cloned into the lentiviral transfer vector pCL6-EG-wo as 
described by Dr. André Görgens (Funktionelle Analyse von Numb und Redefinition 
der humanen hämatopoetischen Hierarchie - 2012). These vectors where then used for 
the production of lentiviral particles in HEK293T cells followed by the transduction 
of MLE12 cells with the produced lentiviral supernatants. The transduced MLE12 
cells were FACS sorted for GFP positive cells in order to obtain purified cell lines 
that stably overexpress the different GFP fusion proteins. 
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2.4.6 GSK3-ß inhibition experiments (WNT/ß-Catenin signaling) 
MLE12 kd cells were seeded on a 6-well-plate (#657160 – Greiner Bio-One) at a 
density of 5 x 105 cells/ well the night before performing the treatment. The cells were 
then treated with 20 mM LiCl (4M Lithiumchlorid stock in H2O, at 4°C, powder: 
#P007.1 - Roth) and 30 µM SB216763 (10 mM stock in DMSO, at -20°C, #ab120202 
– Abcam) to inhibit GSK3ß-activity. Furthermore, cells were treated with 10 µM 
MG132 (10 mM stock in DMSO, at -20°C, #474791 – Calbiochem) to totally block 
proteosomal degradation (positive control). DMSO (0.3 %) treated and untreated cells 
were used as negative controls. The incubation time for the treatment was 2 to 4h at 
37°C/ 5% CO2.  
2.4.7 Cultivation of primary mouse lung epithelial cells 
Isolated, FACS sorted primary lung epithelial cells were plated on a 4-well chamber 
slide (Lab Tek® Chamber SlideTM system, 4-well Permanox® Slide, #177437 Nunc/ 
Sigma-Aldrich) and coated either with fibronectin (FN; #C-43050 – PromoCell; 10µl 
FN/ 1ml 1x PBS; coating 30-60 min at RT) or matrigel (MG; # - ; 1:50 in D-MEM⁄F-
12 (1:1) (1X)/10% FCS/ 1% PSG; coating 2h at RT). Cells were seeded at a density of 
3.0 – 5.0 x 104 cells/ well and kept at humidified conditions at 37°C/ 5% CO2. 
2.5 Isolation of primary lung epithelial cells and FACS 
sorting 
2.5.1 Isolation of primary lung epithelial cells 
Narcotized animals (1:1:1; Ketamin 10% – Medistar, Xylariem® (20mg Xylazin) – 
Ecuphar, 0.9 % NaCl – B Braun) were nicely perfused with 1x PBS via the right 
ventricle to get lungs blood free and primary lung epithelial cells were isolated as 
previously described [133] using a slightly modified procedure. After perfusion the 
lungs were filled up with 1 ml of dispase (#354235 – Corning) and the trachea was 
ligated to keep the dispase in the lung. After isolation of the filled lung it was minced 
into small pieces in a petri dish with a scissor. Lung pieces were transferred with 
additional 1 ml of dispase to a 50 ml Falcon tube (Cellstar® Tubes #227261 – Greiner 
Bio-One) and kept on ice until all samples were prepared. 20µg DNaseI (10mg/ml – 
20U/ml; # ) was added to the lung/dispase suspension (2 ml) followed by digestion of 
the samples on a shaker at 37°C for 45 min. After digestion of the lung pieces, the 
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suspension was resuspended with a plastic pipet (Cellstar® #607180/10ml, 
#606180/5ml – Greiner Bio-One) and passed via a 100µm and a 40µm strainer 
(EASYstrainerTM 100µm, #542000; 40 µm #542040 – Greiner-Bio-One) to obtain a 
primary lung cell homogenate (filters were flushed at each step with D-MEM⁄F-12 
(1:1) (1X)/10% FCS). The homogenates were centrifuged for 10 min at 1200 rpm 
(300 x g) and the supernatant was carefully removed. The cell pellet was resuspended 
in 1 ml of precooled FACS sorting buffer (Table 37) and then passed through the 
filter of a FACS sorting tube (40 µm FALCON®, #352235 – Corning) to get a single 
cell suspension that was subjected to the FACS sorter. 
2.5.2 FACS sorting of YFP+ lung epithelial cells 
Single cell suspensions derived from isolated primary lung epithelial cells (2.5.1) of 
SPCrtTA// Cre// Numb// Numblike// RosaYFP mutant and littermate control mice 
(treated with doxycycline) were subjected to the FACS sorter (BD FACSAria III Cell 
Sorter) in a FACS tube. Samples were nicely resuspended in FACS sorting buffer 
together with DAPI to exclude dead cells during sorting. FACS sorter was gated for 
both YFP+ single cell events (doublet exclusion of FITC high positive events) and 
negative events (FITC low positive events) as control fraction. Both fractions were 
collected in a 15 ml Falcon tube (coated and filled with 4 ml D-MEM⁄F-12 (1:1) 
(1X)/10% FCS) and either seeded for cell culture (2.4.7) or resuspended in 1 ml of 
peqGOLD® TriFast for RNA preparation (2.6.1). 
2.6 RNA preparation and cDNA synthesis 
2.6.1 RNA preparation with peqGOLD® TriFastTM reagent 
In order to isolate RNA of mouse tissue, e.g. mouse lung, organs were isolated from 
the animal, snap frozen in liquid nitrogen, and either stored at -80°C or directly 
resuspended in 1ml of peqGOLD® TriFastTM (#30-2010 – Peqlab) reagent, with the 
help of sterile metal beads (grinding balls ss 5 mm, #22.455.0003 – Retsch) in a tissue 
homogenizer (Retsch MM301). Cells that were grown in cell culture were first 
washed with 1x PBS and then 1ml of peqGOLD® TriFastTM was added directly to the 
dish. The cell samples were harvested with a cell scraper (#83.1830 - Sarstedt), 
transferred to a fresh tube and resuspended with a pipet. After homogenization of the 
samples in peqGOLD® TriFastTM they were incubated 5 min at room temperature 
(RT), 200µl Chloroform (#6340.2 - Roth) was added and the samples mixed well. 
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Once the samples were incubated again for 5 min at RT they were centrifuged at 
12000 rcf (4°C) to perform a phase separation. The upper aqueous phase was 
transferred to a fresh tube (the residual inter- and organic phase were kept at 4°C for 
protein extraction; 2.8). Isopropanol was added to precipitate the RNA (10 min on 
ice). After centrifugation (12000 rcf, 4°C, 10 min) the RNA pellet was washed 2 
times with 75% EtOH. Finally, the dried pellet was resuspended in 20-60µl of RNase 
free H2O and used for cDNA synthesis (storage of RNA at -80°C). 
2.6.2 cDNA synthesis 
In order to perform relative quantitation of RNA expression levels cDNA was 
synthesized. Therefor RNA concentration of the purified RNA samples were 
measured (NanoDrop ND-2000c Spektralphotometer - Peqlab) and 0.5 – 2µg of RNA 
were used for the synthesis (Table 12). After cDNA was synthesized it was diluted 
1:100 with Milli-Q H2O for the use in TaqMan® Gene Expression Assays (Applied 
Biosystems) to determine relative RNA expression levels quantitatively (2.7). 
 
Reagents/Steps cDNA synthesis mix (total 20µl) 
dNTPs (#R0186 – 
Fermentas) 
1µl 
Oligo(dt)15 Primer 
(#C1101 – Promega) 
1µl 
RNA (0.5 – 2µg) xµl 10-x 
RNase free H2O Add to 12µl 
Step 1 (12µl mix) 
65°C 5 min 
4°C Hold 
Add synthesis mix: At 4°C 
5x FS buffer (*) 4µl 
0.1M DTT (*) 2µl 
RNasin Plus (#N2615 
– Promega) 
1µl 
SSII RT (* #18064071 
– Invitrogen) 
1µl 
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Step 2 (20µl mix) 
42°C 50 min 
70°C 15 min 
4°C Hold 
Table 12: cDNA synthesis 
 
2.7 Real-Time PCR (qPCR) 
The quantitation of RNA expression levels was performed in using TaqMan® Gene 
Expression Assays for the corresponding targets (FAM Dye; Table 13) versus an 
endogenous loading control e.g. Gapdh or Hprt that are designed with a different dye 
than the targets (VIC Dye). The quantitation was done by a qPCR thermocycler (Step 
OnePlus Real-Time PCR System – Applied Biosystems) that calculated fold changes 
(RQ-values) of the examined samples based on their ddCT values with the step one 
software (StepOneTM Software v2.3). 
 
Target name TaqMan® Gene Expression Assay 
Numb Mm01302750_m1 
Numb Mm00477927_m1 
Numblike Mm01171278_m1 
Sftpc (SP-C) Mm00488146_g1 
Scgb1a1 (CC-10/CCSP) Mm01230908_m1 
Podoplanin Mm01348912_g1 
Foxj1 Mm01267279_m1 
Ascl2 Mm01268891_g1 
Col1a1 Mm00801666_g1 
Ctgf Mm01192933_g1 
Tnf-alpha Mm00443258_m1 
Acta2 Mm00725412_s1 
Wisp1 Mm01200484_m1 
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FN1 Mm01256744_m1 
Mmp2 Mm00439498_m1 
Mmp9 Mm00442991_m1 
Snai1 Mm00441533_g1 
Twist1 Mm00442036_m1 
Axin1 Mm01299060_m1 
Axin2 Mm00443610_m1 
Ctnnb1 (ß-Catenin) Mm00483039_m1 
cMyc Mm00487804_m1 
T2 (Brachyury2) Mm00496699_m1 
Ccnd1 (CyclinD1) Mm00432359_m1 
Table 13: TaqMan® Gene Expression Assays 
2.8 Protein extraction and analysis 
2.8.1 Preparation of cell/ tissue lysates 
In order to analyze protein levels of cultured cells or isolated mouse tissue samples, 
e.g. lung, the extraction of proteins was either performed in using 5x LB-sample 
buffer (for cell lines; Table 25) or Extraction buffer (EP; for tissue; Table 26) with a 
supplementation of protease inhibitors (Table 29) to homogenize the samples. 
Cultured cells were harvested with a cell scraper after adding 5x LB buffer directly to 
the dish in a reasonable amount (100 – 150µl per 6-well-plate). After transfer to a 
fresh tube samples were resuspended and homogenized properly by pipetting and 
following sonication with a sonicator (00:22 sec/5 cycles/30% power; Bandelin Sono 
Plus). The protein homogenate was centrifuged (10000 rcf, 5 min, RT). Cleared lysate 
was then collected in a fresh tube and protein concentration was measured using 
Bradford method (2.8.2). Samples were diluted in corresponding lysis buffer together 
with NuPAGE® LDS Sample Buffer (4x) (1:3 dilution of Sample; #NP007 – 
ThermoFisher Scientific) to obtain ready-to-use protein working solutions (10-
30µg/µl) that were denatured by supplementation of 1M DTT (4µl per 100µl sample) 
and heating up to 95°C (3 min). Mouse tissue samples were treated the same way as 
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cells after homogenization of the isolated tissue with metal beats in a homogenizer in 
EP-lysis buffer. Protein that was obtained via peqGOLD® TriFastTM phase separation 
(2.6.1) was further processed following stringently the manufacturer’s protocol 
(peqGOLD® TriFastTM) and finally treated the same way as previously described. 
2.8.2 Protein concentration measurement with Bradford 
Protein concentration measurements were performed using the Bradford method. 
Therefor 5µl of protein sample was supplemented with 25µl reagent A (Bio-Rad 
DCTM Protein Assay Reagent A #500-0113 – Biorad) followed by 200µl reagent B 
(DCTM Protein Assay Reagent B #500-0114 – Biorad). Samples were incubated 10 
min at RT (dark) and then added on a 96-well plate (Microplate, #655101 – Greiner-
Bio-One) together with a blank (only lysis buffer) and a BSA protein standard row 
(BSA dilution series: 1, 5, 10, 20, 30 µg; 100x BSA #B9001S - NEB) to measure the 
sample absorptions in a photometric plate reader (FluoStar). Samples were all 
prepared in duplicates. The protein concentrations were calculated based on the 
standard regression curve in an Excel sheet. 
2.8.3 Protein expression analysis by Western Blot 
In order to analyze protein levels based on Western Blot the protein samples were 
first loaded in equal amounts (10 – 30µg per well) on a self-made polyacrylamide gel 
(e.g. 9% PAA gel (Table 36); filled in a purchased NOVEX® Cassettes 1 mm 
#NC2010 – Invitrogen) to perform a separation of the proteins by their mass via 
electrophoresis. The electrophoresis were performed in a gel running chamber 
(NOVEX® Invitrogen) at separation times between 1.5 – 2h using, depending on the 
protein size of interest, either 1x MOPS (>50kDa; Table 30) or 1x MES (<50 kDa; 
Table 31) buffer (Invitrogen). For a better separation and running behavior running 
buffers were supplemented with 5 mM sodium bisulfite (1M sodium bisulfite). 
Protein mass could be detected in using Protein-Marker VI (#27-2311 – Peqlab). 
After separation via gel electrophoresis the proteins were transferred to a 
nitrocellulose membrane (AmershamTM ProtranTM 0.45 µm NC, #10600002 – GE 
Healthcare) in performing Western Blot. The protein transfer was achieved using 1x 
Transfer buffer (Table 32) and blotting times of between 2 to 2.5 h at 30 mV (Power 
Pac 200 – Bio-Rad) in a blotting chamber (NOVEX® XCell II Blot Module – Life 
Technologies/ Invitrogen). After the protein transfer the membranes were stained with 
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1x Red Alert (dilution of 10x Red AlertTM Western Blot Stain #71078-50ML – 
Merck) for 10 min on a shaker (Rotamax120 – Heidolph). The stained membranes 
were washed with desalted water (until band pattern got clear), cut according to the 
size of the proteins of interest and blocked in 5% milk powder solution (#70166-500G 
– Fluka®) in 1x TBS-T (Table 35) for 1h at RT. After blocking the membranes were 
incubated with the primary antibodies at dilutions noted in Table 14 (either in 5% 
BSA/TBS-T or 5% milk powder solution in TBS-T; antibodies: Table 14) over night 
(o.n.) at 4°C. 
After incubation with primary antibody membranes were washed thrice with 1x TBS-
T (15min – 1h each washing step) and then incubated with the secondary antibody 
(Table 14) in 5% milk powder/ 1x TBS-T for 2h at RT. Membranes were washed 
again thrice with 1x TBS-T and then subjected to a chemiluminescence analyzer 
(ChemiDocTM MP Imaging System – Bio-Rad) for detection of protein bands using 
1:1 femto solution (SuperSignal® West Femto Maximum Sensitivity Substrate #34096 
– ThermoFisher Scientific). Densitometry and data analysis was done with Image Lab 
5.1 software (Bio-Rad). 
2.8.4 Co-Immunoprecipitation with magnetic GFP-Trap®_MA beads 
Experiment was executed mostly according to the manufacturers protocol, with slight 
modifications. GFP-overexpressing MLE12 cells (Numb1-4:GFP; Numblike:GFP) 
were cultured as described before (2.4.1) 48 h on a 10 cm culture dish. After removal 
of the culture medium, the cells were washed once with 1 x PBS. Next, 200 µl of 
freshly prepared RIPA modified lysis buffer (Table 27), supplemented with protease 
inhibitors (Table 29), was added to the dish, cells were harvested with a cell scraper 
and the pre-lysate was transferred to pre-cooled 1.5 ml tube. Cell-lysates were placed 
on ice, incubated for 30 min and resuspended with a pipet every 10 min. In order to 
obtain pure lysates and to exclude cell debris, the samples were centrifuged at 4°C at 
a speed of 20000 x g for 10 min. Pure lysates were then transferred to a fresh pre-
cooled 1.5 ml tube and diluted with Dilution/Wash buffer (DB/WB; Table 28), 
including protease inhibitors as well, up to 500 µl in total. For the use of equal 
amounts of protein inputs (Inp) in each immunoprecipitation (IP) sample, protein 
concentrations of the lysates were determined with Bradford (2.8.2). A total amount 
of about 1 mg of protein was applied for each IP, while a residual amount of protein 
was retained as input (Inp) control of each sample for later comparative analysis by 
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western blot. For the IP, 25 µl of GFP-Trap®_MA (gtma-20 (500µl) – ChromoTek) 
bead slurry was equilibrated and washed thrice in cold DB/WB before 1 mg of protein 
lysate was added. The IP works via anti-GFP VHH antibodies that are coupled to 
magnetic agarose beads to precipitate GFP-tagged fusion proteins. Therefor, the 
protein samples with the beads were incubated on a rolling wheel at 4°C for 1 ½ h. 
Finally, after supernatant was removed carefully, while beads are separated with the 
help of a magnetic rack and were washed thrice gently in cold DB/WB (including 
protease inhibitors), the beads were eluted in 50 µl of 2 x LDS sample buffer/40 mM 
DTT (1:1 dilution of 4x LDS sample buffer with RIPA modified including protease 
inhibitors) at 95°C on a 1.5 ml tube shaker at 900 x rpm for 10 min. After elution, the 
beads were magnetically separated in a magnet stand and eluted IP was transferred to 
a fresh tube. IP samples were eventually either loaded on a 4-12% Bis-Tris gel 
(Novex® - NuPAGE 4-12% Bis-Tris Gel, 1.0 mm x 10 well; #NP0321 – Thermo 
Fisher) and then further processed and subjected to mass spectrometry for protein 
quantification (2.8.5) or the samples were loaded on a 9 % PAA gel together with 
inputs to perform PAGE followed by analysis of the co-immunoprecipitated proteins 
by western blot (2.8.3).    
2.8.5 Co-immunoprecipitation with Protein-G Sepharose beads 
In order to precipitate proteins with Protein-G SepharoseTM beads (#17-0618-01, 5ml 
– GE Healthcare) together with an antibody of interest, lysates of GFP-overexpressing 
MLE12 cells (Numb1-4:GFP; Numblike:GFP), that were cultured as described before 
(2.4.1) 48 h on a 10 cm culture dish, were prepared as described in 2.8.4. Protein-G 
SepharoseTM beads slurry (30 µl) was first equilibrated and washed thrice in cold 
DB/WB and each time centrifuged at a speed of 10000 x g at 4°C for 20 sec. In 
further, 1 mg of freshly prepared protein lysate was incubated at first with 8 µg of the 
antibody of interest and additionally a control fraction of lysate was incubated only 
with normal mouse IgG1-isotype (8 µg) as negative IP control. A residual amount of 
protein was retained as input (Inp) control of each sample for later comparative 
analysis by western blot. Incubation of the IP-fractions was performed at 4°C on a 
rolling wheel for 1 ½ h. After that, precipitated proteins were indirectly coupled via 
the 1st antibody to Protein-G SepharoseTM beads. Therefor, whole IP fraction was 
transferred to the pre-washed beads and incubated for another hour at 4°C on a rolling 
wheel. Finally, beads were washed thrice gently in cold DB/WB (including protease 
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inhibitors). The beads were eluted in 50 µl of 2 x LDS sample buffer/40 mM DTT 
(1:1 dilution of 4x LDS sample buffer with RIPA modified including protease 
inhibitors) at 95°C on a 1.5 ml tube shaker at 900 x rpm for 10 min. Finally, beads 
with the coupled precipitates were washed thrice gently in cold DB/WB (including 
protease inhibitors). The beads were then eluted in 50 µl of 2 x LDS sample buffer/ 
40 mM DTT (1:1 dilution of 4x LDS sample buffer with RIPA modified including 
protease inhibitors) at 95°C on a 1.5 ml tube shaker at 900 x rpm for 10 min. After 
elution, the beads were separated by centrifugation at a speed of 10000 x g and 4°C 
for 20 sec and the supernatant containing the eluted precipitates carefully transferred 
to a fresh tube. IP samples were eventually either loaded on a 4-12% Bis-Tris gel 
(Novex® - NuPAGE 4-12% Bis-Tris Gel, 1.0 mm x 10 well; #NP0321 – Thermo 
Fisher) and then further processed and subjected to mass spectrometry for protein 
quantification (2.9) or the samples were loaded on a 9 % PAA gel together with 
inputs to perform PAGE (polyacrylamide gel electrophoresis) followed by analysis of 
the co-immunoprecipitated proteins by western blot (2.8.3). 
2.9  Mass spectrometry analysis 
In order to measure and quantify proteins and potential novel interaction partners of 
immunoprecipitated proteins, that were processed as described in 2.8.4 or 2.8.5, we 
made use of the following methods. These were mainly performed and executed by 
the mass spectrometry facility of the Max Planck Institute Bad Nauheim headed by 
Dr. Ansgar Pötsch, formerly by Dr. Marcus Krüger. 
2.9.1  In-gel digestion 
Protein samples were separated according to their molecular weight by SDS-PAGE 
(Novex® - NuPAGE 4-12% Bis-Tris Gel, 1.0 mm x 10 well; #NP0321 – Thermo 
Fisher) followed by Instant Blue Staining (Instant Blue, Expedeon) for 15 minutes on 
a shaker. Then, gel was washed twice with distilled water. Protein gels were either 
stored at 4°C in destilled water or directly further processed by cutting the single 
lanes into cubic pieces of similar size and subsequently digested in gel as described 
by Shevchenko et al. [134]. Therefore, gel pieces were first decolored by incubating 
twice with 100 µl of 50 mM ammonium bicarbonate (ABC) solution for 20 min. 
Next, the gel pieces were dehydrated by incubating twice with 100 µl ethanol for 10 
min and dried in a SpeedVac (Concentrator plus, Eppendorf) for 5 min at 30°C. In 
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following, protein samples were reduced with 10 mM dithiothreitol (DTT) at 56°C for 
45 min under constant shaking at 600 rpm in a Thermomixer. After this, proteins were 
alkylated with 55 mM iodoacetamide (IAA) in the dark for 30 minutes. In order to 
wash the gel pieces 100 µl 50 mM ABC was added and incubated for 15 min. Then, 
pieces were dehydrated with 100 µl ethanol for 15 min and again washed with 100 µl 
50 mM ABC for 15 min. Final dehydration was performed twice with 100 µl ethanol 
for 15 min. The dehydrated gel pieces were dried in a SpeedVac for 5 min at 30°C 
and subsequently 40 µl 12ng/µl LysC (WAKO) or trypsin (Promega) was added. The 
gel pieces were incubated on ice for 15 min until they swelled, 50 mM ABC was 
added until the gel pieces were fully covered and everything was finally incubated at 
37°C overnight for digestion of the proteins. The next day, digested peptides were 
extracted by increasing acetonitrile (ACN) concentrations. Therefore, enzymatic 
digestion of proteins in the gel pieces was stopped by incubation with 100 µl 30% 
ACN / 3% trifluoroacetic acid (TFA) for 20 minutes. In following, the pieces were 
incubated twice with 100 µl 70% ACN for 20 min and then twice with 100 µl 100% 
ACN for 20 min, while the peptide solution was collected after each of the incubation 
steps. Finally, the collected peptide solutions were concentrated in a SpeedVac to 
about 80 µl and additional 80 µl Buffer C (5% ACN, 1% TFA) was added before the 
samples were desalted by performing the stop and go extraction (STAGE) technique 
on STAGE Tips [135]. These were prepared in advance (self-made) by stacking two 
layers of C18 material in pipette tips. To bring the extracted peptide solutions on the 
C18 material, STAGE Tips were first activated with 20 µl 100% methanol, washed 
with Buffer B (80% ACN, 0.1% formic acid) in order to elute any dirt from the C18 
material and eventually twice with Buffer A (0.1% formic acid) to remove any 
remaining acetonitrile from Buffer B. For these equilibration steps the wash buffers 
were removed from the C18 material by centrifugation at RT and a speed of 2600 rpm 
for 2min each. After the STAGE Tips were equilibrated, digested peptide solutions 
were loaded on the C18 material. All samples were then centrifuged at 2600 rpm and 
RT for 4 min to bind the peptides to the C18 material. At last, STAGE Tips were 
washed with 20 µl Buffer A, dried with a syringe and stored at 4°C until they were 
measurement in the mass spectrometer. 
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2.9.2 Acquisition of mass spectra 
Peptides that were processed and loaded to the C18 material of STAGE Tips as 
described above (2.9.1) were eluted and separated during reversed phase liquid 
chromatography (LC) on an Easy nano-flow UHPLC system (Thermo Fisher 
Scientific). In order to perform mass analysis and quantification of the eluted peptides 
by Tandem Mass Spectrometry (MS/MS) the UHPLC system is connected to the Q 
Exactive or Q Exactive Plus mass spectrometer via a nano electrospray ionization 
source.  
2.9.3 Analysis of data 
The acquired raw data were processed using the MaxQuant software versions 1.3.7.4 
to 1.5.2.8 as well as the implemented Andromeda search engine. In order to perform 
protein identification MS/MS spectra were correlated and compared to the latest 
Uniprot mouse (Mus musculus) data, which involves 74,265 protein sequence entries. 
For the purpose of filtering and exclusion of contaminants an additional list of 
common contaminants was used. Perseus (version 1.4.1.3) and R package was used 
for following data analysis and visualization as well as the statistical environment R. 
Proteins were characterized by quantitative co-enrichment in the IP compared to their 
intensity profiles across triplicates. In order to obtain quantitative protein ratios, the 
normalized intensities of enriched proteins for the baits were compared to the 
normalized intensities of proteins that were detected in lysates of controls. A 
significance line for potential interacting proteins was calculated by Perseus software 
with p < 0.05 and additionally a fold change cut-off was set to FC > 2. Proteins below 
this threshold were either background binding proteins or false positives.  
2.10 Histology 
2.10.1 Preparation of mouse lung for paraffin and cryosections 
Mice were narcotized and perfused with 1x PBS via the right heart ventricle. Perfused 
lungs were then fixed with 4% Paraformaldehyd (PFA, #0335.4 – Roth) for 5 min at 
RT via the vasculature (right ventricle), inflated with 4% PFA via the trachea and 
ligated to keep the lungs expanded. Perfusions and filling were done with a perfusion 
stand and pressure was adjusted to 10 cm water column not to harm structures. The 
inflated lobes were then isolated and fixed in 4% PFA for 2h at 4°C. After fixation 
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lungs were nicely washed thrice with 1x PBS and for Tissue-Tek® O.C.TTM 
embedding (Tissue-Tek® O.C.TTM, #4583 - Sakura) then incubated in 30% sucrose at 
4°C o.n. . After sucrose incubation the lungs were inflated with Tissue-Tek®, then 
embedded in a Tissue-Tek® filled cryo-mold (Tissue-Tek® Cryomold® #4565 – 
Sakura or Peel-A-Way® Disposable Embedding Molds #677352 – Polysciences Inc.) 
on dry ice and frozen at -80°C for later cryo sections. Cryosections were performed in 
a cryotome (Leica CM1950) and sections transferred consecutively (2-3 lung sections 
on one slide) on a glass slide (Superfrost Ultra Plus®; #J3800AMNZ – Thermo 
Scientific) at a thickness of 5 µm. Slides were either used directly for histological 
staining or stored at -80°C. For paraffin sections PBS washed lungs were further 
processed in a dehydration series of 70% EtOH (o.n. at 4°C or for 2 h on a shaker at 
RT), 80% EtOH, 90% EtOH, 100% EtOH (Rothipuran® Ethanol > 99.8 % (EtOH); 
#9065.4 - Roth) for 2h on a shaker at RT each step. Lung samples were then 
incubated in 100% isopropanol (2h or o.n. on a shaker, RT) and after that transferred 
to 1:1 isopropanol/paraffin mix at 65°C for several hours (min. 2h). Finally the lungs 
were transferred to 100% paraffin at 65°C o.n. and before embedding in molds they 
were subjected to a vacuum oven at 65°C to better penetrate the tissue with paraffin 
and to get rid of residual air in the lung lumen. The sections were performed with a 
microtome (Leica RM2265) at 5 – 10 µm and collected on a glass slide (Superfrost 
Ultra Plus®; #J3800AMNZ – Thermo Scientific). Sections were dried on a heating 
plate (42°C; HI1220 – Leica) and stored in a box at RT.      
2.10.2 HE-staining 
Paraffin sections were first deparaffinized (2 x xylene, 5 min; Xylene > 98 % #9713.3 
– Roth) and then rehydrated in a decreasing EtOH row (100%, 90%, 80%, 70%) and 
finally dipped in ddH2O. At -80°C stored cryosections were thawed and dried for 30 
min at RT and then rinsed with ddH2O for 5 min (shaker) to remove Tissue Tec. After 
washing the slides were transferred to Mayer’s hematoxylin (Haemalum, acidic #2E-
038 – Waldeck) and incubated 10 min at RT to stain the nuclei. Subsequently, the 
sections were cleared 10 min in running tap water then dipped 10 times in 2% 
HCL/70% EtOH followed by 2 times in ddH2O. After that the slides were incubated 
in eosine (Eosine Solution, #2C-140 – Waldeck) for 7 min. After the eosin staining 
the slides were dehydrated again in an increasing EtOH series (70%, 80%, 90%, 96% 
- 2 dips each, 100% EtOH 5 min). Finally sections were fixed in xylene (twice 5 min) 
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and mounted with Entellan (Entellan®, #107960, Merck). Images were acquired with 
a Keyence microscope (Keyence BZ-9000) or Zeiss Axioplan 2 microscope. 
2.10.3 Trichrome staining 
Paraffin sections were first deparaffinized and rehydrated (2.10.2). Cryosections were 
thawed and cleaned of Tissue Tec (2.10.2). The sections were stained using the 
Masson-Trichrome kit (HT15, Sigma). Both paraffin and cryosections were then 
processed the same way. After the sections were washed they were incubated at 56 °C 
for 15 min in preheated Bouin’s solution. The slides were then first rinsed in running 
tap water for 20-25 min and shortly dipped in ddH2O. Subsequently, sections were 
incubated 5 min in Mayer’s hematoxylin (Haemalum) to stain the nuclei followed by 
5 min in Biebrich Scarlet-Acid Fuchsin solution, 5 min in working Phosphotungstic/ 
Phosphomolybdic acid/ddH2O solution (1:1:2), 5 min in Anilin Blue solution and 
finally 2 min in acetic acid 1%. Between each step the slides were rinsed in running 
tap water for 5 minutes followed by a short dip in ddH2O. The sections were then 
dehydrated again in an increasing EtOH series (90% EtOH for 2 sec, 96% EtOH for 2 
sec, twice 2 min in 100% EtOH). Finally the sections were fixed twice in xylene for 
10 min each and subsequently mounted with Entellan (Entellan®, #107960, Merck). 
Images were acquired with a Keyence BZ-9000 or Zeiss Axioplan 2 microscope. 
2.10.4 Immunofluorescence analysis 
In order to examine subcellular protein localizations and abundance we made use of 
immunofluorescence labeling of fixed cultured cells and tissue sections. Therefor we 
used a standard antibody staining protocol as described in the data sheet of the 
antibodies (Table 14). It was adjusted depending on the examined cells or tissues. For 
the purpose of immunocytochemistry we first washed (1 x PBS) and fixed (4% PFA, 
1-5 min, RT) cells that were either cultured on cover slips (cover slips 13 mm, 
#41001113 – Hecht-Assistent) or chamber slides (Lab Tek® Chamber SlideTM system, 
4-well Permanox® Slide, #177437 Nunc/Sigma-Aldrich). After that, cells were 
permeabilized (0.1 – 0.3% Triton X100, #6683.1 – Roth) and blocked with a blocking 
solution containing 1% bovine serum albumin (30% BSA, #A7284-500ML – Sigma-
Aldrich), 5% normal goat serum (NGS, #16210-064 – Gibco), 0.1% Triton X100 in 
1x PBS. Subsequently, the blocked cells were incubated with the appropriate primary 
antibody (Table 14) in blocking solution in a humidified chamber o.n. at 4°C. Cells 
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on cover slips were incubated upside-down in a drop of antibody/blocking solution 
(25 µl) on a strip of parafilm (Parafilm® ‘M’ #P7793-1EA – Sigma-Aldrich) while 
cells on a chamberslide were sealed with parafilm. After primary antibody incubation 
the cells were washed 3 times with 1x PBS and then incubated with an appropriate 
secondary antibody (Table 14) in 1x PBS for 2 h at RT in a humidified chamber 
(dark). Finally, the cells were washed again thrice with 1x PBS, nuclei were stained 
with DAPI for 10 min at RT (1:1000 in 1x PBS, #D1306 – Molecular ProbesTM, 
Thermo Fisher), again washed with 1x PBS and mounted with Mowiol (Mowiol® 4-
88, #475904-100GM – Merck Millipore).  
Paraffin sections were first deparaffinized and hydrated (2.10.2). In order to perform 
an antigen retrieval the slides were then cooked in sodium citrate buffer (Table 38) in 
a microwave for 12 min and cooled down at RT. The slides were then treated as cells 
described above. 
Cryosections were thawed and cleaned of Tissue Tec (2.10.2). The slides were then 
treated like cells as described above. Numb antibody staining in tissue sections was 
performed with a TSATM Fluorescein amplification kit (TSATM Fluorescein System 
#NEL701A001KT – Perkin Elmer) and the use of TN buffer (Table 39). 
Immunofluorescence pictures were acquired either with a fluorescence microscope 
(Zeiss Z1, Zeiss Imager) or a confocal laser scanning microscope (CLSM - Leica TCS 
SP2, AOBS) as z-stacks. The acquired images were further processed either with Zen 
software (Zeiss Z1) or multichannel image processing software (Bitplane, Zürich, 
Switzerland). The images were further edited and merged with Adobe Photoshop 
software CC2014. 
2.10.5 Counting of immunofluorescence labeled cells 
In order to determine ATII cell numbers in adult mouse lung (8 week old) 
cryosections were performed as described in 2.10.1 and 5 slides (2-3 consecutive 
sections each) with a distance of about 50 µm to each other were collected for each 
mouse lung. Immunofluorescence double staining was performed using both anti-SPC 
to stain for ATII cells and anti-CC10 to distinguish Clara Cells. As secondary 
antibodies anti-rabbit Alexa594 (ATII cells) and anti-goat Alexa488 (Clara Cells) 
were used (antibodies: Table 14). Nuclei were stained with DAPI (2.10.4). 5 eye 
fields per lung section on one slide were acquired randomly by CLSM in z-stacks 
(2.10.4), edited with Adobe Photoshop CC2014 and analyzed with ImageJ software 
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1.49r (Wayne Rasband – National Institutes of Health, USA). 15 eye fields in total 
were analyzed. Only SPC+/ DAPI+ cells were counted as one event (ATII cell) and 
compared to the total cell number (DAPI+ cells of all eye fields). Double positive 
SPC+/CC10+ as well as single positive CC10+ cells were not counted.  
2.11 Pathology model 
2.11.1 Bleomycin induced lung fibrosis 
In order to induce lung fibrosis in our mice we made use of the quite well established 
bleomycin injury model [62, 136, 137]. The animals that we used for these 
experiments were male dKO and Ctrl (SPCrtTA//Cre//Numb//Numblike//RosaYFP) 
mice at an age of 10-12 weeks upon application of bleomycin. Therefor, we dissolved 
bleomycin sulphate (Bleomedac®, 15 mg, 15 USPI) in sterile NaCl solution (0.9 % 
NaCl – B Braun) and instilled the animals with a single dose of 0.0675 mg in 90 µl 
NaCl solution (2.5 U/kg BW) orotrachealy. As controls, both groups of mice were 
instilled only with NaCl solution. Treated animals were then sacrificed 14 and 21 
days after induction of fibrosis by bleomycin and further analyzed. 
2.11.2 Lung compliance measurement 
The in vivo lung function measurements were performed in using the flexiVentTM 
system (Scireq®, Emka Technologies) [138, 139]. Bleomycin treated animals that 
were analyzed at 14 and 21 days post injury were first narcotisized as described 
previously and then immediately subjected to the flexiVentTM analyzer to assess lung 
compliance parameters such as lung volume, dynamic (Crs) and static (Cst/kg) 
compliance, tissue elastance (dynamic elastance) and tissue damping (dynamic 
resistance). The data acquisition was performed by flexiWare software (Scireq®, 
Emka Technologies) and results were exported to Microsoft Excel and further 
analyzed with Prism 5 software (GraphPad). 
2.11.3 Sircol Collagen Assay 
The total collagen contents of bleomycin treated animals as well as the control groups 
were determined by SIRCOL Collagen Assay (Sircol Collagen Assay Kit: Standard 
Assay (120 assays), #S1000 – Biocolor Ltd.) as described by the manufacturers 
protocol. This assay detects all collagen derivatives in total lung homogenates and 
thereby total collagen content in relation to total lung protein was quantified. 
MATERIAL AND METHODS 
 61 
2.11.4 Fibrotic Score 
In order to assess the actual degree of lung fibrosis in bleomycin treated animals, total 
lung sections were evaluated according to their amount of fibrotic foci by fibrotic 
scoring. Therefore, pictures of whole Trichrome or HE-stained lung tissue sections 
from bleomycin treated animals were acquired with a Keyence BZ-9000 microscope 
and merged lung pictures were randomly chosen for scoring. Each of the 
corresponding single pictures from a whole section scan was then analyzed and values 
from 0 (not fibrotic) to 7 (highly fibrotic) were assigned for all high power fields. The 
scoring results were averaged and presented in a bar diagram (Prism; GraphPad). 
2.12 Statistical analysis 
Data and results were analyzed and visualized with Microsoft Excel 2011 (Microsoft) 
and Prism software version 5 (GraphPad Software, San Diego, CA). Results are 
presented as mean ±SEM and P-values were determined by two-tailed Student’s t-test 
(unpaired). Values of P < 0.05 were considered as significant and n represents the 
number of separate experiments performed. 
2.13 List of Antibodies 
Antibodies Cat. No - Distributor Dilution (WB/ IF/IP) 
Anti-Numb (C29G11) #2756 – Cell Signaling 1:1000/ 1:200-1:1000/ - 
Anti-Numblike #101111-AP – Proteintech 1:1000/ 1:200/ - 
Anti-Numblike (NUMBL) #ab37500 – Abcam 1:500/ 1:200/ - 
Anti-E-Cadherin [DECMA-1] #ab11512 – Abcam 1:1000/ 1:50/ - 
Anit-ß-Catenin (pan) #9562 – Cell Signaling 1:1000/ 1:100/ - 
Anti-phospho-ß-Catenin 
(Ser33/37/Thr41) 
#9561 – Cell Signaling 1:1000/ -/ - 
Anti-non-phospho (active)  
ß-Catenin (Ser33/37/Thr41) 
#8814 – Cell Signaling 1:1000/ -/ - 
Anti-Cortactin #3502 – Cell Signaling 1:1000/ -/ - 
Anti-Cortactin (p80/85),  
Clone 4F11 
#05-180 – EMD Millipore -/ -/ 8µg per mg protein 
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Mouse IgG1 (G3A1) Isotype  
Control 
#5415S – Cell Signaling 
-/ -/ 6-8µg per mg 
protein 
Anti-CK2alpha #2656 – Cell Signaling 1:1000/ -/ - 
Anti-CK2alpha (8E5) 
#LF-MA0223 – Thermo 
Fisher 
-/ -/ 6µg per mg protein 
Anti-CK2beta 
#PA5-27416 – Thermo 
Fisher 
1:1000/ -/ - 
Anti-proSPC #AB3786 – Millipore  -/ 1:400/ - 
Anti-CC10 (T-18) #Sc-9772 - Santa Cruz -/ 1:200/ - 
Anti-ZO-1 (C-19) #Sc-8146 – Santa Cruz 1:500/ -/ - 
Anti-ZO-1/ TJP1  #40-2200 – Thermo Fisher -/ 1:100/ - 
Anti-rabbit-HRP (goat) #31460 – Thermo Fisher 1:1000/ -/ - 
Anti-mouse-HRP (goat) #31430 – Thermo Fisher 1:1000/ -/ - 
Anti-rat HRP (goat) #HAF005 – R&D Systems 1:1000/ -/ - 
Anti-rabbit Alexa488 (goat) #A11070 – Thermo Fisher -/ 1:1000/ - 
Anti-rabbit Alexa594 (goat) #A11012 – Thermo Fisher -/ 1:1000/ - 
Anti-rat Alexa594 (goat) #A11007 – Thermo Fisher -/ 1:1000/ - 
Table 14: Antibodies – Dilutions for Western Blot (WB), immunofluorescence (IF) and 
immunoprecipitation (IP) 
 
2.14 Buffers and solutions 
50x TAE (Tris-acetate-EDTA) 5 l 
Tris (#5429.2 – Roth) 1210 g 
100% Acetic acid 285.5 ml 
0.5 M EDTA 500 ml 
MilliQ-H2O, fill up to 5 L 
Table 15: 50x TAE 
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1x TAE 10 L 
50x TAE 200 ml 
MilliQ-H2O, fill up to 10 L 
Table 16: 1x TAE 
 
10x PBS 1 l 
NaCl (#3957.2 – Roth) 80 g (1.37 M) 
KCl (#6781.3 – Roth) 2 g (27 mM) 
Na2HPO4 14.4 g (100 mM) 
KH2PO4 2.4 g (18 mM) 
Dissolve in ddH2O 800 ml 
Adjust to pH 7.4 (30% HCL), fill up to  1 l 
Table 17: 10x PBS 
 
 
1x PBS 1 l 
10x PBS 100 ml 
H2O dest. 900 ml 
Table 18: 1x PBS 
 
1x Trypsin/EDTA (T/E) 10 ml 
10x T/E (Sigma) 1 ml 
Sterile 1x PBS 9 ml 
Table 19: 1x Trypsin/EDTA (T/E) 
 
Buffer I (4°C) 1 L 
5M EDTA 20 ml 
1M Tris-HCl pH 8.0 50 ml 
H2O dest. Add to 1 L 
Table 20: Buffer I (Mini-preparation) 
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Buffer II (RT) 1 L 
5M NaOH 40 ml 
20 % SDS (or 10g SDS) 50 ml 
H2O dest. Add to 1 L 
Table 21: Buffer II (Mini-preparation) 
 
Buffer III (4°C) 1 L 
3M Potassiumacetate 1 L 
Adjust to pH 5.5 with acetic acid dropwise 
Table 22: Buffer III (Mini-preparation) 
 
TENS-Buffer pH 7.4 500 ml 
1 M Tris/ HCl pH 8.0 25 ml 
0.5 M EDTA 40 ml 
10 % SDS 50 ml 
5 M NaCl 10 ml 
MilliO-H2O 375 ml 
Table 23: TENS-Buffer 
 
TE-Buffer (Tris-EDTA) 50 ml 
1 M Tris pH 8.0 0.5 ml 
0.5 M EDTA pH 8.0 0.1 ml 
MilliQ-H2O 49.4 ml 
Table 24: TE-Buffer 
 
5x LB-sample buffer 45 ml 
1M Tris-Hcl pH 6.8 3 ml 
10% SDS 10 ml 
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H2O 32 ml 
Table 25: 5x LB-sample buffer 
 
Extraction buffer (EP) 100 ml 
1M Tris HCL pH 8.0 10 ml 
SDS powder (#2326.2 – Roth) 10g (=10%) 
EDTA 0,372g 
H2O 50 ml 
With 30% HCl Adjust pH 8.0 
Add H2O To 100 ml 
Aliquots to store at -80°C 2 ml, 10 ml  
Table 26: Extraction buffer (EP) 
 
RIPA modified buffer pH 7.4 100 ml 
1M Tris/HCL pH 7.5 5 ml 
10 % NP-40 (Roth) 10 ml 
Sodium-desoxycholate (Sigma) 0.25 g 
1M NaCl 15 ml 
0.5 M EDTA 200 µl 
Fill up with H2O 70 ml 
Table 27: RIPA modified buffer 
 
 
Dilution/Wash buffer (DB/WB) 100 ml 
1M Tris/HCl pH 7.5 1 ml 
1M NaCl 15 ml 
0.5 M EDTA 100 µl 
Add H2O 84 ml 
Table 28: Dilution/Wash buffer (DB/WB) 
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Protease inhibitors Per 1 ml of lysis buffer 
Benzamidine (250mg/ml) 2µl 
Aprotinin (2mg/ml) 1µl 
Leupetin (2mg/ml) 1µl 
PMSF (0,2M) 10µl 
Na3VO4 (1M) 1µl 
NaF (1M) 20µl 
Table 29: Protease inhibitors 
 
NuPAGE® MOPS SDS running buffer 2.5 l 
20x MOPS (#NP0001-02 – Invitrogen) 0.125 l 
Milli-Q H2O 2.375 l 
Table 30: MOPS running buffer 
 
NuPAGE® MES SDS running buffer 2.5 l 
20x MES (#NP0002-02 – Invitrogen) 0.125 l 
Milli-Q H2O 2.375 l 
Table 31: MES running buffer 
 
1x Transfer buffer 5 l 
100% MeOH 0.250 l 
20x Transfer buffer 1 l 
Milli-Q H2O 3.750 l 
Table 32: 1x Transfer buffer 
 
20x Transfer buffer 2 l 
Bicine 163.2 g 
Bis-Tris 209.6 g 
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EDTA 12 g 
Milli-Q H2O, fill up to 2 l 
Table 33: 10x Transfer buffer 
 
10x TBS 1 l 
NaCl 80 g 
KCl 2g 
1 M Tris pH 7.5 25 ml 
MilliQ-H2O, fill up to 1 l 
Table 34: 10x TBS-T 
 
1x TBS-T 1 l 
10x TBS 100 ml 
Tween 20® (#9127.2 – Roth) 1 ml 
MilliQ-H2O 900 ml 
Table 35: 1x TBS-T 
 
9% Bis-Tris Polyacrylamid gel PAA  
Separation gel: 9 % 
Rotiphorese® Gel 30 (37.5:1) (#3029.1 – 
Roth) 
2.1 ml 
3.5 x bis-Tris pH 6.5 – 6.8 2 ml 
Milli-Q H2O 2.9 ml 
10 % Ammoniumperoxo-disulfat (APS 
#1.01201 - Merck) 
25 µl 
TEMED (#2367.1 – Roth) 7 µl 
Stacking gel: 5 % 
Rotiphorese® Gel 30 (37.5:1) (#3029.1 – 
Roth) 
0.29 ml 
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3.5 x bis-Tris pH 6.5 – 6.8 0.5 ml 
Milli-Q H2O 0.96 ml 
10 % Ammoniumperoxo-disulfat  8 µl 
TEMED  3 µl 
Table 36: 9% Bis-Tris Polyacrylamid Gel 
 
 
FACS sorting buffer 100 ml 
0.5 M EDTA pH 8.0 1 ml 
1 M HEPES 2.5 ml 
1x PBS 96.5 ml 
Table 37: FACS sorting buffer 
 
Sodium citrate buffer pH 6.0 1 L 
Tri-sodium citrate (dihydrate) 1.47 g 
Dissolve in ddH2O 800 ml 
Adjust to pH 6.0 (30% HCl), fill up to 1 L 
Add Tween 20 250 µl 
Table 38: Sodium citrate buffer 
 
TN buffer pH 7.4 1 L 
1 M Tris/ HCl pH 7.5 100 ml 
1 M NaCl 150 ml 
MilliQ-H2O 750 ml 
Adjust to pH 7.4 (30 % HCl) Few drops 
Table 39: TN buffer 
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3 RESULTS 
3.1 Lung epithelial specific inactivation of Numb on a 
Numblike deficient background in mice exhibits mild 
structural phenotype and does not affect viability 
As previously described, constitutive gene inactivation of both Numb alleles in mice 
results in embryonic lethality at day E11.5 associated with neuronal defects as well as 
extensive bleeding, whereas single constitutive depletion of Numblike exhibits only a 
loss of fertility in females [117]. However, constitutive double knockout of both 
Numb and Numblike results in a more severe phenotype accompanied with an earlier 
embryonic lethality at E9.5 [118]. In order to study tissue specific functions of Numb 
and Numblike proteins, conditional inactivation strategies have been utilized and 
studied in brain or heart so far [2, 112, 118]. During heart development for example, 
myocardial directed inactivation of Numb/Numblike revealed that both proteins 
synergistically control myocardial compaction by inhibiting Notch-signaling pathway 
[2]. Actually, there are also investigations in murine lung associating Numb, amongst 
other polarity proteins, with functions in Eya1 controlled epithelial cell polarity as 
well as asymmetric cell division during lung morphogenesis [122]. Additionally, there 
is evidence showing that Numb might exhibit tumor suppressive potential in human 
non-small-cell lung carcinomas (NSCLCs) [127]. Nevertheless, the underlying 
mechanisms, in which Numb might be involved during these processes, remain poorly 
understood. In order to elucidate the functional impact of both proteins Numb and 
Numblike during lung epithelial development and regeneration, conditional loss-of-
function double mutants in mice were performed. 
3.1.1 Conditional Numb/Numblike double mutants display no obvious 
pulmonary epithelial defect 
In order to elucidate the role of Numb and Numblike specifically during murine lung 
epithelial development and regeneration conditional loss-of-function, double mutants 
were generated. The reverse tetracycline transactivator (rtTA) expressed under control 
of the lung epithelial specific Spc promoter (SPCrtTA [130]) was utilized to induce 
Cre-mediated (tetO-Cre) depletion of Numb (Numbfl/fl) on a Numblike deficient 
(Numblike+/-) background upon administration of doxycycline (Tet-On System). To 
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ensure complete recombination of Numbfl/fl in developing lung epithelium, mice 
received doxycycline (Dox) supplemented to their drinking water from gestation to 
postnatal stage P28 (Figure 6A). Offsprings were born according to Mendelian ratios 
and double homozygous Numb/Numblike mutants (dKO) are viable showing no 
severe phenotypic abnormalities of the lung. Additionally, the animals were combined 
with a fluorescent Cre-reporter (RosaYFP) to visualize and trace Cre activity and to 
obtain a tool that enables isolation of lung epithelial cells by FACS sorting (dKO: 
SPCrtTA+/-// tetO-Cre+/-// Numbfl/fl// Numblike-/-// RosaYFP+/-). Dox treated mice 
containing the wild type alleles for Numb and Numblike served as controls (WtCtrl: 
SPCrtTA+/-// tetO-Cre+/-// Numb+/+// Numblike+/+// RosaYFP+/-). As demonstrated in 
Figure 6E, Dox activation of the Cre system from gestation on results in a YFP 
positive lineage tracing of cells comprising the entire mature lung epithelium driven 
by the Alveolar Type II (ATII) cell-specific expression of SPCrtTA+/-//tetO-Cre+/- in a 
proximo-distal pattern. In order to test both the recombination efficiency of 
conditional Numb as well as constitutive Numblike deficiency, RNA of 8 week lungs 
was extracted to determine relative mRNA expression levels for both genes by 
TaqMan® Gene Expression analysis (Figure 6B). Since Numb is expressed in multiple 
cell types of the entire lung no significant reduction of relative mRNA level was 
detectable in the lung epithelial specific dKOs, while Numblike expression was absent 
compared to littermate controls (Ctrl). In order to enrich for a lung epithelial cell 
population, lineage traced YFP positive epithelial cells of dKOs and WtCtrl animals 
were FACS sorted and subjected to TaqMan® Gene Expression analysis. By using 
this approach, Numb expression of dKO derived epithelial cells revealed a dramatic 
and significant reduction in comparison to sorted primary lung epithelial cells from 
WtCtrl animals. This clearly demonstrated that Numbfl/fl was specifically depleted in 
lung epithelial cells, while surrounding mesenchymal cells remained unaffected. 
Numblike mRNA level of sorted epithelial dKO cells showed a robust loss of 
expression as well. Furthermore, protein analysis of total lung homogenates went in 
line with immunofluorescence analysis of embryonic (E16.5) and adult lungs, 
confirming decreased Numb and Numblike expression levels in dKOs (Figure 6C, D). 
Numb protein could be detected with a moderate but significant decrease in adult 
dKO lung homogenates, while immunostained embryonic and adult dKO lung 
sections displayed a specific Numb depletion restricted to lung epithelium from early 
lung development onwards. 
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Figure 6: Inducible conditional knockout of Numb in lung epithelium (Tet-ON). 
A: Mice were crossed as depicted. Induction of the Tet-ON system occurs after administration of 
doxycycline (Dox) supplemented drinking water. The lung specific SPC-promoter drives expression of 
the reverse Tetracycline Repressor domain (rTetR). In the presence of Dox reverse Tetracycline 
Transactivator (rtTA) is expressed and binds to the tet-operon of CMVCre (tetO-Cre). Expressed Cre 
mediates recombination of the floxed ATG region of Numb Exon1. B: Relative mRNA expression 
levels of total lung homogenates and FACS sorted YFP+ primary lung epithelial cells. C: Western Blot 
analysis of total lung protein (n=3 each group) for Numb and Numblike. Densitometry analysis vs. 
GAPDH. D: Cryosections of E16.5 and 8 week old lungs, isolated from dKO and littermate control 
mice treated with Dox, were immunostained for Numb (both) and Numblike (adult). Images were 
acquired as confocal z-stacks. Basal lamina is depicted by dashed line in white (E16.5). White stars 
depict epithelial cells (e.g. ATII) determined by E-Cadherin staining (here not shown). L highlights the 
primordial respiratory lumen. E: Cryosections of adult Dox treated animals, showing proximal and 
distal YFP+ labeled, E-Cadherin positive (E-Cad; red) lung epithelial cells vs. YFP- littermate controls. 
Pictures were acquired with a Leica confocal laser microscope as z-stacks. Scale bars in D: 12 µm 
(digital zoom of 63x magnification), in E: 75 µm (cropped image of 40x magnification). Graphs show 
mean ±SEM of n=3 animals each group with *p < 0.05, ***p < 0.001 and ns = not significant. 
RESULTS 
 72 
Numb expression in mesenchymal lung cells remained unaffected in the mutants, 
which is indicated by their positive indirect immunofluorescence labeling of Numb. 
Immunofluorescence analysis of Numblike showed a loss of protein abundance in the 
entire lung, which was consistent with the loss of relative mRNA expression and 
protein levels of Numblike in total lung homogenates (Figure 6B, C, D). Taken 
together, the data revealed an efficient and lung epithelial specific depletion of the 
floxed first exon encoding the ATG start codon of Numb, which terminates Numb 
translation in Dox induced dKOs. The loss-of-function studies for Numb and 
Numblike in lung epithelium showed that both are dispensable for lung development, 
maturation and maintenance and consequently for survival of the animals.  
3.1.2 Loss of Numb/Numblike in lung epithelium results in reduction of 
ATII cell numbers 
The early embryonic depletion of Numb and Numblike in lung epithelium didn’t affect 
overall lung architecture and had no impact on the viability of dKOs (examination of 
lung structure on HE-stained lung sections, data not shown). However, the Dox 
induced ablation of Numb on a Numblike deficient background was efficient and 
specifically restricted to lung epithelium. In order to get a deeper insight into subtle 
changes of the lung epithelium, mRNA expression of well-defined characteristic 
epithelial marker genes was analyzed to deduce potential changes of different cell 
type abundance along the proximo-distal axis of mature lung epithelium. This 
analysis was performed by using cDNA of total adult lung homogenates and taking in 
consideration that relative expression levels of the examined marker genes correlate to 
the relative cell abundance in the epithelium. The data showed that the expression 
profiles for all tested lung epithelial specific cell marker genes, Pdpn (ATI cell), Sftpc 
(ATII cell), Scgb1a1 (Clara cell), Foxj1 (Ciliated cell) and Ascl2 (Neuroendocrine 
cell), remained unaffected in dKOs except the ATII cell specific Sftpc (SPC) marker 
gene expression, which was significantly decreased by nearly 50 % (Figure 7A). In 
order to correlate the reduced Sftpc expression with ATII cell abundance in the lung 
epithelium of dKOs, tissue sections of mature lungs were labeled with anti-SP-C 
antibody and SP-C+ cells were quantified compared to total cell numbers (DAPI+) per 
high power field (hpf). The results documented that dKOs indeed exhibited a 
significant decrease of SP-C+ labeled ATII cells around nearly one third compared to 
SP-C+ positive cells in Ctrl animals (Figure 7B). This data could be additionally 
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confirmed by quantification of ATII cells on ultrastructural images acquired by 
electron microscopy (Data by Dr. Sawa Kostin, Figure 7C).  
 
 
Figure 7: Reduction of ATII cell abundance in Numb/Numblike dKOs. 
A: Relative expression levels of lung epithelial cell markers of total adult lung RNA. TaqMan® Gene 
Expression probes were used to analyse specific marker genes for ATI cells (pdpn, Podoplanin), ATII 
cells (sftpc, SP-C), Clara cells (scgb1a1, CC10), Ciliated cells (foxj1, Foxj1) and Neuroendocrine cells 
(ascl2, Mash2). B: Cryosections (5µm) of adult dKO and Ctrl lungs immunostained for SP-C (red). 
Three serial lung sections with a distance of 50µm between each other were analyzed per animal. 
Quantification of SP-C+ cells to total cell numbers (DAPI) of 5 randomly acquired confocal z-stack 
images per tissue section. Images at a magnification of 63x, Scale bars 47 µm C: Ultrastructural 
analysis of adult dKO and Ctrl lungs by electron microscopy. Red stars refer to ATII cells that could be 
determined by characteristic ultrastructural features on the image (scale bar 5 µm). All graphs show 
mean ±SEM of n=3 animals each group with *p < 0.05, **p < 0.01 and ns = not significant.  
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3.1.3 Numb/Numblike mediate cell-cell contacts and apico-basal 
epithelial cell polarity 
It has been previously shown that the loss of Numb can influence cell-cell contacts as 
well as an apico-basal polarity of epithelial cells in vitro [10]. In this respect, the 
epithelial cell marker E-Cadherin and its interaction with membrane located Numb 
play an important role. Numb regulates the localization of E-Cadherin to the lateral 
domain of epithelial cell-cell junctions in polarized cells. Reduced Numb protein level 
in these cells promoted by shRNA mediated silencing of Numb expression results in 
baso-lateral to apico-lateral translocation of E-Cadherin and ß-Catenin [10]. Hence, 
the subcellular localization of the adherens junction mediating E-Cadherin was 
examined in dKOs at embryonic stage E16.5 as well as in mature lung epithelium. 
Therefore, immunofluorescence stainings for E-Cadherin and Numb were performed 
on embryonic lungs (E16.5) and adult lungs. Analysis of these stainings revealed a 
translocation of E-Cadherin from baso-lateral to apico-lateral in E16.5 dKO lung 
epithelium in the absence of Numb (Figure 8A), whereas Numb and E-Cadherin 
partially co-localize at the baso-lateral membrane in epithelial cells of control lungs. 
The same phenomenon was observed in mature lung epithelium of dKO animals 
where mislocalized E-Cadherin was identified along the entire proximo-distal axis of 
lung epithelium in an apico-lateral pattern upon loss of Numb and Numblike (Figure 
8B). However, ultrastructural analysis of proximal epithelial cells from adult dKO 
lungs revealed no changes in the presence of cell-cell contacts compared to Ctrl lungs. 
In both groups contact zones could be classified by their morphology in tight junction 
(TJ), adherence junction (AJ) and desmosome (Ds) zones (Figure 8C). Yet, 
ultrastructural analysis of epithelial cell-cell contacts in dKO and Ctrl lungs were not 
statistically evaluated or quantified concerning parameters such as contact zone 
length, interstitial gap opening or numbers of TJ, AJ as well as Ds, which might 
indicate alterations in quality and numbers of contact zones of dKOs. Furthermore, 
previous studies revealed direct interaction between ß-Catenin and E-Cadherin in 
epithelial cells and subcellular localization of ß-Catenin can be influenced by the 
mislocalization of E-Cadherin upon loss of Numb [10, 140, 141]. Accordingly, ß-
Catenin localization was examined in E16.5 dKO lungs where a similar translocation 
of the membrane-tethered E-Cadherin to apical membrane was initially illustrated 
(Figure 8A).  
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Figure 8: Mislocalization of E-Cadherin in Numb/Numblike depleted lung epithelium. 
A + B: Immunofluorescense images for E-Cadherin (red) and Numb (green) of E16.5 and adult lungs. 
Confocal images acquired as z-stacks. Scale bars 12.37 µm (A) and 12 µm (B). Zoom of 63x 
magnification. White dashed lines resemble basal lamina while L highlights the lumen. Stars highlight 
distal ATII cells C: Ultrastructural analysis of cell-cell contacts between proximal lung epithelial cells 
of n = 2 dKO and Ctrl. Scale bar 250 nm. L represents the luminal (apical) side of the epithelium. Cell 
contacts between epithelial cells of dKO and Ctrl are marked by regions of tight junctions (TJ), 
adherence junctions (AJ) and desmosomes (Ds). 
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Additionally, immunofluorescence labeling of ß-Catenin also displayed translocation 
of the protein in primordial lung epithelial cells of E16.5 dKOs to apical cellular 
compartments (Figure 9A). This translocation is nicely depicted by cross-sectional 
projections of x/z and y/z as well as by x/y views of confocal z-stacks where ß-
Catenin positive signal appeared more at the luminal (apical) borders (L) of 
embryonic epithelium, whereas ß-Catenin in E16.5 Ctrls mainly localized at the 
membrane in a baso-lateral pattern. Hence, these results clearly indicated a 
disorganization of E-Cadherin and ß-Catenin, which are both components of the 
adherence junction complex mediating cell-cell contacts [142]. In order to examine 
the state of tight junction mediated cell contacts in Numb and Numblike depleted lung 
epithelium, localization of the tight junction protein ZO-1 was determined in the lung 
epithelial membrane of E16.5 dKOs and their littermate controls by 
immunofluorescence labeling (Figure 9B).  
 
 
Figure 9: Mislocalization of ß-Catenin and ZO-1 in E16.5 lung epithelium. 
A: Cryosections of E16.5 lung immunostained for ß-Catenin. B: Cryosections of E16.5 lung 
immunostained for ZO-1. Dashed lines in A + B represent the basal lamina. L = lumen. Pictures were 
acquired by CLSM as z-stacks and depicted as cross-sections with x/y, x/z, y/z projection. Digital 
zoom of 63x magnification with scale bar at 12µm. Randomly chosen cryosections of n=3 animals 
each group were stained and analyzed. C: Western blot analysis of total E16.5 lung protein 
homogenate for E-Cadherin (E-Cad), ZO-1, pan-ß-Catenin (pan ß-Cat), phospho-ß-Catenin Ser33/37- 
Thr41 (phospho-ß-Cat) and corresponding densitometry vs. GAPDH. n=4 animals each group. All 
graphs show mean ±SEM with **p < 0.01 and ns = not significant.  
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In addition to mislocalization of E-Cadherin and ß-Catenin, the tight junction protein 
ZO-1 also mislocalized in an apical and diffuse pattern in comparison to Ctrls, which 
were marked by defined localization of ZO-1 at the apico-lateral membrane of contact 
zones between epithelial cells. Even though the abundance of ZO-1 signal in E16.5 
dKOs seems slightly weaker compared to control staining, quantitative Western blot 
analysis of total E16.5 lung protein homogenates revealed no significant changes of 
ZO-1 protein abundance (Figure 9C). In order to examine potential alterations of E-
Cadherin and ß-Catenin on the protein level as well, which might accompany their 
subcellular mislocalization, quantitative Western blot analysis of total E16.5 lung 
protein homogenates were performed. Both phospho-ß-Catenin and total ß-Catenin 
(pan) levels remained unaffected in total lung protein of E16.5 dKOs, while E-
Cadherin protein level was significantly increased by two-fold. However, E-Cadherin 
level of total protein homogenates derived from adult dKO lungs was not altered in 
comparison to Ctrl (Figure 10C), while the mislocalization of E-Cadherin in the 
membrane of adult epithelium was still maintained, as described before (Figure 8B). 
Similar to the observations at embryonic stage E16.5, mislocalization of ß-Catenin 
concomitantly to E-Cadherin could be confirmed at adult stages as well. Apical 
localization and accumulation of ß-Catenin in epithelial cells of adult dKO lungs 
could be detected by confocal laser microscopy and was highlighted by white arrows 
on corresponding cross-sectional projections of confocal z-stacks (Figure 10A). This 
translocation of ß-Catenin to the luminal (L) side of the epithelium in dKOs could be 
also observed on x/z and y/z confocal projections, while epithelium of Ctrl lungs 
displayed normal basol-lateral localization of ß-Catenin in all projections. Moreover, 
alveolar compartments of dKO lungs contained ß-Catenin negative ATII cells, 
whereas ATII cells of Ctrls exhibited membrane abundance of ß-Catenin (white 
stars). This partial lack of ß-Catenin could be further verified by Western blot analysis 
of total lung homogenates. Here, significantly decreased protein levels could be 
detected for phospho-ß-Catenin Ser33/37-Thr41 as well as for the active (non-
phosphorylated) form of ß-Catenin, while total ß-Catenin protein amounts remained 
unaltered for both groups (Figure 10C). Similar to E16.5, adult dKO lung epithelium 
displayed a decrease of ZO-1 signal detected by immunohistochemistry and a 
significant reduction of ZO-1 protein level revealed by Western blots from total lung 
homogenates (Figure 10B, C). ZO-1 positive clusters of tight junctions between 
adjacent membranes of distal lung epithelial cells were highlighted by white arrows 
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on cross-sections of confocal z-stacks and were additionally visualized as x/z or y/z 
confocal projections (Figure 10B). These tight junction clusters were barely 
detectable at contact zones of lung epithelial cells in dKO lungs (see white stars 
Figure 10B).  
 
 
Figure 10: Mislocalization and downregulation of ß-Catenin and ZO-1 in adult lung epithelium. 
A: Cryosections of adult lung immunostained for ß-Catenin. Dashed lines represent the basal lamina. 
B: Cryosections of adult lung immunostained for ZO-1. L = lumen. Pictures were acquired by CLSM 
as z-stacks and depicted as cross-section with x/y, x/z, y/z projection. Digital zoom of 63x 
magnification with scale bar at 12µm. Randomly chosen cryosections of n=3 animals each group were 
stained and analyzed. C: Western blot analysis of E-Cadherin (E-Cad), ZO-1, active ß-Catenin (active 
ß-Cat), pan-ß-Catenin (pan ß-Cat), phospho-ß-Catenin (phospho-ß-Cat) from total adult lung protein 
homogenates and corresponding densitometry vs. GAPDH. n=3 animals each group. D: Analysis of 
epithelial barrier leakage. n=4 animals each group were i.p. injected with 1% Evans Blue Dye (EBD) in 
0.9% NaCl solution. After 2h of incubation, first bronchio-alveolar lavage (BAL) was performed and 
BAL fluid collected. Blood was collected via the eyes. Finally, mice were sacrificed and EBD was 
extracted from isolated lung tissue as control for accumulation of dye in lung interstitial spaces (ng 
EBD/mg tissue). Epithelial barrier leakage was determined as percentage EBD in BAL/Serum. All 
graphs show mean ±SEM with *p < 0.05, **p < 0.01 and ns = not significant. 
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Alterations in abundance and localization of adherens and tight junction proteins in 
dKO animals might influence and destabilize the maintenance of the epithelial barrier 
function and thereby the integrity of the entire lung epithelium as well. In order to 
examine potential epithelial barrier leakage in dKO compared to Ctrl lungs, intra 
peritoneal (i.p.) injections of 1% Evans Blue Dye (EBD) solution were conducted and 
leakage of the dye into lung cavity was measured for both groups. After two hours of 
incubation a lung lavage was performed and bronchio-alveo-lavage fluid (BAL) as 
well as blood serum were collected to assess the percentage of EBD BAL/Serum ratio 
by calculating OD600 of BAL and blood serum. This ratio provides information about 
the amount of EBD, which passes the epithelial barrier to the lung lumen. The results 
clearly displayed a more than two-fold increase of EBD BAL/serum ratio for dKOs in 
comparison to Ctrls (Figure 10D). In fact, this strongly indicated a disruption of the 
lung epithelial barrier function, which strengthened the hypothesis of a compromised 
lung epithelial integrity in Numb/Numblike dKOs. The amount of EBD, which 
accumulated in lung interstitial spaces during incubation time, is displayed by the 
amount (ng) of extracted EBD per mg lung tissue (Figure 10D; second graph). These 
results indicated to what extent EBD was absorbed and retained by the interstitium 
and thereby served as an experimental control. After isolation of lung tissue and 
extraction of EBD absorbed by the pulmonary interstitium, the amount of EBD/mg 
lung tissue (ng EBD/mg lung tissue) was determined. Both groups did not reveal any 
significant differences in the amount of EBD that accumulated in lung interstitial 
spaces indicating that the absorption of the dye by the interstitium of dKO and Ctrl 
lungs was equal. Hence, the elevated EBD measured in the lung cavity (BAL) of dKO 
mice clearly resulted by an enhanced paracellular dye leakage via the epithelium, 
whereas the content of the dye that remained in lung interstitial spaces of lungs was 
similar for both groups. In summary, these results suggested that Numb and Numblike 
mediate lung epithelial cell polarity as well as the maintenance of cell-cell contacts. 
3.2 Numb/Numblike in bleomycin induced fibrosis 
3.2.1 Loss of Numb and Numblike is beneficial for survival after lung 
injury 
Previous results of this study unveiled that the conditional lung epithelial specific 
depletion of Numb on a Numblike deficient background neither has impact on lung 
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development and maturation nor leads to any severe phenotypic abnormalities of the 
lung. In order to investigate potential functions of Numb and Numblike in the 
regeneration of respiratory epithelium, lung damage experiments were performed. A 
well-characterized and suitable model to study this is the bleomycin-induced damage 
of distal epithelial airway cells [62, 143-145]. The application of bleomycin (bleo) via 
the trachea leads to an inflammation of mouse lung distal alveolar compartments 
accompanied by a massive onset of fibrogenesis during regeneration, which is 
characterized by collagen deposition in the extracellular matrix of alveolar epithelial 
cells as well as by scar formation [146, 147]. In order to achieve a maximal challenge 
of dKO and Ctrl lungs, bleomycin was administered intratrachealy with sub lethal 
doses of 2.5 U/Kg, while dKO and Ctrl animals treated only with vehicle served as 
non-injured controls. Males at an age of 10 to 12 weeks were injured and analyzed 14 
respectively 21 days after bleomycin application (Figure 11A).  
 
 
Figure 11: Enhanced survival of bleomycin treated Numb/Numblike deficient animals.  
A: 10 to 12 week old males were treated with bleomycin with a dose of 2.5 U/kg at day 0 (0 d). B: 
Survival curve of bleomycin treated animals. Bleomycin challenged dKO animals (n = 10) showed a 
survival rate of about 70%. Ctrls (n = 11) died approximately 10 to 14 days after treatment. Curve 
comparison by Mantel-Cox test p = 0.0028. C: Compliance parameters of narcotized mice were 
measured with FlexiVent system 14 and 21 days after injury (14 d, 21 d). Subsequently, BAL fluid was 
taken from each lung followed by the isolation of both lung lobes. Total left lobe was used for 
histologigal analyses while right lobes were isolated to prepare either RNA or protein. n = 8 NaCl Ctrl, 
n = 7 NaCl dKO, n = 10 Bleo 14 d Ctrl, n = 6 Bleo 14 d dKO, n  = 3 Bleo 21 d Ctrl and n = 5 Bleo 21 d 
dKO animals were analyzed. All graphs show mean ±SEM with *p < 0.05, **p < 0.01. 
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The most striking difference upon lung damage was a significantly improved survival 
of Numb/Numblike dKOs about 70 % after 21 days, while the majority of control mice 
died 15 days after injury (Figure 11B). In order to better characterize the degree of 
fibrotic lesion, lung compliance measurements of narcotized animals were performed 
14 respectively 21 days after bleomycin and vehicle treatment (Figure 11C). Lung 
compliance parameters, which provided information about lung functionality in 
injured dKO and Ctrl mice, were assessed using flexiVentTM analyzer. One of these 
parameters is represented by the lung volume, which reflects the inspiratory capacity 
of the lung in relation to body weight (ml/kg) [148, 149]. In patients with idiopathic 
pulmonary fibrosis (IPF) as well as in experimental lung fibrosis in mice, lung tissue 
is degenerated, stiff and less flexible due to excessive incorporation of extracellular 
matrix proteins into alveolar walls [69, 71]. Hence, inspiratory capacity decreases 
with an increased degree of lung fibrosis [150]. Accordingly, lung volume (ml/kg) of 
bleomycin treated Ctrl mice displayed a reduction by one half for both analyzed time 
points (Figure 11C; first graph). However, lung volume of treated dKOs remained 
relatively normal at 14 respectively 21 days. Moreover, the measurements revealed a 
slightly higher inspiratory capacity of non-injured NaCl treated dKO lungs compared 
to the non-injured Ctrls. Furthermore, dynamic and static compliance resemble 
parameters, which characterize the expansibility of the lung volume in relation to 
pressure [148-150]. According to degeneration and increased stiffness of fibrotic 
lungs, the volume and ease, by which these lungs can be extended at a constant 
pressure, is markedly reduced compared to healthy lungs. These volume alterations in 
relation to pressure are expressed by the dynamic compliance (Crs), which declines 
the more severe lungs are disrupted by fibrosis. Strikingly, the Crs (ml/cmH2O) 
remained only moderately reduced in bleomycin treated dKO lungs reflecting a lower 
degree of fibrotic lung stiffness accompanied by better lung functionality. In contrast, 
injured Ctrl lungs displayed a dramatic reduction of volume per pressure ratios (Crs) 
by one half at 14 days and by two third at 21 days after bleomycin administration in 
comparison to treated dKOs indicating profound fibrotic injury in Ctrl animals 
(Figure 11C; second graph panel). In order to expand fibrotic lungs with the same 
volume of normal lungs, higher pressures are needed due to their stiffness. This static 
elastic recoil pressure of the lung at a given lung volume in relation to the body 
weight is reflected by the static compliance (Cst/kg), which declines like the Crs with 
an increased degree of fibrosis [150, 151]. In line with the previous Crs results, static 
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compliance values (ml/cmH2O*kg) significantly sloped to a similar degree in fibrotic 
Ctrl lungs of about one half at 14 days and two third at 21 days after bleomycin 
treatment compared to treated dKOs. These displayed a static compliance with 
moderate reduction, similar to their Crs values, at both time points, which further 
argued for ameliorated fibrosis in dKO lungs. The previous compliance parameters 
directly revealed alterations in respiratory tissue mechanics of diseased lungs. In order 
to obtain more detailed insights into airway mechanics of injured lungs as well, tissue 
damping and elastance were analyzed in bleomycin treated and non-treated mice 
(Figure 11C; third graph panel). Tissue damping is related to the resistance of lung 
tissue and reflects the energy dissipation in the alveoli at increasing pressure in 
relation to the volume [148]. In healthy lungs lower energy (pressure) is dissipated 
from alveolar walls due to their higher elasticity compared to collagen enriched 
fibrotic alveoli. Thus, the more severe lungs are affected by fibrosis the more 
respiratory pressure is adsorbed by alveolar walls. Consequently, a higher pressure is 
needed to compensate this dissipative energy loss in order to maintain an appropriate 
lung volume. Respectively, bleomycin treated Ctrl mice depicted an increased tissue 
damping (cmH2O/ml) of more than two-fold at 14 days and even about four-fold at 21 
days after injury compared to NaCl treated Ctrls. In contrast, the pressure dissipation 
in alveoli of bleomycin treated Numb/Numblike dKOs was only elevated by two-fold 
at both stages compared to non-injured Ctrls, further arguing for milder fibrotic lung 
damage in these mice. Similar results were obtained for the tissue elastance, which is 
related to the elasticity of lung tissue describing the energy conservation in alveoli at 
a certain pressure in relation to the volume [148]. This parameter is closely coupled to 
tissue damping, since an increased dissipative behavior of distal airways due to 
fibrosis simultaneously compromises tissue elasticity of the alveoli. Hence, higher 
pressure is required to compensate for reduced elasticity in order to maintain a certain 
respiratory lung volume. Equivalent to this, bleomycin treated Ctrls compared to 
NaCl treated animals displayed a pressure per volume ratio (cmH2O/ml) for the tissue 
elastance, which was three times higher at 14 days and even more than four times 
higher at 21 days after lung injury. This clearly reflected dramatically reduced tissue 
elasticity of the alveolar compartments as a result of excessive alveolar matrix protein 
deposition in these mice. Although the required respiratory airway pressure in 
bleomycin treated dKO lungs increased by twofold after 14 days compared to NaCl 
treated controls, tissue elastance did not further deteriorate 21 days after injury and 
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maintained at a similar level. However, the tissue elastance of treated dKOs remained 
significantly ameliorated for both time points compared to bleomycin treated Ctrl 
lungs. Strikingly, airway elasticity of Numb/Numblike dKO lungs after 21 days was 
even improved by one half compared to the strongly compromised tissue elastance in 
challenged Ctrl mice. Interestingly, non-injured dKO lungs revealed in terms of tissue 
elastance a slight but significant decrease of the required respiratory airway pressure 
compared to NaCl treated Ctrls, while both displayed no significant changes at the 
level of tissue damping. Hence, this suggested an enhanced elasticity of distal airways 
in lungs of non-injured Numb/Numblike dKO mice. Taken together, both parameters, 
the tissue damping and elastance, demonstrated that the alveolar airway mechanics 
were highly impaired 21 days after bleomycin injury underlining a severe fibrotic 
damage at this stage in treated Ctrl animals. In contrast, challenged Numb/Numblike 
dKO lungs displayed airway function that was similar for both time points suggesting 
that epithelial loss of Numb and Numblike is ameliorative for bleomycin-induced 
lung fibrosis in mice. Beyond that, this model might propose potential therapeutic 
targets for the human lung disease IPF, which is marked by similar abnormalities like 
enhanced production of extracellular matrix proteins at the level of respiratory 
airways compromising lung function. The underlying mechanisms that may lead to 
this amelioration were further elucidated in this work. 
3.2.2 Epithelial Numb/Numblike depletion reduces expression of 
profibrotic markers during fibrogenesis 
In order to further validate the observed compliance phenomena and to pinpoint the 
actual degree of fibrosis in the animals, bleomycin-injured and non-injured dKOs as 
well as Ctrls were characterized based on histological and molecular analysis. 
Bleomycin induced fibrosis in mice as well as IPF in humans are marked by elevated 
expression of profibrotic markers such as Col1a1 or Ctgf accompanied by enhanced 
deposition of collagen into the extracellular matrix of distal lung cells [69-71]. 
Therefore, trichrome stainings of left lung lobe sections from animals treated with 
bleomycin or NaCl were performed to evaluate the degree of tissue disruption 21 days 
after lung injury (Figure 12A). Using this approach, massive accumulation of 
deposited collagen in the extracellular matrix of distal lung cells was observed 21 
days after bleomycin (bleo) injury in Ctrl lungs, whereas the amount and size of 
collagen deposited spots in injured dKOs was significantly removed after 21 days in 
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comparison to bleo Ctrls. Besides the enlargement of fibrotic areas, bleo treated Ctrl 
lungs additionally displayed characteristic honeycomb formation of distal respiratory 
epithelium, a clear sign for end-stage pulmonary fibrosis [152], whereas these 
structures were less pronounced in bleo dKOs. In order to elucidate the actual degree 
of fibrosis, total lung sections were evaluated according to their amount of fibrotic 
foci per high power field from 0 (not fibrotic) to 7 (highly fibrotic). This unbiased 
fibrotic scoring (Figure 12C) further supported the histological data and clearly 
confirmed a significant reduction of fibrotic tissue areas in bleo treated dKOs 
compared to bleo Ctrl animals 21 days after lung damage. NaCl treated animals, both 
Ctrls and dKOs, did not reveal any lung structural disruptions, thus remained 
completely unaffected by the carrier treatment. Reduced deposition of collagen I 
(ColI) fibers in bleo treated dKO lungs was additionally confirmed by ultrastructural 
analysis comparing sections of bleo treated Ctrl and dKO animals with NaCl treated 
controls 21 days after treatment (Figure 12B). Collagen I fibers of bleo dKO lungs 
were smaller in size compared to bleo Ctrls whereas carrier treated lungs (NaCl Ctrl 
21d) showed normal alveolar wall thickness without pro-fibrotic collagen deposition. 
Moreover, quantification of collagen content from whole lung homogenates was 
performed by SIRCOL assay (Figure 12E) comparing bleo injured and non-injured 
lungs. This assay detects all collagen forms, pro-fibrotic as well as non-fibrotic 
derivatives, and quantitative analysis of these total collagen contents in both bleo 
dKO and Ctrl lung homogenates displayed a significant increase by about two-fold 
after 14 days compared to collagen abundance in NaCl treated Ctrls. However, bleo 
dKOs revealed a significant decrease of collagen content compared to bleo Ctrls 21 
days after injury supporting the previously observed histological results. Nevertheless, 
ameliorated collagen deposition in bleo dKO lungs was not fully restored to normal 
level detected in NaCl treated mice and remained slightly elevated in comparison to 
non-injured Ctrls at this time point. As expected, collagen deposition in whole lung 
homogenates of non-injured NaCl treated dKO mice was not affected. In order to 
unveil further molecular changes, mRNA expression analysis was performed for well-
defined pro-fibrotic marker like collagen I (Col1a1), connective tissue growth factor 
(Ctgf), tumor necrosis factor alpha (Tnf-alpha) and alpha-smooth muscle actin (Acta2) 
(Figure 12D). In line with the reduced collagen content in bleo injured lung tissue of 
dKOs, relative Col1a1 mRNA expression also revealed significant decrease to normal 
levels of NaCl Ctrls after 21 days whereas Col1a1 expression remained 3-fold 
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upregulated at 14 days. However, bleo Ctrl lungs displayed nearly 3 times increased 
Col1a1 mRNA expression level compared to non-injured Ctrls at both time points, 14 
and 21 days post bleo injury (Figure 12D; Col1a1). 
  
Figure 12: Reduced profibrotic markers in bleomycin treated dKO animals.  
A: Trichrome staining of parafine sections (5 µm) of bleomycin injured dKO vs. Ctrl as well as NaCl 
controls at day 21 after treatment. Blue staining shows the profibrotic collagen deposition (fibrotic 
foci) in the lung periphery. Scale bars at 100 µm. B: Electron microscopic pictures of bleomycin 
treated animals at day 21 after injury showing collagen I fibers (ColI) deposited into the extracellular 
matrix of distal alveolar cells. Scale bar at 1 µm. C: Fibrotic score of bleomycin injured dKO (n=5) vs. 
Ctrl (n=3) animals 21 days post treatment. The degree of fibrosis was evaluated by analyzing randomly 
chosen trichrome stained tissue sections for each animal. According to the amount of fibrotic foci per 
high power fields of a whole lung section, values between 0 for non-fibrotic and 7 highly fibrotic tissue 
were assigned and averaged. D: Real time quantitative RNA expression level analysis of right lobe 
lung homogenates of bleomycin injured dKO (n=5) vs. Ctrl (n=3) as well as NaCl controls (n=3 each) 
at day 14 and 21 after treatment for profibrotic markers collagen I (Col1a1), connective tissue growth 
factor (Ctgf), tumor necrosis factor alpha (Tnf-alpha) and alpha-smooth muscle actin (Acta2). All are 
normalized to Hprt. E: SIRCOL assay of bleomycin injured dKO vs. Ctrl as well as NaCl controls at 
day 14 and 21 after treatment. Graphs show the percentage of collagen content of total lung 
homogenates under different conditions. All graphs are presented as mean ±SEM with *p < 0.05, **p < 
0.01, ***p < 0.001 and ns = not significant. Non-marked bars are as well considered as not significant 
compared to control. 
RESULTS 
 86 
Ctgf, a member of the CCN-family of secreted proteins, exhibits high expression 
during experimental lung fibrosis in mice and serves as a marker for lung fibrosis 
[62]. Strikingly, relative mRNA level of Ctgf in bleo dKOs revealed a moderate 
increase of only 2-fold compared to non-injured controls at day 14 post injury. In 
contrast, Ctgf displayed 5-fold higher relative mRNA level at this stage than NaCl 
treated control animals accounting for more than two times the Ctgf expression 
observed in bleo dKO lungs. However, expression of Ctgf was attenuated to a normal 
level in both bleomycin treated dKOs and Ctrls after 21 days. Non-injured (NaCl 
treated) dKO lungs expectedly did not reveal any altered Ctgf mRNA level compared 
to NaCl Ctrls. Analysis of Tnf-alpha, a pro-inflammatory cytokine upregulated in 
bleomycin-induced lung fibrosis and IPF [153], revealed only moderate increase of 
mRNA expression in bleo dKO lungs by 2-fold after 14 days, while mRNA level in 
bleo Ctrls was more than 3-fold higher compared to non-injured NaCl Ctrl animals at 
this time point. Furthermore, relative Tnf-alpha expression in bleo dKOs was fully 
restored after 21 days, whereas corresponding bleo Ctrls maintained a 2-fold higher 
mRNA level in comparison to NaCl Ctrls. Under non-injured (NaCl) conditions, 
dKOs exhibited no alterations in Tnf-alpha expression compared to Ctrls. In order to 
obtain insights into potential changes of fibroblast/myofibroblasts differentiation, 
which is another indication for lung fibrosis progression [76], Acta2 mRNA 
expression levels were analyzed. The results clearly demonstrated that expression of 
Acta2 in bleomycin treated (14 and 21 days) and NaCl treated Numb/Numblike dKOs 
remained unaffected. Exclusively, bleo Ctrl animal revealed a significant increase by 
2-fold compared to NaCl Ctrls at 14 days post injury, but Acta2 expression 
normalizes again after 21 days. In conclusion, these data supported the previous 
observations and suggested a considerable improvement of fibrosis in lung epithelial 
specific Numb and Numblike depleted animals after bleomycin injury. 
3.2.3 Reduction of profibrotic Wnt/ß-Catenin downstream targets in lung 
epithelial Numb/Numblike dKO mice 
Based on the reduced active ß-Catenin protein level and mislocalization in lung 
epithelium (Figure 9 and Figure 10) we concluded that Wnt/ß-Catenin signaling might 
be altered in non-injured dKOs. Since Wnt/ß-Catenin signaling has been previously 
implicated in pulmonary fibrosis [62, 72, 74], this signaling pathway was analyzed in 
lung epithelial specific Numb/Numblike dKOs to elucidate potential alterations under 
RESULTS 
 87 
normal and disease conditions. Apart from the reduced ß-Catenin protein level, 
relative ß-Catenin mRNA expression in non-injured adult dKO lungs remained 
unchanged in comparison to mRNA levels of Ctrls (Figure 13B). In order to shed 
light on the impact of declined active ß-Catenin regarding Wnt-signaling in dKO 
lungs, additional qPCR based expression analysis of well-defined Wnt-downstream 
target genes was performed in lung homogenates of bleomycin and NaCl treated dKO 
mice. All relative mRNA expression levels that are depicted in the graphs below 
(Figure 13A) and were normalized to the relative expression levels of NaCl treated 
Ctrls (fold change = 1).  
 
    
Figure 13: Wnt target gene expression of bleo injured and non-injured dKO vs. Ctrl lungs. 
A: Relative mRNA expression analysis of Wnt/ß-Catenin signaling target genes Wisp1, Fn1, Mmp9, 
Snai1, Twist1, Axin2 and Axin2 of bleo injured (14 and 21 days) vs. vehicle treated dKO (n=3) vs Ctrl 
(n=3) lungs. Animals used for experiments in average n=5 to n=3 for all conditions. B: Relative mRNA 
level of ß-Catenin of uninjured lungs (n=3 each). All normalized to Hprt. All graphs are presented as 
mean ±SEM with *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 and ns = not significant. Bars 
without asterisc are also considered as not significantly altered compared to control.  
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Wnt1-inducible signaling protein-1 (Wisp1/CCN4) is one of the targets, which has 
also been previously linked to pulmonary fibrosis and belongs like Ctgf (CCN2) to the 
CCN-family of matricellular proteins [62]. Wisp1 exhibits a high expression level in 
bleomycin-induced murine lung fibrosis model as well as in patients with idiopathic 
pulmonary fibrosis (IPF). Highly increased Wisp1 mRNA expression in bleomycin-
injured Ctrl lungs was confirmed in this study at 14 days after treatment by an 
approximately 13-fold upregulation. Strikingly, the expression level of Wisp1 in 
damaged dKO lungs was reduced by more than one half (5,627 ± 0,3674, n=5) 
compared to bleo Ctrls at this time point. Remarkably, Wisp1 level of bleo treated 
dKOs was restored to normal expression 21 days post injury, while the relative 
mRNA level of Wisp1 in bleo Ctrls remained significantly elevated. It is worth 
mentioning that Wisp1 expression in whole lung homogenates of vehicle (NaCl) 
treated dKOs was not altered. The matrix metalloprotease Mmp9, another Wnt-
signaling downstream target and profibrotic marker [154], was significantly 
upregulated 3-fold in bleo treated Ctrl mice after 14 days whereas Mmp9 in bleo 
treated dKOs remained at a normal level. 21 days after bleo treatment, normal Mmp9 
expression in dKOs was still maintained whereas the mRNA level in Ctrls was 
reconstituted to normal expression. However, the most dramatic changes were 
identified in expression of the Wnt target Fibronectin1 (Fn1) [155], which displayed a 
50-fold increase in bleo treated Ctrl mice at 14 days whereas bleo treated dKOs 
revealed a 15-fold upregulation of Fn1. The relative Fn1 expression in bleo dKOs 
decreased to less than 4-fold after 21 days whereas corresponding bleo treated Ctrls 
maintained a 10-fold increased Fn1 mRNA level. Hence, a significant difference 
between the Fn1 expression levels of both treated mouse groups was observed for 
each time point. Furthermore, no significant alteration of Fn1 expression was detected 
in the lungs of vehicle treated dKO animals. Moreover, Wnt/ß-catenin targets 
involved in EMT processes, which are believed to be a potential source of pulmonary 
fibrosis as mentioned above [76], were checked. One of these targets that play a 
crucial role in EMT is Snai1 (also: Snail) [79]. Strikingly, Snai1 revealed already a 
significant lower relative mRNA expression level in non-injured NaCl treated dKOs 
by almost one half (0,5999 ± 0,05153, n=3). Additionally, Snai1 level increased only 
moderately during lung fibrosis progression in bleo treated dKOs to an expression 
level comparable with NaCl treated Ctrls after 14 days and decreased after 21 days to 
a similar level observed in the NaCl treated dKOs. Snai1 expression in bleo treated 
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Ctrl lungs did not change significantly after 14 days but displayed 2-fold increased 
level 21 days post injury. Comparable to Snai1, the EMT marker and Wnt/ß-Catenin 
target gene Twist1 [78] displayed also a significant decrease of mRNA level in non-
injured NaCl treated dKO lungs. However, bleomycin treatment of dKOs revealed 
normal expression of Twist1 14 respectively 21 days post injury. In contrast, 
bleomycin treated Ctrl animals exhibited significantly higher Twist1 expression after 
14 days compared to corresponding bleo treated dKOs but this level was restored to 
normal after 21 days. Wnt/ß-Catenin target genes like Axin1 and Axin2 [156] 
demonstrated significantly decreased expression in dKO animals 21 days after 
fibrosis induction. Moreover, similar extents of induction (about 2- to 2.5-fold) were 
observed for Axin1 expression in bleo treated dKO and Ctrl lungs after 14 days, while 
Axin2 expression stayed at normal levels under all other conditions. In summary, 
these data provided further evidence for the impairment of Wnt/ß-catenin signaling in 
Numb/Numblike dKOs resulting in the inhibition of Wnt-downstream gene 
expression. Thereby, reduced profibrotic signals under non-injured conditions as well 
as upon bleomycin treatment suggested an amelioration of fibrosis in mice lacking 
Numb and Numblike specifically in lung epithelium. 
3.3 Mechanistic studies on the role of Numb/Numblike in 
Mouse Lung Epithelial cells MLE12 
In order to elucidate underlying mechanisms explaining the disruption of epithelial 
cell polarity and integrity as well as decreased fibrosis under pathological conditions 
in lung epithelial Numb and Numblike dKOs, in vitro experiments were performed 
using the mouse lung epithelial derived MLE12 cell line. These cells provide a perfect 
in vitro system for analyzing Numb and Numblike in lung epithelial cells and 
complementing the in vivo system. Therefore, silencing of Numb and Numblike in 
MLE12 cells mediated by shRNAs was conducted to examine changes that 
accompany Numb/Numblike inactivation by IHC, Western blot and RT-PCR analysis. 
Further mechanistic characterization of molecular alterations was promoted by 
additional screening for novel Numb and Numblike interaction partners based on 
GFP-tagged Numb and Numblike overexpressing MLE12 cells.  
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3.3.1 Mislocalization of E-Cadherin and ß-Catenin in Numb and 
Numblike double knockdown MLE12 cells  
Towards the establishment of an in vitro system resembling the in vivo situation of 
epithelial specific Numb and Numblike depletion in lung, small hairpin RNA 
(shRNA) directed against Numb (shNb) and Numblike (shNbL) were utilized to 
generate a Numb/Numblike double knockdown (dKD) in MLE12 cells. These viral 
transduced and puromycin selected stable dKD cells were initially tested for 
Numb/Numblike inactivation efficiency. The analysis of Numb/Numblike mRNA 
expression levels as well as Numb and Numblike protein abundance clearly showed a 
highly efficient dKD of both genes in the stable transduced cell lines (Figure 14A, B). 
This was further validated by Numb and Numblike immunostainings of fixed 
Numb/Numblike dKD cells in comparison to shScramble (shScr) control cells (Figure 
14C, D). Positive Numb antibody staining was mainly detected at the lateral 
membrane of contacting shScr cells as well as in cytosolic vesicle-like speckles, 
which couldn’t be detected in Numb/Numblike dKD cells. Additionally, Numblike 
antibody staining clearly displayed cytosolic localization in shScr MLE12 control 
cells whereas dKD cells were negative for Numblike signal indicating an efficient 
depletion (Figure 14D). Previous studies demonstrated that silencing of Numb 
expression in the polarized Mardin Darby Kidney cell line (MDCKII) results in 
mislocalization of the adherens junction protein E-cadherin indicating a loss of 
polarity in these epithelial cells [10]. Strikingly, co-immunofluorescence stainings for 
Numb and Numblike in combination with E-Cadherin revealed the same 
mislocalization phenomenon in Numb/Numblike dKD MLE12 cells. Furthermore, it 
has been shown that mislocalisation of E-Cadherin in epithelial cells mediated by a 
loss of Numb additionally results in mislocalization of ß-Catenin [10]. In order to 
determine a potential ß-Catenin mislocalization in Numb/Numblike dKD cells, co-
immunofluorescence stainings for ß-Catenin and E-Cadherin were performed. 
Concomitant with the alteration of E-Cadherin localization, dKD cells exhibited 
changes in the subcellular localization of ß-Catenin from the lateral membrane to 
apical parts. In comparison to shScr control cells, which displayed a prominent co-
localization of ß-Catenin and E-Cadherin at the membranes of contacting cells typical 
for epithelial cells [10], ß-Catenin staining in Numb/Numblike dKD cells appeared 
weaker (Figure 14E). These results indicated that a loss of Numb and Numblike 
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mediates the subcellular translocation of adherens junction proteins and thereby 
disrupts epithelial cell polarity. 
 
 
Figure 14: Mislocalization of E-Cadherin and ß-Catenin in shNumb/shNumblike double 
knockdown MLE12 cells. 
A: Relative mRNA expression levels of Taq Man Assays for Numb and Numblike indicating 
shNumb/shNumblike KD efficiency in MLE12 cells. B: Western Blot analysis including quantitative 
densitometry (normalization vs. GAPDH) of the protein levels for Numb and Numblike confirming 
decreased Numb and Numblike in shNb/shNbL MLE12 cells. All graphs show mean ±SEM with *p < 
0.05, ***p < 0.001 and ****p < 0.0001. C-E: Immunostaining of fixed shNb/shNbL vs. shScr MLE12 
cells for Numb and E-Cadherin (C), Numblike and E-Cadherin (D) as well as ß-Catenin and E-
Cadherin (E) displaying reduction of Numb and Numblike abundance in shNb/shNbL cells 
accompanied by mislocalization of E-Cadherin and ß-Catenin. Nuclear staining with DAPI (blue). 
Pictures were acquired by CLSM as z-stacks and depicted as cross-sections with x/y, x/z, y/z 
projection. Digital zoom of 63x magnification with scale bar at 12µm. Randomly chosen representative 
images of n=3 different cell vials for each condition that were fixed and stained on cover slips (24-well 
plate) are shown.  
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3.3.2 Disruption of WNT/ß-Catenin signaling in Numb/Numblike dKD 
MLE12 cells 
The previous results demonstrated aberrant subcellular localization of the adherens 
junction proteins E-Cadherin and ß-Catenin in Numb and Numblike depleted lung 
epithelial cells in vivo and in vitro. Further protein analysis by Western blot was 
performed to quantify alterations of ß-Catenin and E-Cadherin abundance mediated 
by Numb/Numblike dKD. Densitometry analysis revealed that total (pan-) as well as 
non-phosphorylated active ß-Catenin was significantly reduced by one half (Figure 
15A) in dKD cells, which reflected the diminished ß-Catenin staining observed in 
these cells (Figure 14E), whereas E-Cadherin abundance (data not shown) in dKD 
cells was not altered. It is important to note that ß-Catenin acts not only as a 
component of the adherence junction complex but also exerts its function directly in 
Wnt-signal transduction. The cytosolic protein level of ß-Catenin is thereby 
negatively regulated by GSK-3ß [43], which mediates ß-Catenin phosphorylation and 
its subsequent targeting to the proteosomal degradation pathway under normal 
conditions [43, 157, 158]. In this respect, inhibition of GSK-3ß by the chemical 
compounds LiCl and SB216763, which promote activation of WNT/ß-Catenin 
signaling [159, 160], was conducted in shScr and KD cells in order to elucidate a 
GSK-3ß dependent loss of ß-Catenin abundance in Numb and Numblike depleted 
epithelial cells (Figure 15B). MG132 treatment of the cells served as a positive 
control in order to block total proteasomal degradation [161, 162]. In general, 
Western blot and consequent densitometry analysis revealed that initial low ß-Catenin 
levels were restored in dKD cells by the treatment with GSK-3ß inhibitors after 4 
hours (Figure 15B). Nevertheless, GSK-3ß inhibition displayed differences in the 
amounts of attenuated active and total (pan-) ß-Catenin protein. Total ß-Catenin level 
in Numb/Numblike dKD cells was increased by more than 2-fold, similar to the 
treated shScr controls after 4h of incubation with LiCl (20 mM) and SB216763 (30 
µM). Expectedly, MG132 (10 µM) treatment displayed an effective block of 
proteasomal degradation in dKD and control cells reflected by increased total ß-
Catenin protein levels. Furthermore, also active ß-Catenin protein abundance in GSK-
3ß inhibitor and MG132 treated dKD cells was restored to normal levels. Moreover, 
all compound-treated control cells displayed a two-fold increased active ß-Catenin 
protein level.  
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Figure 15: Disruption of WNT/ß-Catenin signaling in shNb/NbL KD MLE12 cells 
A: Western blot analysis of non-phosphorylated (active) ß-Catenin and total (pan-) ß-Catenin. Relative 
quantification of protein by densitometry (n=3). Normalization to GAPDH. B, D: GSK-3ß inhibition 
experiment. shNb/shNbL and shScr MLE12 cells were cultured in D-MEM⁄F-12 (1:1) (1X)/10% FCS/ 
1% PSG in a 6-well plate 24 h before they were treated with chemical compounds. 20 mM LiCl and 30 
µM SB216763 were then supplemented to the culture medium and cells were incubated 4h at 37°C to 
inhibit GSK-3ß activity. In order to block proteasomal degradation, cells were cultured in medium 
containing 10µM MG132 serving as positiv control. As negative control cells were cultured in medium 
supplemented either with 0.3 % DMSO or without DMSO (untreated). To elucidate the effect of GSK-
3ß inhibition, either protein levels of active and pan-ß-Catenin were analyzed by Western blot and 
quantified by densitometry normalized to GAPDH (n=2; B) or relative mRNA expression analysis was 
determined by TaqMan assays (n=3) vs. Hprt for ß-catenin, Axin1, Axin2, Snai1, cMyc, Brachyury2, 
Mmp9 (only untreated cells; C) as well as Wisp1, Cyclin-d1 and Mmp2 (treated cells; D). All graphs 
show mean ±SEM with *p < 0.05, ***p < 0.001 and ***p < 0.001. 
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Similar to the in vivo studies, relative mRNA expression levels of Wnt-downstream 
target genes were analyzed to pinpoint effects of reduced ß-Catenin protein in dKD 
cells (Figure 15C, D). Expression level of ß-Catenin mRNA remained unaffected in 
dKD cells compared to controls indicating that ß-Catenin is exclusively regulated on 
the protein level (Figure 15C). Surprisingly, no expression alterations were detected 
for the Wnt-target genes Axin1, Axin2, Snai1, cMyc, Brachyury2 or Mmp9 in dKD 
cells in comparison to controls. However, dKD cells revealed reduced mRNA 
expression levels for Wisp1, Cyclin-d1 and Mmp2 compared to shScr cells (vehicle 
treated cells Figure 15D). Moreover, expression of the target genes Wisp1 and Cyclin-
d1 was rescued after 4h treatment with the GSK-3ß inhibitor SB216763 (30 µM) and 
displayed mRNA levels similar to controls. Wisp1 expression in Numb/Numblike KD 
cells was approximately 2-fold higher compared to control shScr cultured in medium 
containing 0.3 % DMSO. Incubation with 20 mM LiCl did not restore low Wisp1 
expression levels in dKD cells, whereas Cyclin d1 expression displayed amelioration 
similar to SB216763 treatment. MG132 control treatment (10 µM) had a strong effect 
elevating Wisp1 expression level more than two-fold in dKD and shScr cells. In 
contrast, Cyclin-d1 expression remained unaffected in MG132 treated dKD cells as 
well as shScr cells, resembling endogenous expression levels of DMSO treated 
controls. Surprisingly, dKD cells maintained significantly low Mmp2 expression 
levels despite of their treatment with inhibitors. In summary these results clearly 
indicate that the previously observed mislocalization of ß-Catenin in cells lacking 
Numb and Numblike is accompanied by a GSK-3ß dependent decrease of total and 
active ß-Catenin protein levels, which finally results in the inhibition of a subset of 
Wnt/ß-Catenin downstream genes. 
3.3.3 Screening for novel Numb/Numblike interacting proteins  
Numb is an adaptor protein involved in multiple biological and cellular processes 
[163] like endocytosis [164, 165], endosomal trafficking [9], proteosomal degradation 
[8, 166] as well as inhibition of the Notch signaling pathway [2, 5, 167]. Thereby, 
Numb has been shown to interact with numerous proteins promoting their functions 
during these processes. Another important role of Numb is the establishment and 
stabilization of cell-cell contacts mediating polarity in epithelial cells [10]. In this 
respect, Numb has been previously described to directly associate with E-Cadherin 
facilitating the subcellular localization of the adherens junction protein to lateral parts 
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of epithelial cell membranes, which was also confirmed in this study in vitro and in 
vivo (Figure 8, Figure 14). In contrast, Numblike, the cytosolic Numb homolog, is 
only poorly characterized. In order to gain more detailed information about potential 
binding partners of both Numb and Numblike, epithelial MLE12 cells were 
lentivirally transduced, overexpressing human Numb isoforms 1 to 4 as well as 
human Numblike C-terminally fused to GFP, and thereafter utilized for co-
immunoprecipitation (Co-IP) of interacting proteins. Hence, this cellular system 
provided an optimal tool to screen for isoform-specific co-enrichment of proteins. 
Anti-GFP-immunoprecipitation (IP) for each of the baits in triplicates, separation by 
SDS-PAGE, and gel extraction of the fractioned proteins was performed. 
Subsequently, proteins were digested into peptides and subjected to mass 
spectrometry (MS) analysis and label-free quantification by MaxQuant software. Bait 
proteins as well as potential interactors were characterized by quantitative co-
enrichment given by their intensity profiles across the triplicates [168, 169]. In order 
to obtain quantitative protein ratios, normalized intensities of enriched proteins for 
Numb1-4:GFP and Numblike:GFP were compared to normalized intensities of 
proteins that were detected in lysates of GFP expressing control MLE12 cells (GFP 
Ctrl). Label-free IPs were validated according to the p-value resulting from a standard 
‘equal group variance’ t-test of the observed protein intensity fold changes (FC) 
between IP fractions derived from bait overexpression and GFP-control cell lines 
[169]. Calculated fold changes were plotted against the negative logarithmic p-value 
of the t-test resulting in volcano plots (Figure 16A-E). Proteins with a high fold 
change and a high –log10 p-value were considered as significant interaction partners 
[169]. In order to set thresholds defining detected proteins as potential interaction 
partners, a significance line was calculated by Perseus software with p < 0.05 and FC 
> 2 (blue). Proteins below this threshold were either background binding proteins or 
false positives. Background binding proteins (grey) are characterized by a ratio of 
about 1:1 and located in vicinity to the y-axis and 0 in the volcano plots, whereas false 
positive candidates (red) display significant ratios with a fold change FC < 0.5 
indicating an enrichment of proteins in IPs of GFP-control cells. The total numbers of 
proteins, which were detected in each IP with a p-value resulting from the t-test 
validation of the triplicates, are displayed in Figure 16F combined with the 
corresponding percentages and numbers of common specific interactions in contrast 
to the background and false positive proteins. 
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Figure 16: Mass spectrometric analysis and screening for novel Numb/Numblike interactors. 
A-E: Determination of potential Numb and Numblike interacting proteins. Triplicates of label-free IPs 
from Numb1-4:GFP, Numblike:GFP and GFP control overexpressing MLE12 cells were validated 
based on a t-test of the ratios between the protein intensities in Numb-isoform respectively Numblike 
overexpression and GFP-control cells. Fold changes (log2 protein ratios) were plotted against -log10 p-
values of the t-test and visualized as volcano plots. Proteins with high fold change and p-value (FC>2; 
p<0.05) were considered as true candidates including the baits (blue). Proteins below this threshold 
were considered as background binding proteins (FC<2; grey) and false positives (FC<0.5; red). 
Proteins highlighted in blue and green represented potential interaction candidates related to cellular 
components of cell junctions (GO-term analysis). F: Percentage of all potential interacting proteins for 
each of the baits in relation to overall IP detected proteins (total) with a p-value (Co-IP efficiency). 
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In general, the Co-IP efficiency calculated by the percentages of potential interaction 
partners for each individual IP varied in a range of about 30 to 50 percent of total 
detected proteins (Figure 16F). In order to better characterize and narrow down 
potential interaction candidates, GOrilla gene ontology enrichment analysis [170, 
171] was performed for detected interacting proteins in relation to the corresponding 
background binding events. Interestingly, analysis of the interacting protein groups by 
cellular components, selected and compiled according to the p-values of their GO-
term enrichment, revealed a broad cellular components diversity for Numb1:GFP and 
Numb2:GFP Co-IPs. In contrast, Numb3:GFP, Numb4:GFP and Numblike:GFP Co-
IPs were related to lower amounts of significantly enriched cellular components with 
smaller cohorts of protein groups (Figure 17A-E). The results of this GO-term 
analysis revealed protein clusters related to cellular components of the cell junctions, 
ribonucleoprotein complexes and cytosolic parts (cytoplasmatic proteins) representing 
components with highly significant GO-term enrichment for all Numb isoforms and 
Numblike. Expectedly, a subset of previously reported Numb interaction partners was 
detected in all Numb isoform IP fractions with high and significant ratios (Table 40), 
e.g. proteins of the endocytic trafficking machinery like Clathrin (Cltc), AP-1 (i.e. 
subunit ß1; Ap1b1) and AP-2 complex subunits (i.e. alpha-adaptin; Ap2a1) [9, 164, 
165]. Moreover, Numb is involved in cell migratory processes and has been 
previously described to interact with Integrin-ß1 (Itgb1) as well [110], which was 
significantly enriched in an isoform specific manner for Numb1:GFP, Numb2:GFP as 
well as Numblike:GFP Co-IPs (Table 40). The detection of these known Numb 
interacting proteins additionally underlines the efficiency and specificity of the 
performed IPs. The present study supported previous findings that Numb and 
Numblike concomitantly mediate lung epithelial integrity in vivo by controlling the 
subcellular localization of adherens junction proteins like E-Cadherin and ß-Catenin. 
Although the mechanism remains still unclear this phenotype was validated in lung 
epithelial cell lines. Hence, in order to elucidate the underlying mechanism promoting 
these processes, characterization of potential interacting proteins was focused on 
those protein groups that were annotated by GO-term analysis as cellular components 
of cell junctions. This cohort revealed as previously mentioned high p-values in the 
GO-term enrichment analysis (Figure 17A-E). The percentage of these cell junction 
proteins in relation to the total amounts of detected interacting candidates for each 
bait is displayed by the bar diagram in Figure 17F and corresponding proteins are 
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highlighted with blue and green dots on the volcano plots (Figure 16). The results 
demonstrated that the amounts of cell junction proteins in relation to total interactions 
were detected with lower abundance for Numb3 (39 proteins; 22.8%), Numb4 (40 
proteins; 27.6%) and Numblike (37 proteins; 23.1%), compared to Numb1 (116 
proteins; 38.1%) and Numb2 (96 proteins; 37.3%). For the latter two, cell junction 
related candidates were identified in cohorts of approximately 40 percent compared to 
all potential interacting proteins (Figure 16A-E, Figure 17). 
 
 
Figure 17: Analysis of GO-term enrichment for Numb/Numblike interacting proteins. 
A-E: Compilation of protein subsets related to their cellular components determined by GO-term 
enrichment analysis. Cellular components were selected and presented according to their significances 
of enrichment (p<10-3). Negative logarithmic p-values were plotted on the x-axis. Numbers at the right 
end of the bars represent the detected proteins in each cellular component. Components that were 
related to cell junctional components were highlighted in green. F: Percentage of proteins related to 
cell junctions relative to the total number of detected potential interaction candidates for each IP. 
 
Proteins like Vinculin (Vcl) as well as some Arp2/3 complex subunits (Arpc1b, 
Arpc4, Arpc5) represent candidates belonging to the subset of cell junction proteins 
shared exclusively by Numb1 and Numb2 but not by Numb3, Numb4 and Numblike 
(Table 40). These proteins are involved in stabilization of adherens junctions linking 
cytoskeletal F-actin to proteins of the junction complex. Vinculin can thereby directly 
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interact with F-actin, ß-Catenin and Cortactin [172]. Strikingly, Cortactin (Cttn) was 
also significantly enriched in the Numb1:GFP IPs (Table 40). Moreover, MS analysis 
revealed a significant enrichment of serine/threonine kinase CK2 alpha and beta 
subunits (Casein kinase II, Csnk2a1/a2, Csnk2b), which was specifically enriched in 
Numb1:GFP, Numb2:GFP and also Numblike:GFP but not in Numb3:GFP and 
Numb4:GFP. CK2 has been shown to phosphorylate E-Cadherin and ß-Catenin 
stabilizing their interactions in the adherens junction complex [173, 174]. 
Additionally, CK2 can phosphorylate Histone deacetylase 6 (HDAC6), a known 
interaction partner of Cortactin [175], thereby promoting its deacetylase activity 
[176]. Furthermore, CK2 has been enrolled in the negative regulation of EMT 
processes by synergistically acting with GSK-3ß [177]. Taken together, these findings 
clearly demonstrated the abundance of novel potential interaction partners for Numb 
and Numblike including a certain subset of proteins with cell junction related 
functions. In order to validate the identified potential novel interaction partners in the 
context of the four different Numb isoforms and also their specificity, reciprocal co-
immunoprecipitation in combination with Western blot analysis was conducted 
comparatively for Numb1-4:GFP and Numblike:GFP overexpressing cell lines. The 
corresponding results are described in the following part.  
 
 
Table 40: Selected list of Numb and Numblike interacting proteins. 
The list represents a selection of proteins that depicted high and significant protein ratios originating 
from the label-free MS analysis of the in triplicates performed GFP-IP experiments. The table indicates 
the differences in the abundance of potential interaction candidates for the four Numb isoforms and 
Numblike displayed by their gene names. 
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3.3.4 Cortactin and CK2, novel Numb/Numblike interaction partners  
Mass spectrometry analysis of the GFP-IP experiments for Numb1-4:GFP and 
Numblike:GFP revealed bulks of potential interaction partners for all Numb isoforms 
and Numbilke. Two significantly enriched candidates, Cortactin and CK2, arose our 
interest because both proteins are involved in controlling adherens junction stability 
and cytoskeleton binding. In order to gather more detailed knowledge about novel 
potential cross talks of these candidates with Numb or Numblike and to validate the 
MS results, reciprocal Co-IP experiments were performed for all GFP fusion proteins 
and for Cortactin as well as CK2-alpha vice versa (Figure 18). GFP-IP of protein 
lysates from Numb1-4:GFP and Numblike:GFP overexpressing MLE12 cells and 
subsequent Western blot analysis strikingly revealed co-immunoprecipitation of 
endogenous Cortactin in all Numb isoforms and Numblike, whereas it was 
exclusively detected in Numb1:GFP IPs by MS analysis (Figure 18A).  
 
  
Figure 18: Cortactin and CK2 verified as novel interaction partners of Numb and Numblike. 
A-C: Western blot analysis of Co-IP with anti-GFP (A) and vice versa with anti-Cortactin (anti-Cttn; 
B) as well as anti-CK2-alpha (anti-CK2α; C) for Numb1-4:GFP (Nb1-4:GFP), Numblike:GFP 
(NbL:GFP) and GFP control (GFP Ctrl) overexpression in MLE12 cells. A: Detection of 
immunoprecipitated GFP-fusion proteins with anti-GFP and co-precipitated proteins E-Cadherin, 
Cortactin, CK2-alpha and CK2-beta subunits with the corresponding endogenous antibodies. B: 
Detection of immunoprecipitated endogenous Cortactin and co-precipitated endogenous ZO-1, 
overexpressed Numb1-4:GFP and Numblike:GFP (by anti-GFP and anti-Numb or anti-Numblike) as 
well as endogenous Numb and Numblike. C: Detection of immunoprecipitated endogenous CK2-alpha 
and co-precipitated overexpressed Numb1-4:GFP and Numblike:GFP (by anti-GFP). Numb1:GFP cell 
lysates were used for control IPs with IgG1 mouse isotype antibody (IgG1-Ctrl; B and C). 
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Co-immunoprecipitation of the CK2-alpha and CK2-beta subunits was specifically 
detected for Numb1:GFP, Numb2:GFP as well as for Numblike:GFP but not for 
Numb3:GFP and Numb4:GFP, correlating with the MS results. Expectedly, GFP-
control (GFP-Ctrl) IPs did not display any Cortactin or CK2 subunit co-enrichment. 
The GFP-IPs were efficient for all GFP-fusion proteins as well as for the GFP-Ctrl, 
indicated by GFP antibody detection. Additionally, detection of endogenous E-
Cadherin was confirmed in IPs of Numb:GFP and Numblike:GFP expressing cells as 
a positive control for Co-IP conditions, since E-Cadherin-Numb interaction has been 
previously shown [10]. Reciprocally, IPs for Cortactin were performed from lysates 
of Numb1-4:GFP and Numblike:GFP overexpressing MLE12 cells, which clearly 
indicated an Co-IP of all the different overexpressed GFP-fusion proteins in the 
corresponding Cortactin-IP fractions as well as a co-enrichment of endogenous Numb 
and Numblike (Figure 18B). Moreover, the tight junction protein ZO-1, a known 
interaction partner of Cortactin, was detected in all Cortactin-IPs, serving as a positive 
control for the Co-IP efficiency. IP of endogenous CK2-alpha from Numb1-4:GFP 
and Numblike:GFP overexpressing MLE12 cells confirmed CK2-alpha interaction 
with Numb1:GFP, Numb2:GFP and Numblike:GFP reciprocally to the corresponding 
GFP-IPs (Figure 18C). Taken together, these results strongly suggest an interaction of 
both Numb and Numblike with Cortactin as well as the holoenzyme of CK2. Numb 
interactions with CK2 occur in this context specifically for Numb isoform 1 and 
isoform 2. In order to further strengthen the findings of Cortactin-Numb/Numblike 
interactions, subcellular co-localization of Cortactin, Numb and Numblike was 
investigated by co-immunofluorescence analysis. To approach this, immuno-
fluorescence staining for Cortactin was performed on fixed MLE12 cells 
overexpressing GFP tagged Numb and Numblike versions. The z-stack projections 
acquired by confocal microscopy (Figure 19) clearly indicated overlapping areas of 
Cortactin with GFP signal for all different Numb isoforms and Numblike. 
Numb1:GFP and Numb2:GFP displayed clear membrane localization, whereas GFP 
positive signal derived from Numb3:GFP and Numb4:GFP revealed predominant 
cytosolic distribution in vesicle-like speckles, but also partial membrane localization. 
In contrast, Numblike displayed a clear homogenous cytoplasmatic GFP signal of the 
overexpressed GFP-fusion protein as expected from the endogenous Numblike 
localization.  
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Figure 19: Subcellular localization studies for Cortactin in Numb:GFP and Numblike:GFP 
overexpressing MLE12 cells. 
Randomly chosen representative pictures of fixed immunofluorescece stained Numb1-4:GFP and 
Numblike:GFP (green) overexpressing MLE12 cells with anti-Cortactin (red) to study subcellular co-
localization of the proteins. Cells were seeded on glass cover slips in a 48-well plate for 24 h, fixed and 
stained indirectly with anti-Cortactin. Nuclei were visualized using DAPI. Pictures were acquired 
randomly by confocal microscopy as z-stacks at a magnification of 63x and digital zoom. Pictures are 
presented as cross sections concomitantly with x/z-view and y/z-view. Scale bars at 12 µm. 
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Figure 20: Subcellular localization of Cortactin in shNumb/shNumblike MLE12 cells. 
A+B: Randomly chosen representative pictures of fixed immunofluorescece stained shNb/shNbL vs. 
shScr MLE12 cells with Cortactin (red) to study subcellular co-localization after Numb/Numblike 
knockdown. Cells were seeded on glass cover slips in a 48-well plate for 24 h, fixed and indirectly 
stained with anti-Cortactin together with anti-Numb (green, A) or anti-Numblike (NumbL; green, B). 
Nuclei were visualized using DAPI. Pictures were acquired randomly by confocal microscopy as z-
stacks at a magnification of 63x and digital zoom. Pictures are presented as cross sections 
concomitantly with x/z-view and y/z-view. Scale bars at 12 µm. 
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Furthermore, all MLE12 overexpression conditions displayed partial and dot-like co-
localization of Cortactin with the GFP-tagged Numb and Numblike underlining the 
Co-IP results. For Numb1:GFP and Numb2:GFP these Cortactin co-localization spots 
were predominantly detected in membrane regions of contacting neighboring cells. In 
contrast, Cortactin co-localized with Numb3:GFP and Numb4:GFP in prominent 
cytoplasmatic speckles as well as in perinuclear compartments of the cells. Similarly, 
also Numblike:GFP overexpressing MLE12 cells displayed Cortactin co-localization 
with the GFP-fusion protein predominantly in perinuclear areas. In line with previous 
subcellular localization studies of this work, subcellular distribution of Cortactin was 
also examined in shRNA-silenced Numb and Numblike deficient MLE12 cells. 
Therefore, co-immunofluorescence stainings for Numb or Numblike in combination 
with Cortactin were performed in dKD and Scramble control cells. The absence of 
Numb and Numblike (Figure 20A+B) resulted in a shift of subcellular Cortactin 
localization from the cell membrane, where it was predominantly detected in shScr 
cells, to the cytoplasma accumulating in perinuclear speckles. In previous studies, 
changes in subcellular distribution of Cortactin have been correlated with altered actin 
polymerization and stabilization of the cytoskeleton [178-180]. Furthermore, control 
cells displayed areas of Numb and Cortactin co-localization at the membrane as well 
as co-localization of Numblike and Cortactin in the cytoplasm (Figure 20A and B, 
arrows). Additionally, this subcellular co-localization of Numb/Numblike and 
Cortactin in shScr MLE12 cells clearly reflected the co-localization previously 
observed in Numb:GFP and Numblike:GFP overexpressing MLE12 cells (Figure 19). 
Taken together, the Co-IP experiments validated Cortactin and CK2 as two novel 
interaction partners for Numb and Numblike. Cortactin furthermore exhibited 
membrane co-localization with Numb isoform 1 and isoform 2 as well as cytosolic 
co-localization with Numb isoform 3, isoform 4 and Numblike. The underlying 
mechanisms promoted by these interactions, mediating formation and stabilization of 
the cell junctions, which is an essential for epithelial integrity, still need to be 
elucidated more detailed. Interactions of Numb and Numblike with CK2 might as 
well play an important role in this process of junctional complex formation and 
stabilization potentially modulated by CK2 kinase activity at the adherens junction 
level. 
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4 DISCUSSION 
The adaptor proteins Numb and Numblike are widely expressed in different mouse 
tissues of the ectodermal, mesodermal and endodermal lineage during development 
and adulthood [115, 181], for instance in brain [98, 118, 119, 182], muscle [167], 
heart [2, 183] or lung [121]. In the developing, differentiating as well as adult lung, 
Numb and Numblike expression is detected in both epithelium and mesenchyme, 
which has been shown by previous investigations and also in this present study [99, 
121]. During morphogenic and epithelial specification process, Numb has been 
involved in promoting cell polarity and asymmetric cell division [122, 123]. 
Furthermore, altered Numb protein expression in lung epithelial cells has been linked 
to Non-small-cell lung carcinoma (NSCLC), which resembles a predominant lung 
cancer type [127]. In order to pinpoint the lung epithelial specific enrolment of Numb 
and Numblike during lung development and regeneration, lung epithelial specific 
depletion of both genes was conducted in mice at early primordial stages of lung 
sprouting, which surprisingly did not exhibit any severe effects on lung development 
and maturation as well as on the vitality. Changes were unveiled in the composition of 
the distal airway epithelium and a disruption in cell-cell junctions along the entire 
proximo-distal axis of the lung epithelium resulting in a loss of polarity and integrity. 
Moreover, this study provided profound data suggesting an improvement after 
bleomycin induced lung fibrosis due to the absence of Numb and Numblike. In this 
respect, we propose an impairment and inhibition of WNT/ß-Catenin signaling 
underlying the improved pathological phenotype. This was further supported by 
mechanistic in vitro studies using Numb/Numblike double knockdown as well as 
Numb and Numblike overexpressing MLE12 cells. Besides mislocalization of the 
adherens junctional proteins E-Cadherin and ß-Catenin, loss of Numb and Numblike 
resulted in reduced WNT/ß-Catenin signaling, which was reflected by low levels of 
active ß-Catenin accompanied by decreased expression of several WNT/ß-Catenin 
downstream targets. Strikingly, we identified Cortactin and CK2 as novel interaction 
partners of Numb and Numblike. Numb and Numblike silencing additionally 
displayed mislocalization of Cortactin, ß-Catenin and E-Cadherin, which is supposed 
to cause destabilization of the cell junction complex. Based on our findings we 
propose a potential mechanism for the maintenance of epithelial cell polarity and 
integrity, which is discussed in the third section. 
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4.1 Lung epithelial specific Numb/Numblike knockout mice 
show loss of epithelial polarity and integrity 
Previous studies showed, that the evolutionary conserved membrane-associated 
adaptor protein Numb plays an important role in asymmetric cell division and cell fate 
determination of sensory neurons in Drosophila by antagonizing Notch signaling 
[184, 185]. Similarly, there is evidence that both Numb and its homolog Numblike in 
mice exhibit redundant functions in maintenance and differentiation of neural 
progenitor cells by eliminating Notch signaling [118, 119, 186]. As both paralogs are 
widely expressed in various cell types, tissue specific conditional knockout 
approaches were used to decipher their functions in neuronal [118, 119] and 
epicardial development [112]. Interestingly, epicardial specific depletion of Numb and 
Numblike results in disruption of adherens junctions and cell polarity [112], while 
concomitant inactivation of both genes in the myocardium has been related to 
regulation of myocardial trabeculation and compaction by repressing Notch2 and 
BMP10 signaling as well as ERBB2/STAT5 signaling [2, 187]. In fact, these 
observations provided evidence for tissue specific involvement of Numb and 
Numblike in controlling cell polarity and cell-cell contact. Moreover, studies in a 
subset of human lung cancer, so called non-small-cell lung carcinomas (NSCLCs), 
revealed an activation of Notch signaling accompanied by a loss of Numb abundance 
[127]. These findings suggested tumor suppressive functions for Numb, which has 
also been previously proposed in breast cancer [109, 126]. However, the role of 
Numb and Numblike during lung development and adult stages remained rarely 
investigated so far.  
In this study we approach this issue by investigating a targeted deletion of Numbfl/fl 
specifically in mouse lung epithelium on a Numblike deficient background since it 
had been reported that a total knockout of Numb and Numblike in mice results in early 
embryonic lethality [118, 129]. Lung epithelial specific Numb/Numblike dKO was 
generated by utilizing the doxycycline inducible SP-CrtTA/tetOCre system (Figure 
6A) [130]. Efficient inactivation of Numb expression was confirmed exclusively in 
lung epithelium (Figure 6B, C, D), while Numblike was constitutively depleted in the 
entire mouse. Meanwhile, Numb expression in non-targeted mesenchymal cells of 
dKO lungs remained unaffected. Specific activation of the combined Rosa26YFP Cre-
reporter additionally revealed YFP+ lineage tracing of cells along the entire proximo-
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distal axis of the mature respiratory epithelium, indicating an onset of Cre activity 
driven by SP-CrtTA expression at early lung developmental stages (Figure 6E) and 
underlining the tissue specificity of the system since we could not find YFP+ cells in 
other tissues (data not shown). Surprisingly, induced dKO mice exhibit normal 
lifespan and indicate no severe phenotypic alterations of the mature lung. Analysis of 
the different cell types, residing along the entire mature lung epithelium, revealed 
reduced ATII cell abundance in dKO animals. Quantification of SP-C positive ATII 
cells compared to total DAPI positive cells of adult lung tissue sections, displayed a 
30 % decrease in ATII cell numbers of dKO lungs compared to Ctrls (Figure 7B). 
This result was supported by decreased mRNA expression of the ATII cell marker 
Sftpc in total lung homogenates of dKOs. By which mechanism this ATII cell 
reduction is promoted remains still unclear and requires further investigations. There 
are studies correlating a targeted ablation of ATII cells with a higher susceptibility for 
pulmonary fibrosis and enhanced risk of respiratory failure [188, 189]. In contrast, 
conditional lung epithelial specific deletion of Integrin α3ß1 has been linked to 
increased ATII cell abundance accompanied by an ameliorated fibrotic response to 
bleomycin treatment. In this particular case, reduced fibrosis was closely correlated 
with impaired ß-Catenin/Smad2 signaling rather than the higher ATII cell abundance 
[190]. Together, these observations argue for altered ATII cell self-renewal and 
differentiation to ATI cells [191] in our lung epithelial depleted Numb/Numblike 
animals, since dKOs neither display lethality by respiratory failure nor exhibit an 
enhanced susceptibility for pulmonary fibrosis under non-injured conditions despite 
the decreased ATII cell numbers. Indeed, Numb and Numblike have been implicated 
in regulating maintenance and differentiation of progenitor cells during neurogenesis 
[118, 119]. Hence, a loss of Numb and Numblike might impair the maintenance of 
ATII cells or even proliferation and differentiation of lung epithelial progenitor cells 
at earlier developmental stages. The latter may lead to an imbalance in the epithelial 
progenitor determination towards distinct epithelial cell fates. In order to clarify this 
hypothesis, differential expression analysis of different lung epithelial markers was 
performed to identify potential alterations in epithelial cell abundance. However, 
analysis of ATI cell (Pdpn), Clara cell (Scgb1a1), Ciliated cell (Foxj1) or 
Neuroendocrinal cell (Ascl2) marker expression did not reveal any changes indicating 
altered numbers of the corresponding epithelial cell types. Furthermore, there is 
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evidence that Numb exerts its function as a key determinant of asymmetric versus 
symmetric cell division [192, 193]. Importantly, proper balance between self-renewal 
and differentiation of lung specific stem or progenitor cells is indispensable and 
critical for normal lung morphogenesis [194-196]. In particular, Numb has been 
involved in asymmetric cell division of distal embryonic lung epithelial progenitor 
cells [121], which supports the idea of an imbalanced early epithelial progenitor or 
ATII cell proliferation and differentiation. Hence, profound proliferation analysis at 
different developmental stages might clarify this issue; however the cause of ATII 
cell reduction, which surprisingly has no severe effects on viability of the dKO 
animals, still remains unclear.  
On the subcellular level, lung epithelial specific Numb/Numblike double knockout 
animals displayed mislocalization of the adherens junction proteins E-Cadherin and ß-
Catenin in primordial epithelium of E16.5 lungs as well as in the mature lung 
epithelium (Figure 8, Figure 9, Figure 10). This observation perfectly correlated with 
the results of previous studies revealing that Numb regulates cell-cell adhesion and 
epithelial polarity in polarized cells [10, 197]. Numb depleted MDCKII epithelial 
kidney cells display a mislocalization of E-Cadherin and ß-Catenin from basolateral 
to apicolateral. In addition, the authors demonstrate a direct interaction between the 
PTB domain of Numb with the conserved DNYYY motif of E-Cadherin. This 
interaction can be suppressed by Src kinase mediated tyrosine phosphorylation of the 
DNYYY motif, which is promoting the internalization of E-Cadherin [10, 198, 199]. 
E-Cadherin is known to associate directly with ß-Catenin [200, 201] as well as other 
adherens junction proteins like p120-Catenin, α-Catenin or the Src substrate 
Cortactin, which links the adherens junction complex to F-Actin [172, 202]. In this 
respect, we conclude that a loss of the physical interaction between Numb and E-
Cadherin, due to the absence of Numb, might result in a destabilization of the 
adherens junction complex in the respiratory epithelium of dKO animals. In addition, 
Numb has also been identified as a mediator of endocytosis [102], for example 
controlling internalization of E-Cadherin [203]. In this respect, studies revealed that 
the endocytosis of E-Cadherin, and thereby its trafficking to the lateral membrane of 
epithelial cells, can be negatively regulated by aPKC mediated phosphorylation of 
Numb. Consequently, Numb depletion has been shown to result in marked defects in 
E-Cadherin redistribution and trafficking to the plasma membrane by affecting 
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endocytosis [197, 203]. In the present study, we observed similar membrane 
mislocalization of E-Cadherin and ß-Catenin upon loss of Numb and Numblike. 
According to our findings in lung epithelium of dKO mice and previously in MDCKII 
cells, we here provided additional evidence for Numb/Numblike double knockdown 
mediated mislocalization of E-Cadherin and ß-Catenin in MLE12 cells. Alteration of 
E-Cadherin localization in E16.5 dKOs is accompanied by a significant increase in its 
protein level, whereas E-Cadherin protein level was unaffected in adult lungs though 
subcellular E-Cadherin localization remained perturbed. In contrast, the epithelium of 
adult dKOs revealed a ß-Catenin mislocalization concomitant with downregulated ß-
Catenin protein level in distal airway cells (Figure 10A). Interestingly, no significant 
alteration of ß-Catenin protein level was detected in E16.5 dKOs, whereas reduced 
Serin 33/37 - Threonin 41 phosphorylation of ß-Catenin in total adult dKO lung 
homogenates provided evidence for an altered GSK-3ß regulated ß-Catenin stability 
[204], which was underlined by decreased active non-phosphorylated ß-Catenin level. 
Activated Wnt/ß-Catenin signaling is marked by nuclear accumulation of active ß-
Catenin, which transactivates expression of WNT/ß-Catenin downstream targets in 
the nucleus [205]. However, total ß-Catenin level in whole dKO lung remained 
unchanged although distal airway cells in our animal model displayed decreased or 
complete lack of ß-Catenin. Since ß-Catenin is also expressed in lung mesenchyme 
[44, 155, 206], slight changes in lung epithelial ß-Catenin protein level are probably 
undetectable in total lung homogenates. In conclusion, lung epithelial loss of Numb 
and Numblike mediates mislocalization and an altered phosphorylation state of ß-
Catenin. Numerous studies provide evidence that WNT/ß-Catenin signaling promotes 
cell proliferation and differentiation in different cell types [207-209]. Investigations of 
canonical WNT/ß-Catenin signaling in lung revealed that an activation of this 
pathway mediates enhanced epithelial cell proliferation, especially of distal ATII cells 
under disease conditions like pulmonary fibrosis or lung cancer [62, 72, 210, 211]. 
Based on these findings, decreased epithelial ß-Catenin protein level, in particular that 
of active ß-Catenin, in Numb/Numblike mutants might provide an additional 
explanation for the observed ATII cell reduction in adult dKO lungs. This further 
supports the hypothesized imbalance in lung epithelial progenitor proliferation and 
differentiation during development of our Numb/Numblike mutants.  
The observation of reduced tight junctional protein ZO-1 in distal airway cells of 
adult dKO lungs (Figure 10B, C) suggests further consequence of the perturbed 
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adherens junctions, which are linked to tight junction proteins via the F-actin 
cytoskeleton [212]. Besides the fact that the adhesive force of adherens junctions is 
necessary to maintain the structural integrity of tight junctions [213-216], studies also 
suggest Numb as an important factor dynamically linking adherens and tight junctions 
by associating with the Par3-aPKC-Par6 polarity complex [10]. However, despite the 
epithelial mislocalization of E-Cadherin and ß-Catenin from basolateral to 
apicolateral ultrastructural analysis of adult proximal and distal epithelium did not 
reveal any abnormalities in dKOs correlating with the weak phenotype in our 
Numb/Numblike mutants. Overall, the adherence and tight junction structures in 
proximal and distal epithelial cells of dKO lungs were detectable and unaffected at the 
membrane of neighboring cells. Nevertheless, subtle changes in the quality and 
establishment of cell-cell contacts could not be ruled out yet, since we found no 
adequate method for a robust quantification of parameters, like length or opening of 
the cell junctional zones formed by tight and adherens junctions, at the ultrastructural 
level. The quantification of a potential phenotype proved to be difficult due to the fact 
that the planes and angles of cell junction cross sections are not consistent. 
Concomitant with the disruption of adherens junctions, loss of tight junction contacts, 
induced by the ablation of Numb and Numblike in the lung epithelium of dKO mice, 
was underlined by an increased epithelial barrier leakage observed in dKO mutants 
(Figure 10D). To further validate this physiological phenotype of a disrupted 
epithelial barrier, lung injury experiments utilizing influenza virus infection, 
representing a commonly used model to investigate epithelial barrier function, are 
planned for the future [217-219]. With this injury model, we attempt to prove an 
increased susceptibility of our dKO mutants to the influenza injury due to their loss of 
epithelial integrity. Taken together, these results clearly suggest an essential role for 
Numb and likely for Numblike in the maintenance of lung epithelial polarity as well 
as integrity preserving a physiological epithelial barrier.  
4.2 Loss of Numb/Numblike suppresses bleomycin-induced 
lung fibrosis 
Our results so far demonstrated moderate alterations in Numb/Numblike depleted lung 
epithelium under basal conditions. Moreover, we found that dKO mice exhibit a 
significantly increased permeability of the physiological epithelial barrier caused by 
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the disruption of tight and adherens junctional cell-cell contacts. Hence, we reasoned 
a higher susceptibility of the Numb/Numblike depleted lung epithelium to bleomycin 
induced lung injury, a well-characterized model to study pulmonary fibrosis [62, 143-
145]. Bleomycin treatment causes alveolar cell damage and provokes a pulmonary 
inflammatory response accompanied by apoptotic as well as hyperplastic ATII cells 
[220-223]. Concomitantly, activated fibroblasts or myofibroblasts form fibrotic foci 
exhibiting an enhanced expression of Acta2 and deposition of extracellular matrix 
proteins, like Connective tissue growth factor (Ctgf), Collagen I (Col1a1), Fibronectin 
(Fn1) and the matrix metalloproteinases Mmp2 or Mmp9 [62, 224-226]. The abnormal 
accumulation of extracellular matrix proteins within these fibrotic foci causes 
stiffness and damage of lung architecture resulting in respiratory failure and lethality 
[55, 227]. Unexpectedly, we found that bleomycin injured Numb/Numblike dKOs 
displayed a significantly improved survival rate compared to Ctrls, which started to 
die after 10 days upon injury (Figure 11B). This was surprising since we expected a 
dramatic effect for Numb/Numblike ablated animals given by the fact that lung 
epithelial integrity of mutants is disrupted in the steady state. Improved survival of 
Numb/Numblike dKOs was further reflected by the significantly attenuated 
compliance parameters, which were observed for injured mutants at both time points 
(14 and 21 days). The increased lung volume as well as the enhanced tissue elastance 
of NaCl treated dKOs might result from the compromised epithelial integrity (Figure 
11C). Together, the improved survival and compliance of the challenged dKO 
animals suggest that a lack of Numb and Numblike in lung epithelium might restrict 
progression of fibrosis. Further histological trichrome stainings strengthened this 
hypothesis (Figure 12A). I could clearly confirm reduced fibrotic foci numbers in 
bleomycin treated dKO animals, reflected by the fibrotic score (Figure 12C). This was 
additionally indicated by the ultrastructural analysis of alveolar septae that revealed a 
smaller size of collagen fibers in bleomycin treated dKO lungs (Figure 12B). The 
histological evidences clearly show a milder and attenuated fibrotic phenotype in 
injured Numb/Numblike dKOs. Protein analysis of collagen contents as well as 
relative mRNA expression analysis for profibrotic markers, like Col1a1, Ctgf, Tnf-
alpha or Acta2, validated reduced fibrosis at the molecular level in injured lungs 
(Figure 12D, E). In bleomycin-induced lung fibrosis of wild type mice, Ctgf level is 
strongly upregulated [228] promoted by enhanced TGF-ß cytokine release from 
damaged alveolar epithelial cells, which stimulates fibroblast to myofibroblasts 
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differentiation [71]. Moreover, TGF-ß signaling drives Tnf-alpha expression and 
secretion, which plays a crucial role in the recruitment of fibroblasts and their 
differentiation to pro-fibrotic, alpha-smooth muscle actin (Acta2) expressing 
myofibroblasts as well [62, 75]. Both, Tnf-alpha and Acta2, show an attenuated 
expression response in bleomycin treated dKO mice. In particular, Acta2 mRNA 
levels remained completely unchanged suggesting a block of excessive fibroblast 
proliferation and their differentiation to myofibroblasts after lung injury in mutants. 
Therefore, disruption of profibrotic TGF-ß signaling as a consequence of lung 
epithelial Numb and Numblike depletion might be one explanation for reduced fibrosis 
in Numb/Numblike dKO mice. Additionally, substantial evidence for an impaired 
Wnt/ß-Catenin signaling in dKOs was provided by the observation of altered Wnt-
target gene expression. Decreased ß-Catenin protein levels in dKO animals under 
basal conditions are most likely the cause of post-translational protein modifications, 
indicated by the unchanged relative ß-Catenin mRNA expression in mutant lungs 
(Figure 13B). Meanwhile, dKO lungs strikingly displayed lower Wnt-target gene 
expression in response to bleomycin treatment, whereas the expression of all tested 
targets remained unaffected under non-pathologic conditions, except the EMT 
markers Snai1 and Twist1, which can be alternatively activated by TGF-ß signaling 
[77-79] (Figure 13A). Thus, the reduction of Snai1 and Twist1 further supports 
potential impairment of the TGF-ß pathway, which is a well known mediator of 
fibrosis [227, 229]. Moreover, studies revealed a Dickkopf-1 (Dkk1) regulated 
crosstalk between both signaling pathways, TGF-ß and Wnt/ß-Catenin, particularly in 
the pathogenesis of fibrotic disease, indicating that canonical Wnt-signaling is a 
requirement for TGF-ß-mediated fibrosis [230]. However, it currently remains 
unclear, whether the loss of Numb/Numblike also directly affects TGF-ß pathway or 
if the observations only reflect indirect effects promoted by impaired Wnt/ß-Catenin 
signaling. Furthermore, Wisp1 (CCN4), a well-established Wnt-signaling downstream 
target, displayed ameliorated expression upon bleomycin treatment in our 
Numb/Numblike mutants. Wisp1 belongs to the large Ctgf (CCN2) containing CCN 
family of secreted matricellular proteins [231] and is strongly upregulated in 
bleomycin-induced pulmonary fibrosis of wild type mice as well as in IPF patients 
[62]. In further consequence, this is accompanied by an increased lung epithelial 
expression of Wnt/ß-Catenin signaling components like ß-Catenin, Gsk3-ß, Wnt 
molecules as well as Frizzled receptors during the early regeneration phase providing 
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broad evidence for activated Wnt-signaling during experimental fibrosis [62]. Under 
these conditions, Wisp1 expression is exclusively elevated in ATII cells, whereas 
fibroblasts are not affected. Based on this, it is suggested that Wisp1 secreted by ATII 
cells exerts autocrine effects by inducing proliferation as well as the expression of 
pro-fibrotic mediators like Mmp9 [62]. In addition, secreted Wisp1 induces the 
expression of pro-fibrotic genes like Col1a1, Fn1 in fibroblasts and enhances 
extracellular matrix deposition. However, neutralization of elevated Wisp1 secretion 
has been demonstrated to revert previously mentioned effects [62]. In conclusion, I 
suggest reduced fibrosis in bleomycin treated Numb/Numblike dKO animals by 
attenuated expression of Wisp1, Fn1, Col1a1 and Ctgf, while Mmp9 and Acta2 
expression even remain at unchanged levels. 
 
 
Figure 21: Decreased Wisp1 level in Numb/Numblike dKOs results in reduced lung fibrosis. 
Reduced numbers of ATII cells (green) as well as reduced ß-Catenin protein level in Numb/Numblike 
dKOs decreases Wnt-signaling activated Wisp1 secretion (red) upon bleomycin induced lung fibrosis. 
This results in reduction of fibroblast/myofibroblast (brown) activation, profibrotic marker expression, 
extracellular matrix deposition and fibrotic foci. 
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Considering elevated Wisp1 expression in ATII cells as a major trigger of fibrosis 
progression, I conclude that the reduction of ATII cells observed in Numb/Numblike 
dKOs accompanied by reduced Wisp1 expression in the remaining ATII cells upon 
bleomycin injury results in reduced global Wisp1 secretion, which correlates with 
decreased activation of profibrotic markers and hence less pronounced fibrosis 
(Figure 21). Even though this ameliorated phenotype we observe after respiratory 
injury seems to reflect secondary effects mediated by lung epithelial specific Numb 
and Numblike depletion, we propose that the epithelial loss of Numb and Numblike 
initiates these advantageous changes by impairment of canonical Wnt-signaling.    
4.3 Numb/Numblike interaction with Cortactin and CK2 
regulates cell junction complex stability in lung 
epithelial cells  
In order to investigate the impact of Numb and Numblike on cell junction 
components, double knockdown (dKD) experiments were performed in mouse lung 
epithelial MLE12 cells. Concomitant loss of Numb and Numblike protein revealed 
altered subcellular membrane distribution of E-Cadherin from predominantly 
basolateral to apicolateral. This observation reflects previous studies in polarized 
MDCKII cells showing that E-Cadherin and Numb physically interact, as previously 
mentioned, and that a loss of Numb results in an equivalent E-Cadherin 
mislocalization [10]. Besides that, altered E-Cadherin localization in Numb/Numblike 
dKD MLE12 cells matched perfectly with the in vivo findings revealing apicolateral 
shift of E-Cadherin in Numb/Numblike dKO lung epithelium. Since E-Cadherin is 
known to directly interact with ß-Catenin within an adherens junction protein 
complex during maintenance of cell-cell contacts, we addressed the question if E-
Cadherin mislocalization simultaneously affects subcellular localization of ß-Catenin 
as previously shown in MDCKII cells [10]. Furthermore, translocation of ß-Catenin in 
Numb/Numblike dKD MLE12 cells from basolateral to apicolateral (Figure 14E) 
additionally confirmed our in vivo observations displaying apicolateral accumulation 
of ß-Catenin in dKO lung epithelium. Moreover, Numb/Numblike dKD MLE12 cells 
displayed profound reduction of both total (pan) and “activated”, non-phosphorylated 
ß-Catenin suggesting a disruption of ß-Catenin transactivation potential in the nucleus 
and thereby an inhibition of Wnt-signaling (Figure 15A, B) [232]. Unaltered relative 
DISCUSSION 
 115 
mRNA expression of ß-Catenin in both double knockdown MLE12 cells as well as 
dKO lungs strongly argued for a reduction of ß-Catenin protein levels by post-
translational regulation. This hypothesis was corroborated by GSK3-ß inhibitors (SB-
216763 [160] and lithium chloride (LiCl) [159]) treated MLE12 cells mimicking Wnt-
signaling activation. GSK3-ß inhibition restored the reduced active and pan-ß-Catenin 
protein levels in Numb/Numblike dKD cells to the level of untreated controls (Figure 
15B). However, decreased ß-Catenin levels in untreated dKD cells affected only a 
subset of Wnt-downstream target genes on the transcriptional level. Well-established 
targets like Wisp1, CyclinD1 and Mmp2 revealed significantly reduced levels in 
untreated Numb/Numblike dKD cells, whereas  Axin1/2, Snai1, cMyc, Brachyury2 and 
Mmp9 expression remained unexpectedly unchanged (Figure 15C). Hence, these 
divergent alterations argued either for compensational crosstalk with other signaling 
pathways or for residual ß-Catenin activity in dKD cells, which might be sufficient to 
promote efficient target gene expression. Taken together, I conclude that ß-Catenin 
mediated transcriptional activation is partially disrupted upon concomitant loss of 
Numb and Numblike. LiCl as well as SB-216763 treatment demonstrated reactivation 
of Wisp1 and CyclinD1 expression in double knockdown cells, whereas Mmp2 
expression remained unaffected indicating that additional signaling pathways might 
compensate for altered Wnt-signaling. Unaltered Snai1 and Mmp9 expression in dKD 
cells might be explained by compensatory activation of TGF-ß-signaling restoring the 
expression of these genes. Further evidence supporting the hypothesis of impaired 
Wnt/ß-Catenin signaling was provided by reduced Wisp1 expression levels in both the 
dKD and dKO system. As previously mentioned, secreted Wisp1 stimulates enhanced 
EMT-marker expression in ATII cells promoting transition to (myo-) fibroblasts, a 
crucial step during pulmonary fibrosis onset [62]. The decreased EMT marker 
expression in Numb/Numblike deficient cells suggests reduced susceptibility for EMT 
supporting ameliorated pulmonary fibrosis in bleomycin treated dKO animals.  
In order to gain deeper insights into functional mechanisms mediated by Numb and 
Numblike, a quantitative MS based interactome screen was performed to identify 
novel isoform-specific Numb as well as Numblike interaction partners in lung 
epithelial cells. A substantial number of enriched proteins for Numb1-4:GFP co-
immunoprecipitation included several previously reported Numb interaction partners, 
e.g. Clathrin, AP-1 complex subunits or alpha-adaptin, which are members of the 
endosomal trafficking machinery [102]. Remarkably, a small subset of these proteins, 
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e.g. AP-1 or AP-2 subunits, were additionally identified in Numblike:GFP Co-IPs as 
well.  
GO-term analysis of enriched Numb/Numblike interactors revealed a large subset of 
proteins involved in cell junction and cortical cytoskeleton maintenance, e.g. 
Vinculin, Arp2/3 as well as additional Actin-related proteins like Cortactin. The 
majority of cortical and junctional proteins, including Cortactin, Vinculin and Arp2/3 
complex units, was exclusively co-immunoprecipitated with the membrane associated 
isoforms (Numb1 or 2), whereas a small subset of Actin-related proteins was 
identified for both cytoplasmic Numb isoforms (Numb3, 4) and for Numblike as well. 
Besides the previously described Numb interaction partner E-Cadherin [10], we could 
validate Cortactin as a novel interaction partner of Numb and also Numblike by 
reciprocal co-immunoprecipitation analysis. Cortactin serves as scaffold protein in 
actin cytoskeleton organization by binding to F-actin and Arp2/3 [179]. In epithelial 
cells, Cortactin provides a platform for ß-Catenin, E-Cadherin and Vinculin 
interactions linking F-actin to the adherens junction complex [172, 178]. Based on 
these findings, we imply a potential involvement of Cortactin in Numb/Numblike 
mediated cell-cell contact organization.  
It’s well established that the SH3-domain of Drosophila and mouse Cortactin 
facilitates a direct interaction with the tight junction protein ZO-1 [233]. Based on our 
previously reported ZO-1 mislocalization and protein reduction in Numb/Numblike 
dKO lung epithelium as well as Cortactin/ZO-1 interaction in MLE12 cells, we assign 
Numb/Numblike as mediators of adherens and tight junctional cell-cell contacts. This 
hypothesis is further supported by subcellular co-localization of Numb/Numblike and 
Cortactin in MLE12 cells (Figure 19). Thereby, we demonstrated that overexpressed 
Numb1:GFP and Numb2:GFP exclusively co-localized with Cortactin in membrane-
associated speckles, whereas overexpressed Numb3:GFP, Numb4:GFP and 
Numblike:GFP overlapped with Cortactin predominantly in perinuclear speckles. 
Expectedly, shRNA mediated loss of Numb and Numblike in MLE12 cells displayed 
disruption of subcellular Cortactin localization, further suggesting Numb/Numblike 
function as adaptor proteins of Cortactin (Figure 20), which might regulate the 
stabilization of the membrane-tethered cell junction complexes. Post-translational 
modifications of Cortactin have been linked to regulate adherens junctional anchoring 
to the cytoskeleton and therefore facilitate the formation of a stable E-Cadherin-ß-
Catenin-Cortactin-Vinculin complex, which in turn is essential to link this complex to 
DISCUSSION 
 117 
the actin cytoskeleton [172]. In general, post-translational modifications of Cortactin 
play important roles in multiple actin dependent cellular processes, like the formation 
of podosomes in fibroblasts [234], of invadopodia in breast cancer cells [235], of 
Clathrin-coated pits during endosomal trafficking [236, 237] or, as previously 
mentioned, the establishment and stabilization of adhesive contact zones in epithelial 
cells [178]. Additional indication for the involvement of Numb and Numblike as 
adaptor proteins in actin mediated stabilization of epithelial cell-cell contacts was 
provided by the identification of multiple actin related proteins for all Numb isoforms 
as well as Numblike in our MS based interaction screen (Table 40). The modulation 
of Cortactin activity is mainly regulated by serine-threonine/tyrosine phosphorylation 
[172, 238] and deacetylation through Histone-deacetylase HDAC6 [175], in the latter 
case promoting Cortactin/F-actin interaction. Therefore, I suggest an enrolment of 
Numb/Numblike in orchestrating post-translational modifications of Cortactin as well 
as an indirect impact in cell-cell contact stabilization. Intriguingly, Casein-kinase II 
(CK2), a serine/threonine-kinase, which has been shown to increase HDAC6 
deacetylase activity [176], is highly enriched in the Numb/Numblike MS based 
screen. Additional validation of CK2 alpha and beta subunits by reciprocal Co-IP 
revealed physical interaction with Numb isoform 1 and 2 as well as Numblike (Figure 
18A). In conclusion, I propose here a potential mechanism for Numb and Numblike in 
the regulation of tight and adherens junction stability in lung epithelium involving 
Cortactin and CK2 (Figure 22).  
In our model we assign adaptor function to Numb isoforms 1 and 2 linking CK2 to 
the adherens junction complex (Figure 22). CK2 has been shown to phosphorylate E-
Cadherin and E-Cadherin-tethered ß-Catenin at adherens junctions facilitating a 
strong interaction of both adherens junction proteins in the complex [173, 174]. In 
particular, CK2 phosphorylation of ß-Catenin additionally supports stable interaction 
of ß-Catenin and α-Catenin, a further F-Actin linking protein in the adhesion complex 
[174]. Moreover, Numb-Cortactin interaction might substantially contribute to the 
stabilization of the actin cytoskeleton linked complex, which includes E-Cadherin, ß-
Catenin, Vinculin and α-Catenin. In such a scenario, Numb associated CK2 may 
facilitate HDAC6 mediated deacetylation of Cortactin [175], which in turn becomes 
more susceptible to associate with F-actin filaments [176]. Direct Cortactin/ZO-1 
binding may in part contribute to the organization and assembly of membrane 
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networks within tight junctions [179, 233]. Hence, due to Numb/Cortactin interaction 
I suggest that Numb might additionally facilitate ZO-1/Cortactin mediated 
organization and stabilization of tight junctions involving Cortactin deacetylation by 
HDAC6 and F-actin coupling. 
 
 
Figure 22: Potential mechanism for Numb and Numblike in regulation of cell-contact zones. 
A: In the presence of Numb and Numblike adaptor proteins, Numb interacts with E-Cadherin and 
Cortactin at adherens junctions potentially involving complexation with CK2, which promotes HDAC6 
activation and thus deacetylation of Cortactin. Consequently, F-actin binding activity of Cortactin 
increases. CK2 phosphorylation additionally strengthens interactions of E-Cadherin, ß-Catenin and α-
Catenin in the junction complex including Vinculin representing a further crucial F-actin linking 
component. Cortactin/ZO-1 association mediated by Numb and Numblike as well links tight junctions 
to the cytoskeleton supporting cell-cell contact stability. Numblike/CK2 interaction in the cytoplasm 
may as well contribute to increased Cortactin affinity for F-actin. 
 
However, Cortactin has also been identified as a component of Clathrin-coated pits in 
the process of endosomal trafficking [236, 237]. Although the involvement of Numb 
in Clathrin-mediated endosomal trafficking has been well characterized so far [164, 
165, 239], to my knowledge there has been no clear evidence directly linking 
Numblike to endocytosis. Thus, the observed Numblike/Cortactin interaction 
proposes novel regulatory functions of Numblike as a cytoplasmic adaptor protein for 
Cortactin endorsing protein shuttling to tight and adherens junctions. This 
hypothesized cytoplasmic adaptor function is further supported by multiple 
indications, like cytosolic co-localization of Numblike/Cortactin, high structural 
similarity of Numblike/Numb isoform 1 [98] and the substantial enrichment of AP-1 
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and AP-2 complex subunits in both of the MS based screens for Numb and Numblike. 
In line with suggested Numb1/2 adaptor functions of CK2 binding, we propose 
similar functions for Numblike. Numblike associated CK2 may recruit Cortactin for 
subsequent CK2 activated HDAC6 deacetylation, which consequently enhances the 
F-actin binding affinity of Cortactin [175, 176], a requirement for stabilized tight and 
adherens junctions [172, 178]. 
Based on this model, I conclude that the concomitant loss of both adaptor proteins 
Numb and Numblike in lung epithelial cells primarily compromises the establishment 
of proper cell-cell contacts by perturbing tight and adherens junctional protein 
complexes. In consequence, the disruption of these protein complexes exhibited by 
mislocalization of E-Cadherin, ß-Catenin and Cortactin, affects the maintenance of 
epithelial cell polarity and barrier function [10, 111, 240]. To date we have no 
explanation for the decline of total and active ß-Catenin protein in vivo and in vitro, 
which was accompanied by reduced Wnt/ß-Catenin target gene expression including 
Wisp1, CyclinD1, Snai1 and Twist1. Intriguingly, CK2 and GSK-3ß synergistically 
diminish the cytoplasmic ß-Catenin level in a multi-protein complex that controls ß-
Catenin degradation [174]. CK2 thereby mediates initial ß-Catenin phosphorylation, 
which subsequently facilitates ß-Catenin/GSK-3ß binding. In consequence, GSK-3ß 
phosphorylated ß-Catenin is subjected to proteasomal degradation [174]. Chemical 
GSK-3ß inhibition clearly demonstrated a restoration of the reduced total and active 
ß-Catenin protein as well as Wisp1 and CyclinD1 expression levels indicating 
enhanced GSK-3ß dependent degradation of ß-Catenin in Numb/Numblike deficient 
epithelial cells.  
Therefore, we hypothesize that Numb/Numblike interaction with CK2 might either 
influence CK2 substrate specificity or general CK2 kinase activity consequently 
regulating cytosolic ß-Catenin stability. This hypothesis is further supported by 
studies, which revealed that a down regulation of CK2-subunits (i.e. CK2-ß) in tumor 
cells correlates with an induced expression of EMT marker genes like Snai1 [177]. 
CK2-ß inactivated epithelial cells display EMT-like changes in morphology, 
increased migration, as well as anchorage-independent growth, alterations that depend 
on Snai1 induction [177]. Snai1 expression in epithelial cells is negatively regulated 
concomitantly by CK2 and GSK-3ß, which suppresses EMT and thereby maintains 
epithelial integrity [177].  
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In order to investigate potential activity changes of CK2 in Numb/Numblike deficient 
cells, I will apply a CK2 specific kinase assay in the future, which might pinpoint 
potential impairment of CK2 substrate specificity. Phospho-proteome analysis of 
Numb/Numblike dKD MLE12 cells will be utilized to elucidate alterations in the 
phosphorylation state of adherens junctional proteins. Moreover, for better 
characterization of Numb/Numblike dependent tight and adherens junction complex 
stabilization, I plan to decipher interactions between different complex components in 
more detail using quantitative Co-IP approaches in dKD MLE12 cells. 
In summary, our results demonstrated decreased epithelial integrity combined with 
altered cell polarity in Numb/Numblike deficient lung epithelium. Moreover, I 
corroborated these findings in a polarized Numb and Numblike silenced lung epithelial 
cell line and in addition to this revealed novel interaction partners of both Numb and 
Numblike, which unveiled a new potential regulatory mechanism of intracellular ß-
Catenin stability. Tight and adherens junctional organization and stabilization 
mediated by Numb, Numblike, Cortactin and CK2 interactions might involve control 
of ß-Catenin promoted signal transduction proposing a novel mechanism in cell 
junction dependent regulation of Wnt/ß-Catenin signaling. I further demonstrated 
reduced bleomycin induced fibrosis in Numb/Numblike depleted lung epithelium as a 
result of the perturbed ß-Catenin transactivation assuming canonical Wnt/ß-Catenin 
signaling as crucial trigger of pulmonary fibrosis [62, 72, 241]. Thus, interference 
with Numb/Numblike mediated ß-Catenin signaling offers a way to treat IPF in 
humans. This conclusion is also supported by studies correlating inhibition of the 
ATII cell secreted Wnt target Wisp1 with reduced lung fibrosis [62, 210, 242]. In 
order to better understand the underlying molecular mechanisms in our model, future 
work will require a more detailed characterization of Numb/Numblike mediated 
regulation of ß-Catenin stability. 
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